id	sid	tid	token	lemma	pos
dpc-4489	1	1	dermatology	dermatology	NOUN
dpc-4489	1	2	:	:	PUNCT
dpc-4489	1	3	practical	practical	ADJ
dpc-4489	1	4	and	and	CCONJ
dpc-4489	1	5	conceptual	conceptual	ADJ
dpc-4489	1	6	original	original	ADJ
dpc-4489	1	7	article	article	NOUN
dpc-4489	1	8	|	|	ADV
dpc-4489	1	9	dermatol	dermatol	ADJ
dpc-4489	1	10	pract	pract	NOUN
dpc-4489	1	11	concept	concept	NOUN
dpc-4489	1	12	.	.	PUNCT
dpc-4489	2	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	2	2	1	1	NUM
dpc-4489	2	3	might	might	AUX
dpc-4489	2	4	necrotic	necrotic	ADJ
dpc-4489	2	5	keratinocytes	keratinocyte	NOUN
dpc-4489	2	6	contribute	contribute	VERB
dpc-4489	2	7	to	to	ADP
dpc-4489	2	8	the	the	DET
dpc-4489	2	9	diagnosis	diagnosis	NOUN
dpc-4489	2	10	and	and	CCONJ
dpc-4489	2	11	pathogenesis	pathogenesis	NOUN
dpc-4489	2	12	of	of	ADP
dpc-4489	2	13	psoriasis	psoriasis	NOUN
dpc-4489	2	14	?	?	PUNCT
dpc-4489	3	1	bengü	bengü	PROPN
dpc-4489	3	2	çevirgen	çevirgen	PROPN
dpc-4489	3	3	cemil1	cemil1	PROPN
dpc-4489	3	4	,	,	PUNCT
dpc-4489	3	5	aysun	aysun	PROPN
dpc-4489	3	6	gökçe2	gökçe2	PROPN
dpc-4489	3	7	,	,	PUNCT
dpc-4489	3	8	gamze	gamze	VERB
dpc-4489	3	9	taş	taş	NOUN
dpc-4489	3	10	aygar1	aygar1	PROPN
dpc-4489	3	11	,	,	PUNCT
dpc-4489	3	12	selda	selda	PROPN
dpc-4489	3	13	pelin	pelin	PROPN
dpc-4489	3	14	kartal1	kartal1	PROPN
dpc-4489	3	15	1	1	NUM
dpc-4489	3	16	university	university	PROPN
dpc-4489	3	17	of	of	ADP
dpc-4489	3	18	health	health	PROPN
dpc-4489	3	19	sciences	sciences	PROPN
dpc-4489	3	20	,	,	PUNCT
dpc-4489	3	21	etlik	etlik	ADJ
dpc-4489	3	22	city	city	NOUN
dpc-4489	3	23	hospital	hospital	NOUN
dpc-4489	3	24	,	,	PUNCT
dpc-4489	3	25	dermatology	dermatology	NOUN
dpc-4489	3	26	clinic	clinic	NOUN
dpc-4489	3	27	,	,	PUNCT
dpc-4489	3	28	ankara	ankara	PROPN
dpc-4489	3	29	,	,	PUNCT
dpc-4489	3	30	turkey	turkey	PROPN
dpc-4489	3	31	2	2	NUM
dpc-4489	3	32	university	university	NOUN
dpc-4489	3	33	of	of	ADP
dpc-4489	3	34	health	health	PROPN
dpc-4489	3	35	sciences	sciences	PROPN
dpc-4489	3	36	,	,	PUNCT
dpc-4489	3	37	etlik	etlik	ADJ
dpc-4489	3	38	city	city	NOUN
dpc-4489	3	39	hospital	hospital	NOUN
dpc-4489	3	40	,	,	PUNCT
dpc-4489	3	41	pathology	pathology	NOUN
dpc-4489	3	42	clinic	clinic	NOUN
dpc-4489	3	43	,	,	PUNCT
dpc-4489	3	44	ankara	ankara	PROPN
dpc-4489	3	45	,	,	PUNCT
dpc-4489	3	46	turkey	turkey	PROPN
dpc-4489	3	47	key	key	ADJ
dpc-4489	3	48	words	word	NOUN
dpc-4489	3	49	:	:	PUNCT
dpc-4489	3	50	necrotic	necrotic	ADJ
dpc-4489	3	51	keratinocytes	keratinocyte	NOUN
dpc-4489	3	52	,	,	PUNCT
dpc-4489	3	53	panoptosis	panoptosis	NOUN
dpc-4489	3	54	,	,	PUNCT
dpc-4489	3	55	psoriasis	psoriasis	NOUN
dpc-4489	3	56	,	,	PUNCT
dpc-4489	3	57	psoriasiform	psoriasiform	NOUN
dpc-4489	3	58	spongiotic	spongiotic	ADJ
dpc-4489	3	59	dermatitis	dermatitis	PROPN
dpc-4489	3	60	citation	citation	NOUN
dpc-4489	3	61	:	:	PUNCT
dpc-4489	3	62	çevirgen	çevirgen	PROPN
dpc-4489	3	63	cemil	cemil	PROPN
dpc-4489	3	64	c	c	PROPN
dpc-4489	3	65	,	,	PUNCT
dpc-4489	3	66	gökçe	gökçe	PROPN
dpc-4489	3	67	a	a	PRON
dpc-4489	3	68	,	,	PUNCT
dpc-4489	3	69	taş	taş	NOUN
dpc-4489	3	70	aygar	aygar	NOUN
dpc-4489	3	71	g	g	PROPN
dpc-4489	3	72	,	,	PUNCT
dpc-4489	3	73	kartal	kartal	PROPN
dpc-4489	3	74	sp	sp	NOUN
dpc-4489	3	75	.	.	PROPN
dpc-4489	3	76	might	might	AUX
dpc-4489	3	77	necrotic	necrotic	ADJ
dpc-4489	3	78	keratinocytes	keratinocyte	NOUN
dpc-4489	3	79	contribute	contribute	VERB
dpc-4489	3	80	to	to	ADP
dpc-4489	3	81	the	the	DET
dpc-4489	3	82	diagnosis	diagnosis	NOUN
dpc-4489	3	83	and	and	CCONJ
dpc-4489	3	84	pathogenesis	pathogenesis	NOUN
dpc-4489	3	85	of	of	ADP
dpc-4489	3	86	psoriasis	psoriasis	NOUN
dpc-4489	3	87	?	?	PUNCT
dpc-4489	4	1	dermatol	dermatol	NOUN
dpc-4489	4	2	pract	pract	NOUN
dpc-4489	4	3	concept	concept	NOUN
dpc-4489	4	4	.	.	PUNCT
dpc-4489	5	1	2024;14(3):e2024213	2024;14(3):e2024213	X
dpc-4489	5	2	.	.	X
dpc-4489	5	3	doi	doi	PROPN
dpc-4489	5	4	:	:	PUNCT
dpc-4489	5	5	https://doi.org/10.5826/dpc.1403a213	https://doi.org/10.5826/dpc.1403a213	PROPN
dpc-4489	5	6	accepted	accept	VERB
dpc-4489	5	7	:	:	PUNCT
dpc-4489	5	8	june	june	PROPN
dpc-4489	5	9	23	23	NUM
dpc-4489	5	10	,	,	PUNCT
dpc-4489	5	11	2024	2024	NUM
dpc-4489	5	12	;	;	PUNCT
dpc-4489	5	13	published	publish	VERB
dpc-4489	5	14	:	:	PUNCT
dpc-4489	6	1	july	july	PROPN
dpc-4489	6	2	2024	2024	NUM
dpc-4489	6	3	copyright	copyright	NOUN
dpc-4489	6	4	:	:	PUNCT
dpc-4489	6	5	©	©	PROPN
dpc-4489	6	6	2024	2024	NUM
dpc-4489	6	7	çevirgen	çevirgen	NOUN
dpc-4489	6	8	cemil	cemil	PROPN
dpc-4489	6	9	et	et	PROPN
dpc-4489	6	10	al	al	PROPN
dpc-4489	6	11	.	.	PUNCT
dpc-4489	7	1	this	this	PRON
dpc-4489	7	2	is	be	AUX
dpc-4489	7	3	an	an	DET
dpc-4489	7	4	open	open	ADJ
dpc-4489	7	5	-	-	PUNCT
dpc-4489	7	6	access	access	NOUN
dpc-4489	7	7	article	article	NOUN
dpc-4489	7	8	distributed	distribute	VERB
dpc-4489	7	9	under	under	ADP
dpc-4489	7	10	the	the	DET
dpc-4489	7	11	terms	term	NOUN
dpc-4489	7	12	of	of	ADP
dpc-4489	7	13	the	the	DET
dpc-4489	7	14	creative	creative	ADJ
dpc-4489	7	15	commons	common	NOUN
dpc-4489	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4489	7	17	license	license	NOUN
dpc-4489	7	18	(	(	PUNCT
dpc-4489	7	19	by	by	ADP
dpc-4489	7	20	-	-	PUNCT
dpc-4489	7	21	nc-4.0	nc-4.0	NOUN
dpc-4489	7	22	)	)	PUNCT
dpc-4489	7	23	,	,	PUNCT
dpc-4489	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4489	7	25	,	,	PUNCT
dpc-4489	7	26	which	which	PRON
dpc-4489	7	27	permits	permit	VERB
dpc-4489	7	28	unrestricted	unrestricted	ADJ
dpc-4489	7	29	noncommercial	noncommercial	ADJ
dpc-4489	7	30	use	use	NOUN
dpc-4489	7	31	,	,	PUNCT
dpc-4489	7	32	distribution	distribution	NOUN
dpc-4489	7	33	,	,	PUNCT
dpc-4489	7	34	and	and	CCONJ
dpc-4489	7	35	reproduction	reproduction	NOUN
dpc-4489	7	36	in	in	ADP
dpc-4489	7	37	any	any	DET
dpc-4489	7	38	medium	medium	NOUN
dpc-4489	7	39	,	,	PUNCT
dpc-4489	7	40	provided	provide	VERB
dpc-4489	7	41	the	the	DET
dpc-4489	7	42	original	original	ADJ
dpc-4489	7	43	authors	author	NOUN
dpc-4489	7	44	and	and	CCONJ
dpc-4489	7	45	source	source	NOUN
dpc-4489	7	46	are	be	AUX
dpc-4489	7	47	credited	credit	VERB
dpc-4489	7	48	.	.	PUNCT
dpc-4489	8	1	funding	funding	NOUN
dpc-4489	8	2	:	:	PUNCT
dpc-4489	8	3	none	none	NOUN
dpc-4489	8	4	.	.	PUNCT
dpc-4489	9	1	competing	compete	VERB
dpc-4489	9	2	interests	interest	NOUN
dpc-4489	9	3	:	:	PUNCT
dpc-4489	9	4	none	none	NOUN
dpc-4489	9	5	.	.	PUNCT
dpc-4489	10	1	authorship	authorship	NOUN
dpc-4489	10	2	:	:	PUNCT
dpc-4489	10	3	all	all	DET
dpc-4489	10	4	authors	author	NOUN
dpc-4489	10	5	have	have	AUX
dpc-4489	10	6	contributed	contribute	VERB
dpc-4489	10	7	significantly	significantly	ADV
dpc-4489	10	8	to	to	ADP
dpc-4489	10	9	this	this	DET
dpc-4489	10	10	publication	publication	NOUN
dpc-4489	10	11	.	.	PUNCT
dpc-4489	11	1	corresponding	correspond	VERB
dpc-4489	11	2	author	author	NOUN
dpc-4489	11	3	:	:	PUNCT
dpc-4489	11	4	çevirgen	çevirgen	PROPN
dpc-4489	11	5	cemil	cemil	PROPN
dpc-4489	11	6	bengü	bengü	PROPN
dpc-4489	11	7	,	,	PUNCT
dpc-4489	11	8	university	university	NOUN
dpc-4489	11	9	of	of	ADP
dpc-4489	11	10	health	health	PROPN
dpc-4489	11	11	sciences	sciences	PROPN
dpc-4489	11	12	,	,	PUNCT
dpc-4489	11	13	etlik	etlik	ADJ
dpc-4489	11	14	city	city	NOUN
dpc-4489	11	15	hospital	hospital	NOUN
dpc-4489	11	16	,	,	PUNCT
dpc-4489	11	17	dermatology	dermatology	NOUN
dpc-4489	11	18	clinic	clinic	NOUN
dpc-4489	11	19	,	,	PUNCT
dpc-4489	11	20	ankara	ankara	PROPN
dpc-4489	11	21	,	,	PUNCT
dpc-4489	11	22	turkey	turkey	PROPN
dpc-4489	11	23	,	,	PUNCT
dpc-4489	11	24	+905336296195	+905336296195	NOUN
dpc-4489	11	25	.	.	PUNCT
dpc-4489	12	1	email	email	NOUN
dpc-4489	12	2	:	:	PUNCT
dpc-4489	13	1	dbcemil@yahoo.com	dbcemil@yahoo.com	X
dpc-4489	13	2	introduction	introduction	NOUN
dpc-4489	13	3	:	:	PUNCT
dpc-4489	13	4	psoriasis	psoriasis	NOUN
dpc-4489	13	5	is	be	AUX
dpc-4489	13	6	a	a	DET
dpc-4489	13	7	chronic	chronic	ADJ
dpc-4489	13	8	inflammatory	inflammatory	ADJ
dpc-4489	13	9	skin	skin	NOUN
dpc-4489	13	10	disease	disease	NOUN
dpc-4489	13	11	that	that	PRON
dpc-4489	13	12	can	can	AUX
dpc-4489	13	13	pose	pose	VERB
dpc-4489	13	14	challenges	challenge	NOUN
dpc-4489	13	15	for	for	ADP
dpc-4489	13	16	histopathological	histopathological	ADJ
dpc-4489	13	17	diagnosis	diagnosis	NOUN
dpc-4489	13	18	.	.	PUNCT
dpc-4489	14	1	recent	recent	ADJ
dpc-4489	14	2	research	research	NOUN
dpc-4489	14	3	has	have	AUX
dpc-4489	14	4	emphasized	emphasize	VERB
dpc-4489	14	5	the	the	DET
dpc-4489	14	6	importance	importance	NOUN
dpc-4489	14	7	of	of	ADP
dpc-4489	14	8	necrotic	necrotic	ADJ
dpc-4489	14	9	keratinocytes	keratinocyte	NOUN
dpc-4489	14	10	,	,	PUNCT
dpc-4489	14	11	meaning	mean	VERB
dpc-4489	14	12	keratinocytes	keratinocyte	NOUN
dpc-4489	14	13	undergoing	undergo	VERB
dpc-4489	14	14	programmed	programmed	ADJ
dpc-4489	14	15	cell	cell	NOUN
dpc-4489	14	16	death	death	NOUN
dpc-4489	14	17	,	,	PUNCT
dpc-4489	14	18	for	for	ADP
dpc-4489	14	19	diagnosing	diagnose	VERB
dpc-4489	14	20	psoriasis	psoriasis	NOUN
dpc-4489	14	21	.	.	PUNCT
dpc-4489	15	1	it	it	PRON
dpc-4489	15	2	has	have	AUX
dpc-4489	15	3	also	also	ADV
dpc-4489	15	4	become	become	VERB
dpc-4489	15	5	increasingly	increasingly	ADV
dpc-4489	15	6	evident	evident	ADJ
dpc-4489	15	7	that	that	SCONJ
dpc-4489	15	8	programmed	program	VERB
dpc-4489	15	9	cell	cell	NOUN
dpc-4489	15	10	death	death	NOUN
dpc-4489	15	11	pathways	pathway	NOUN
dpc-4489	15	12	play	play	VERB
dpc-4489	15	13	a	a	DET
dpc-4489	15	14	significant	significant	ADJ
dpc-4489	15	15	role	role	NOUN
dpc-4489	15	16	in	in	ADP
dpc-4489	15	17	psoriasis	psoriasis	NOUN
dpc-4489	15	18	’s	’s	PART
dpc-4489	15	19	pathogenesis	pathogenesis	NOUN
dpc-4489	15	20	,	,	PUNCT
dpc-4489	15	21	development	development	NOUN
dpc-4489	15	22	,	,	PUNCT
dpc-4489	15	23	and	and	CCONJ
dpc-4489	15	24	progression	progression	NOUN
dpc-4489	15	25	,	,	PUNCT
dpc-4489	15	26	including	include	VERB
dpc-4489	15	27	via	via	ADP
dpc-4489	15	28	a	a	DET
dpc-4489	15	29	recently	recently	ADV
dpc-4489	15	30	identified	identify	VERB
dpc-4489	15	31	programmed	program	VERB
dpc-4489	15	32	cell	cell	NOUN
dpc-4489	15	33	death	death	NOUN
dpc-4489	15	34	mechanism	mechanism	NOUN
dpc-4489	15	35	called	call	VERB
dpc-4489	15	36	“	"	PUNCT
dpc-4489	15	37	panoptosis	panoptosis	NOUN
dpc-4489	15	38	.	.	PUNCT
dpc-4489	15	39	”	"	PUNCT
dpc-4489	16	1	objectives	objective	NOUN
dpc-4489	16	2	:	:	PUNCT
dpc-4489	16	3	in	in	ADP
dpc-4489	16	4	our	our	PRON
dpc-4489	16	5	study	study	NOUN
dpc-4489	16	6	,	,	PUNCT
dpc-4489	16	7	we	we	PRON
dpc-4489	16	8	aimed	aim	VERB
dpc-4489	16	9	to	to	PART
dpc-4489	16	10	investigate	investigate	VERB
dpc-4489	16	11	the	the	DET
dpc-4489	16	12	significance	significance	NOUN
dpc-4489	16	13	of	of	ADP
dpc-4489	16	14	necrotic	necrotic	ADJ
dpc-4489	16	15	keratinocytes	keratinocyte	NOUN
dpc-4489	16	16	in	in	ADP
dpc-4489	16	17	both	both	CCONJ
dpc-4489	16	18	the	the	DET
dpc-4489	16	19	diagnosis	diagnosis	NOUN
dpc-4489	16	20	and	and	CCONJ
dpc-4489	16	21	pathogenesis	pathogenesis	NOUN
dpc-4489	16	22	of	of	ADP
dpc-4489	16	23	psoriasis	psoriasis	NOUN
dpc-4489	16	24	.	.	PUNCT
dpc-4489	17	1	methods	method	NOUN
dpc-4489	17	2	:	:	PUNCT
dpc-4489	17	3	we	we	PRON
dpc-4489	17	4	analyzed	analyze	VERB
dpc-4489	17	5	the	the	DET
dpc-4489	17	6	number	number	NOUN
dpc-4489	17	7	of	of	ADP
dpc-4489	17	8	necrotic	necrotic	ADJ
dpc-4489	17	9	keratinocytes	keratinocyte	NOUN
dpc-4489	17	10	in	in	ADP
dpc-4489	17	11	135	135	NUM
dpc-4489	17	12	samples	sample	NOUN
dpc-4489	17	13	of	of	ADP
dpc-4489	17	14	psoriasis	psoriasis	NOUN
dpc-4489	17	15	,	,	PUNCT
dpc-4489	17	16	57	57	NUM
dpc-4489	17	17	samples	sample	NOUN
dpc-4489	17	18	of	of	ADP
dpc-4489	17	19	psoriasiform	psoriasiform	NOUN
dpc-4489	17	20	spongiotic	spongiotic	PROPN
dpc-4489	17	21	dermatitis	dermatitis	PROPN
dpc-4489	17	22	,	,	PUNCT
dpc-4489	17	23	and	and	CCONJ
dpc-4489	17	24	71	71	NUM
dpc-4489	17	25	samples	sample	NOUN
dpc-4489	17	26	of	of	ADP
dpc-4489	17	27	normal	normal	ADJ
dpc-4489	17	28	skin	skin	NOUN
dpc-4489	17	29	.	.	PUNCT
dpc-4489	18	1	we	we	PRON
dpc-4489	18	2	additionally	additionally	ADV
dpc-4489	18	3	assessed	assess	VERB
dpc-4489	18	4	the	the	DET
dpc-4489	18	5	distribution	distribution	NOUN
dpc-4489	18	6	of	of	ADP
dpc-4489	18	7	necrotic	necrotic	ADJ
dpc-4489	18	8	keratinocytes	keratinocyte	NOUN
dpc-4489	18	9	in	in	ADP
dpc-4489	18	10	the	the	DET
dpc-4489	18	11	upper	upper	ADJ
dpc-4489	18	12	,	,	PUNCT
dpc-4489	18	13	middle	middle	ADJ
dpc-4489	18	14	,	,	PUNCT
dpc-4489	18	15	and	and	CCONJ
dpc-4489	18	16	lower	low	ADJ
dpc-4489	18	17	thirds	third	NOUN
dpc-4489	18	18	of	of	ADP
dpc-4489	18	19	the	the	DET
dpc-4489	18	20	epidermis	epidermis	NOUN
dpc-4489	18	21	.	.	PUNCT
dpc-4489	19	1	results	result	NOUN
dpc-4489	19	2	:	:	PUNCT
dpc-4489	19	3	our	our	PRON
dpc-4489	19	4	findings	finding	NOUN
dpc-4489	19	5	revealed	reveal	VERB
dpc-4489	19	6	a	a	DET
dpc-4489	19	7	significant	significant	ADJ
dpc-4489	19	8	difference	difference	NOUN
dpc-4489	19	9	in	in	ADP
dpc-4489	19	10	the	the	DET
dpc-4489	19	11	total	total	ADJ
dpc-4489	19	12	number	number	NOUN
dpc-4489	19	13	of	of	ADP
dpc-4489	19	14	necrotic	necrotic	ADJ
dpc-4489	19	15	keratinocytes	keratinocyte	NOUN
dpc-4489	19	16	and	and	CCONJ
dpc-4489	19	17	their	their	PRON
dpc-4489	19	18	distribution	distribution	NOUN
dpc-4489	19	19	within	within	ADP
dpc-4489	19	20	epidermal	epidermal	ADJ
dpc-4489	19	21	regions	region	NOUN
dpc-4489	19	22	between	between	ADP
dpc-4489	19	23	patients	patient	NOUN
dpc-4489	19	24	with	with	ADP
dpc-4489	19	25	psoriasis	psoriasis	NOUN
dpc-4489	19	26	and	and	CCONJ
dpc-4489	19	27	both	both	CCONJ
dpc-4489	19	28	the	the	DET
dpc-4489	19	29	psoriasiform	psoriasiform	NOUN
dpc-4489	19	30	spongiotic	spongiotic	PROPN
dpc-4489	19	31	dermatitis	dermatitis	PROPN
dpc-4489	19	32	and	and	CCONJ
dpc-4489	19	33	control	control	NOUN
dpc-4489	19	34	groups	group	NOUN
dpc-4489	19	35	(	(	PUNCT
dpc-4489	19	36	p	p	X
dpc-4489	19	37	<	<	X
dpc-4489	19	38	.001	.001	NUM
dpc-4489	19	39	)	)	PUNCT
dpc-4489	19	40	.	.	PUNCT
dpc-4489	20	1	in	in	ADP
dpc-4489	20	2	particular	particular	ADJ
dpc-4489	20	3	,	,	PUNCT
dpc-4489	20	4	necrotic	necrotic	ADJ
dpc-4489	20	5	keratinocytes	keratinocyte	NOUN
dpc-4489	20	6	were	be	AUX
dpc-4489	20	7	predominantly	predominantly	ADV
dpc-4489	20	8	found	find	VERB
dpc-4489	20	9	in	in	ADP
dpc-4489	20	10	the	the	DET
dpc-4489	20	11	upper	upper	ADJ
dpc-4489	20	12	epidermis	epidermis	NOUN
dpc-4489	20	13	(	(	PUNCT
dpc-4489	20	14	77.5	77.5	NUM
dpc-4489	20	15	%	%	NOUN
dpc-4489	20	16	)	)	PUNCT
dpc-4489	20	17	in	in	ADP
dpc-4489	20	18	patients	patient	NOUN
dpc-4489	20	19	with	with	ADP
dpc-4489	20	20	psoriasis	psoriasis	NOUN
dpc-4489	20	21	.	.	PUNCT
dpc-4489	21	1	we	we	PRON
dpc-4489	21	2	also	also	ADV
dpc-4489	21	3	observed	observe	VERB
dpc-4489	21	4	a	a	DET
dpc-4489	21	5	strong	strong	ADJ
dpc-4489	21	6	correlation	correlation	NOUN
dpc-4489	21	7	between	between	ADP
dpc-4489	21	8	psoriasis	psoriasis	NOUN
dpc-4489	21	9	area	area	NOUN
dpc-4489	21	10	and	and	CCONJ
dpc-4489	21	11	severity	severity	NOUN
dpc-4489	21	12	index	index	NOUN
dpc-4489	21	13	scores	score	NOUN
dpc-4489	21	14	and	and	CCONJ
dpc-4489	21	15	the	the	DET
dpc-4489	21	16	total	total	ADJ
dpc-4489	21	17	count	count	NOUN
dpc-4489	21	18	of	of	ADP
dpc-4489	21	19	necrotic	necrotic	ADJ
dpc-4489	21	20	keratinocytes	keratinocyte	NOUN
dpc-4489	21	21	in	in	ADP
dpc-4489	21	22	patients	patient	NOUN
dpc-4489	21	23	with	with	ADP
dpc-4489	21	24	psoriasis	psoriasis	NOUN
dpc-4489	21	25	(	(	PUNCT
dpc-4489	21	26	r	r	NOUN
dpc-4489	21	27	=	=	SYM
dpc-4489	21	28	.72	.72	NUM
dpc-4489	21	29	)	)	PUNCT
dpc-4489	21	30	.	.	PUNCT
dpc-4489	22	1	conclusions	conclusion	NOUN
dpc-4489	22	2	:	:	PUNCT
dpc-4489	22	3	our	our	PRON
dpc-4489	22	4	results	result	NOUN
dpc-4489	22	5	highlight	highlight	VERB
dpc-4489	22	6	the	the	DET
dpc-4489	22	7	role	role	NOUN
dpc-4489	22	8	of	of	ADP
dpc-4489	22	9	necrotic	necrotic	ADJ
dpc-4489	22	10	keratinocytes	keratinocyte	NOUN
dpc-4489	22	11	,	,	PUNCT
dpc-4489	22	12	resulting	result	VERB
dpc-4489	22	13	from	from	ADP
dpc-4489	22	14	programmed	program	VERB
dpc-4489	22	15	cell	cell	NOUN
dpc-4489	22	16	death	death	NOUN
dpc-4489	22	17	,	,	PUNCT
dpc-4489	22	18	as	as	ADP
dpc-4489	22	19	important	important	ADJ
dpc-4489	22	20	marker	marker	NOUN
dpc-4489	22	21	cells	cell	NOUN
dpc-4489	22	22	in	in	ADP
dpc-4489	22	23	both	both	CCONJ
dpc-4489	22	24	the	the	DET
dpc-4489	22	25	diagnosis	diagnosis	NOUN
dpc-4489	22	26	and	and	CCONJ
dpc-4489	22	27	pathogenesis	pathogenesis	NOUN
dpc-4489	22	28	of	of	ADP
dpc-4489	22	29	psoriasis	psoriasis	NOUN
dpc-4489	22	30	.	.	PUNCT
dpc-4489	23	1	abstract	abstract	ADJ
dpc-4489	23	2	2	2	NUM
dpc-4489	23	3	original	original	ADJ
dpc-4489	23	4	article	article	NOUN
dpc-4489	23	5	|	|	ADV
dpc-4489	23	6	dermatol	dermatol	ADJ
dpc-4489	23	7	pract	pract	NOUN
dpc-4489	23	8	concept	concept	NOUN
dpc-4489	23	9	.	.	PUNCT
dpc-4489	24	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	24	2	introduction	introduction	NOUN
dpc-4489	24	3	psoriasis	psoriasis	NOUN
dpc-4489	24	4	,	,	PUNCT
dpc-4489	24	5	a	a	DET
dpc-4489	24	6	chronic	chronic	ADJ
dpc-4489	24	7	inflammatory	inflammatory	ADJ
dpc-4489	24	8	skin	skin	NOUN
dpc-4489	24	9	disease	disease	NOUN
dpc-4489	24	10	that	that	PRON
dpc-4489	24	11	occurs	occur	VERB
dpc-4489	24	12	worldwide	worldwide	ADV
dpc-4489	24	13	,	,	PUNCT
dpc-4489	24	14	is	be	AUX
dpc-4489	24	15	associated	associate	VERB
dpc-4489	24	16	with	with	ADP
dpc-4489	24	17	multiple	multiple	ADJ
dpc-4489	24	18	systemic	systemic	ADJ
dpc-4489	24	19	complications	complication	NOUN
dpc-4489	24	20	that	that	PRON
dpc-4489	24	21	significantly	significantly	ADV
dpc-4489	24	22	impact	impact	VERB
dpc-4489	24	23	patients	patient	NOUN
dpc-4489	24	24	’	'	PUNCT
dpc-4489	24	25	quality	quality	NOUN
dpc-4489	24	26	of	of	ADP
dpc-4489	24	27	life	life	NOUN
dpc-4489	24	28	as	as	ADV
dpc-4489	24	29	well	well	ADV
dpc-4489	24	30	as	as	ADP
dpc-4489	24	31	physical	physical	ADJ
dpc-4489	24	32	and	and	CCONJ
dpc-4489	24	33	mental	mental	ADJ
dpc-4489	24	34	health	health	NOUN
dpc-4489	24	35	[	[	X
dpc-4489	24	36	1	1	NUM
dpc-4489	24	37	]	]	PUNCT
dpc-4489	24	38	.	.	PUNCT
dpc-4489	25	1	many	many	ADJ
dpc-4489	25	2	efforts	effort	NOUN
dpc-4489	25	3	have	have	AUX
dpc-4489	25	4	been	be	AUX
dpc-4489	25	5	devoted	devote	VERB
dpc-4489	25	6	to	to	ADP
dpc-4489	25	7	understanding	understand	VERB
dpc-4489	25	8	the	the	DET
dpc-4489	25	9	primary	primary	ADJ
dpc-4489	25	10	pathogenic	pathogenic	ADJ
dpc-4489	25	11	mechanisms	mechanism	NOUN
dpc-4489	25	12	and	and	CCONJ
dpc-4489	25	13	cellular	cellular	ADJ
dpc-4489	25	14	components	component	NOUN
dpc-4489	25	15	responsible	responsible	ADJ
dpc-4489	25	16	for	for	ADP
dpc-4489	25	17	the	the	DET
dpc-4489	25	18	onset	onset	NOUN
dpc-4489	25	19	of	of	ADP
dpc-4489	25	20	psoriasis	psoriasis	NOUN
dpc-4489	25	21	[	[	X
dpc-4489	25	22	2	2	NUM
dpc-4489	25	23	]	]	PUNCT
dpc-4489	25	24	,	,	PUNCT
dpc-4489	25	25	the	the	DET
dpc-4489	25	26	pathogenesis	pathogenesis	NOUN
dpc-4489	25	27	of	of	ADP
dpc-4489	25	28	which	which	PRON
dpc-4489	25	29	is	be	AUX
dpc-4489	25	30	known	know	VERB
dpc-4489	25	31	to	to	PART
dpc-4489	25	32	be	be	AUX
dpc-4489	25	33	influenced	influence	VERB
dpc-4489	25	34	by	by	ADP
dpc-4489	25	35	factors	factor	NOUN
dpc-4489	25	36	including	include	VERB
dpc-4489	25	37	the	the	DET
dpc-4489	25	38	environment	environment	NOUN
dpc-4489	25	39	,	,	PUNCT
dpc-4489	25	40	genetics	genetic	NOUN
dpc-4489	25	41	,	,	PUNCT
dpc-4489	25	42	and	and	CCONJ
dpc-4489	25	43	the	the	DET
dpc-4489	25	44	dysfunction	dysfunction	NOUN
dpc-4489	25	45	of	of	ADP
dpc-4489	25	46	immune	immune	ADJ
dpc-4489	25	47	cells	cell	NOUN
dpc-4489	25	48	such	such	ADJ
dpc-4489	25	49	as	as	ADP
dpc-4489	25	50	t	t	PROPN
dpc-4489	25	51	cells	cell	NOUN
dpc-4489	25	52	and	and	CCONJ
dpc-4489	25	53	dendritic	dendritic	ADJ
dpc-4489	25	54	cells	cell	NOUN
dpc-4489	25	55	as	as	ADV
dpc-4489	25	56	well	well	ADV
dpc-4489	25	57	as	as	ADP
dpc-4489	25	58	nonimmune	nonimmune	ADJ
dpc-4489	25	59	cells	cell	NOUN
dpc-4489	25	60	such	such	ADJ
dpc-4489	25	61	as	as	ADP
dpc-4489	25	62	keratinocytes	keratinocyte	NOUN
dpc-4489	25	63	[	[	X
dpc-4489	25	64	1	1	NUM
dpc-4489	25	65	]	]	PUNCT
dpc-4489	25	66	.	.	PUNCT
dpc-4489	26	1	in	in	ADP
dpc-4489	26	2	the	the	DET
dpc-4489	26	3	longstanding	longstanding	ADJ
dpc-4489	26	4	debate	debate	NOUN
dpc-4489	26	5	on	on	ADP
dpc-4489	26	6	the	the	DET
dpc-4489	26	7	pathogenic	pathogenic	ADJ
dpc-4489	26	8	role	role	NOUN
dpc-4489	26	9	of	of	ADP
dpc-4489	26	10	keratinocytes	keratinocyte	NOUN
dpc-4489	26	11	in	in	ADP
dpc-4489	26	12	psoriasis	psoriasis	NOUN
dpc-4489	26	13	,	,	PUNCT
dpc-4489	26	14	extensive	extensive	ADJ
dpc-4489	26	15	research	research	NOUN
dpc-4489	26	16	has	have	AUX
dpc-4489	26	17	indicated	indicate	VERB
dpc-4489	26	18	that	that	SCONJ
dpc-4489	26	19	the	the	DET
dpc-4489	26	20	hyperproliferation	hyperproliferation	NOUN
dpc-4489	26	21	and	and	CCONJ
dpc-4489	26	22	abnormal	abnormal	ADJ
dpc-4489	26	23	differentiation	differentiation	NOUN
dpc-4489	26	24	of	of	ADP
dpc-4489	26	25	keratinocytes	keratinocyte	NOUN
dpc-4489	26	26	are	be	AUX
dpc-4489	26	27	secondary	secondary	ADJ
dpc-4489	26	28	effects	effect	NOUN
dpc-4489	26	29	triggered	trigger	VERB
dpc-4489	26	30	by	by	ADP
dpc-4489	26	31	immune	immune	ADJ
dpc-4489	26	32	activation	activation	NOUN
dpc-4489	26	33	.	.	PUNCT
dpc-4489	27	1	while	while	SCONJ
dpc-4489	27	2	the	the	DET
dpc-4489	27	3	immune	immune	ADJ
dpc-4489	27	4	hypothesis	hypothesis	NOUN
dpc-4489	27	5	,	,	PUNCT
dpc-4489	27	6	which	which	PRON
dpc-4489	27	7	focuses	focus	VERB
dpc-4489	27	8	on	on	ADP
dpc-4489	27	9	the	the	DET
dpc-4489	27	10	pathogenic	pathogenic	ADJ
dpc-4489	27	11	functions	function	NOUN
dpc-4489	27	12	of	of	ADP
dpc-4489	27	13	dendritic	dendritic	ADJ
dpc-4489	27	14	cells	cell	NOUN
dpc-4489	27	15	and	and	CCONJ
dpc-4489	27	16	t	t	NOUN
dpc-4489	27	17	cells	cell	NOUN
dpc-4489	27	18	,	,	PUNCT
dpc-4489	27	19	has	have	AUX
dpc-4489	27	20	been	be	AUX
dpc-4489	27	21	supported	support	VERB
dpc-4489	27	22	by	by	ADP
dpc-4489	27	23	the	the	DET
dpc-4489	27	24	efficacy	efficacy	NOUN
dpc-4489	27	25	of	of	ADP
dpc-4489	27	26	immunetargeting	immunetargete	VERB
dpc-4489	27	27	treatments	treatment	NOUN
dpc-4489	27	28	,	,	PUNCT
dpc-4489	27	29	psoriasis	psoriasis	NOUN
dpc-4489	27	30	is	be	AUX
dpc-4489	27	31	recognized	recognize	VERB
dpc-4489	27	32	as	as	ADP
dpc-4489	27	33	being	be	AUX
dpc-4489	27	34	not	not	PART
dpc-4489	27	35	only	only	ADV
dpc-4489	27	36	a	a	DET
dpc-4489	27	37	t	t	NOUN
dpc-4489	27	38	-	-	PUNCT
dpc-4489	27	39	cell	cell	NOUN
dpc-4489	27	40	-	-	PUNCT
dpc-4489	27	41	dependent	dependent	ADJ
dpc-4489	27	42	disease	disease	NOUN
dpc-4489	27	43	.	.	PUNCT
dpc-4489	28	1	on	on	ADP
dpc-4489	28	2	that	that	DET
dpc-4489	28	3	count	count	NOUN
dpc-4489	28	4	,	,	PUNCT
dpc-4489	28	5	it	it	PRON
dpc-4489	28	6	is	be	AUX
dpc-4489	28	7	now	now	ADV
dpc-4489	28	8	widely	widely	ADV
dpc-4489	28	9	acknowledged	acknowledge	VERB
dpc-4489	28	10	that	that	SCONJ
dpc-4489	28	11	keratinocytes	keratinocyte	NOUN
dpc-4489	28	12	play	play	VERB
dpc-4489	28	13	a	a	DET
dpc-4489	28	14	pivotal	pivotal	ADJ
dpc-4489	28	15	role	role	NOUN
dpc-4489	28	16	in	in	ADP
dpc-4489	28	17	initiating	initiate	VERB
dpc-4489	28	18	early	early	ADJ
dpc-4489	28	19	pathogenic	pathogenic	ADJ
dpc-4489	28	20	events	event	NOUN
dpc-4489	28	21	and	and	CCONJ
dpc-4489	28	22	sustaining	sustain	VERB
dpc-4489	28	23	the	the	DET
dpc-4489	28	24	disease	disease	NOUN
dpc-4489	28	25	’s	’s	PART
dpc-4489	28	26	chronic	chronic	ADJ
dpc-4489	28	27	progression	progression	NOUN
dpc-4489	29	1	[	[	X
dpc-4489	29	2	2	2	NUM
dpc-4489	29	3	]	]	PUNCT
dpc-4489	29	4	.	.	PUNCT
dpc-4489	30	1	in	in	ADP
dpc-4489	30	2	psoriasis	psoriasis	NOUN
dpc-4489	30	3	,	,	PUNCT
dpc-4489	30	4	the	the	DET
dpc-4489	30	5	breakdown	breakdown	NOUN
dpc-4489	30	6	of	of	ADP
dpc-4489	30	7	the	the	DET
dpc-4489	30	8	epidermal	epidermal	ADJ
dpc-4489	30	9	barrier	barrier	NOUN
dpc-4489	30	10	heightens	heighten	VERB
dpc-4489	30	11	the	the	DET
dpc-4489	30	12	susceptibility	susceptibility	NOUN
dpc-4489	30	13	of	of	ADP
dpc-4489	30	14	keratinocytes	keratinocyte	NOUN
dpc-4489	30	15	to	to	ADP
dpc-4489	30	16	external	external	ADJ
dpc-4489	30	17	harmful	harmful	ADJ
dpc-4489	30	18	substances	substance	NOUN
dpc-4489	30	19	,	,	PUNCT
dpc-4489	30	20	which	which	PRON
dpc-4489	30	21	can	can	AUX
dpc-4489	30	22	result	result	VERB
dpc-4489	30	23	in	in	ADP
dpc-4489	30	24	cell	cell	NOUN
dpc-4489	30	25	damage	damage	NOUN
dpc-4489	30	26	or	or	CCONJ
dpc-4489	30	27	death	death	NOUN
dpc-4489	31	1	[	[	X
dpc-4489	31	2	3	3	NUM
dpc-4489	31	3	]	]	PUNCT
dpc-4489	31	4	.	.	PUNCT
dpc-4489	32	1	programmed	program	VERB
dpc-4489	32	2	cell	cell	NOUN
dpc-4489	32	3	death	death	NOUN
dpc-4489	32	4	(	(	PUNCT
dpc-4489	32	5	pcd	pcd	NOUN
dpc-4489	32	6	)	)	PUNCT
dpc-4489	32	7	is	be	AUX
dpc-4489	32	8	a	a	DET
dpc-4489	32	9	vital	vital	ADJ
dpc-4489	32	10	process	process	NOUN
dpc-4489	32	11	during	during	ADP
dpc-4489	32	12	development	development	NOUN
dpc-4489	32	13	that	that	PRON
dpc-4489	32	14	plays	play	VERB
dpc-4489	32	15	an	an	DET
dpc-4489	32	16	important	important	ADJ
dpc-4489	32	17	role	role	NOUN
dpc-4489	32	18	in	in	ADP
dpc-4489	32	19	maintaining	maintain	VERB
dpc-4489	32	20	homeostasis	homeostasis	NOUN
dpc-4489	32	21	and	and	CCONJ
dpc-4489	32	22	defending	defend	VERB
dpc-4489	32	23	against	against	ADP
dpc-4489	32	24	various	various	ADJ
dpc-4489	32	25	pathogens	pathogen	NOUN
dpc-4489	32	26	and	and	CCONJ
dpc-4489	32	27	stimuli	stimulus	NOUN
dpc-4489	32	28	.	.	PUNCT
dpc-4489	33	1	pcd	pcd	NOUN
dpc-4489	33	2	has	have	VERB
dpc-4489	33	3	specific	specific	ADJ
dpc-4489	33	4	genetically	genetically	ADV
dpc-4489	33	5	encoded	encode	VERB
dpc-4489	33	6	requirements	requirement	NOUN
dpc-4489	33	7	[	[	X
dpc-4489	33	8	4	4	NUM
dpc-4489	33	9	]	]	PUNCT
dpc-4489	33	10	.	.	PUNCT
dpc-4489	34	1	panoptosis	panoptosis	NOUN
dpc-4489	34	2	,	,	PUNCT
dpc-4489	34	3	a	a	DET
dpc-4489	34	4	recently	recently	ADV
dpc-4489	34	5	defined	define	VERB
dpc-4489	34	6	form	form	NOUN
dpc-4489	34	7	of	of	ADP
dpc-4489	34	8	pcd	pcd	NOUN
dpc-4489	34	9	that	that	PRON
dpc-4489	34	10	has	have	AUX
dpc-4489	34	11	become	become	VERB
dpc-4489	34	12	a	a	DET
dpc-4489	34	13	new	new	ADJ
dpc-4489	34	14	focus	focus	NOUN
dpc-4489	34	15	of	of	ADP
dpc-4489	34	16	research	research	NOUN
dpc-4489	34	17	[	[	X
dpc-4489	34	18	5	5	NUM
dpc-4489	34	19	]	]	PUNCT
dpc-4489	34	20	,	,	PUNCT
dpc-4489	34	21	is	be	AUX
dpc-4489	34	22	regulated	regulate	VERB
dpc-4489	34	23	by	by	ADP
dpc-4489	34	24	the	the	DET
dpc-4489	34	25	panoptosome	panoptosome	NOUN
dpc-4489	34	26	complex	complex	NOUN
dpc-4489	34	27	,	,	PUNCT
dpc-4489	34	28	which	which	PRON
dpc-4489	34	29	entails	entail	VERB
dpc-4489	34	30	the	the	DET
dpc-4489	34	31	substantial	substantial	ADJ
dpc-4489	34	32	interaction	interaction	NOUN
dpc-4489	34	33	and	and	CCONJ
dpc-4489	34	34	coordination	coordination	NOUN
dpc-4489	34	35	of	of	ADP
dpc-4489	34	36	pyroptosis	pyroptosis	NOUN
dpc-4489	34	37	(	(	PUNCT
dpc-4489	34	38	p	p	NOUN
dpc-4489	34	39	)	)	PUNCT
dpc-4489	34	40	,	,	PUNCT
dpc-4489	34	41	apoptosis	apoptosis	NOUN
dpc-4489	34	42	(	(	PUNCT
dpc-4489	34	43	a	a	NOUN
dpc-4489	34	44	)	)	PUNCT
dpc-4489	34	45	,	,	PUNCT
dpc-4489	34	46	and/or	and/or	CCONJ
dpc-4489	34	47	necroptosis	necroptosis	NOUN
dpc-4489	34	48	(	(	PUNCT
dpc-4489	34	49	n	n	CCONJ
dpc-4489	34	50	)	)	PUNCT
dpc-4489	35	1	[	[	X
dpc-4489	35	2	4,6	4,6	X
dpc-4489	35	3	]	]	PUNCT
dpc-4489	35	4	.	.	PUNCT
dpc-4489	36	1	although	although	SCONJ
dpc-4489	36	2	the	the	DET
dpc-4489	36	3	relationship	relationship	NOUN
dpc-4489	36	4	between	between	ADP
dpc-4489	36	5	panoptosis	panoptosis	NOUN
dpc-4489	36	6	and	and	CCONJ
dpc-4489	36	7	psoriasis	psoriasis	NOUN
dpc-4489	36	8	remains	remain	VERB
dpc-4489	36	9	largely	largely	ADV
dpc-4489	36	10	unclear	unclear	ADJ
dpc-4489	36	11	,	,	PUNCT
dpc-4489	36	12	mounting	mount	VERB
dpc-4489	36	13	evidence	evidence	NOUN
dpc-4489	36	14	suggests	suggest	VERB
dpc-4489	36	15	that	that	SCONJ
dpc-4489	36	16	panoptosis	panoptosis	NOUN
dpc-4489	36	17	is	be	AUX
dpc-4489	36	18	implicated	implicate	VERB
dpc-4489	36	19	in	in	ADP
dpc-4489	36	20	pathogenesis	pathogenesis	NOUN
dpc-4489	36	21	’s	’s	PART
dpc-4489	36	22	psoriasis	psoriasis	NOUN
dpc-4489	36	23	[	[	X
dpc-4489	36	24	5,7	5,7	NUM
dpc-4489	36	25	]	]	PUNCT
dpc-4489	36	26	.	.	PUNCT
dpc-4489	37	1	programmed	program	VERB
dpc-4489	37	2	apoptosis	apoptosis	NOUN
dpc-4489	37	3	,	,	PUNCT
dpc-4489	37	4	necrosis	necrosis	NOUN
dpc-4489	37	5	,	,	PUNCT
dpc-4489	37	6	and	and	CCONJ
dpc-4489	37	7	pyroptosis	pyroptosis	NOUN
dpc-4489	37	8	have	have	AUX
dpc-4489	37	9	also	also	ADV
dpc-4489	37	10	been	be	AUX
dpc-4489	37	11	shown	show	VERB
dpc-4489	37	12	to	to	PART
dpc-4489	37	13	be	be	AUX
dpc-4489	37	14	associated	associate	VERB
dpc-4489	37	15	with	with	ADP
dpc-4489	37	16	inflammation	inflammation	NOUN
dpc-4489	37	17	in	in	ADP
dpc-4489	37	18	psoriasis	psoriasis	NOUN
dpc-4489	37	19	[	[	X
dpc-4489	37	20	5	5	NUM
dpc-4489	37	21	]	]	PUNCT
dpc-4489	37	22	.	.	PUNCT
dpc-4489	38	1	previous	previous	ADJ
dpc-4489	38	2	research	research	NOUN
dpc-4489	38	3	has	have	AUX
dpc-4489	38	4	additionally	additionally	ADV
dpc-4489	38	5	demonstrated	demonstrate	VERB
dpc-4489	38	6	that	that	SCONJ
dpc-4489	38	7	the	the	DET
dpc-4489	38	8	presence	presence	NOUN
dpc-4489	38	9	of	of	ADP
dpc-4489	38	10	necrotic	necrotic	ADJ
dpc-4489	38	11	keratinocytes	keratinocyte	NOUN
dpc-4489	38	12	,	,	PUNCT
dpc-4489	38	13	meaning	mean	VERB
dpc-4489	38	14	keratinocytes	keratinocyte	NOUN
dpc-4489	38	15	undergoing	undergo	VERB
dpc-4489	38	16	pcd	pcd	NOUN
dpc-4489	38	17	,	,	PUNCT
dpc-4489	38	18	which	which	PRON
dpc-4489	38	19	are	be	AUX
dpc-4489	38	20	not	not	PART
dpc-4489	38	21	typically	typically	ADV
dpc-4489	38	22	seen	see	VERB
dpc-4489	38	23	in	in	ADP
dpc-4489	38	24	the	the	DET
dpc-4489	38	25	classical	classical	ADJ
dpc-4489	38	26	histopathology	histopathology	NOUN
dpc-4489	38	27	of	of	ADP
dpc-4489	38	28	psoriasis	psoriasis	NOUN
dpc-4489	38	29	,	,	PUNCT
dpc-4489	38	30	is	be	AUX
dpc-4489	38	31	significant	significant	ADJ
dpc-4489	38	32	for	for	ADP
dpc-4489	38	33	the	the	DET
dpc-4489	38	34	disease	disease	NOUN
dpc-4489	38	35	’s	’s	PART
dpc-4489	38	36	diagnosis	diagnosis	NOUN
dpc-4489	39	1	[	[	X
dpc-4489	39	2	8	8	NUM
dpc-4489	39	3	]	]	PUNCT
dpc-4489	39	4	.	.	PUNCT
dpc-4489	40	1	objectives	objective	NOUN
dpc-4489	40	2	in	in	ADP
dpc-4489	40	3	our	our	PRON
dpc-4489	40	4	study	study	NOUN
dpc-4489	40	5	,	,	PUNCT
dpc-4489	40	6	we	we	PRON
dpc-4489	40	7	aimed	aim	VERB
dpc-4489	40	8	to	to	PART
dpc-4489	40	9	investigate	investigate	VERB
dpc-4489	40	10	the	the	DET
dpc-4489	40	11	role	role	NOUN
dpc-4489	40	12	of	of	ADP
dpc-4489	40	13	necrotic	necrotic	ADJ
dpc-4489	40	14	keratinocytes	keratinocyte	NOUN
dpc-4489	40	15	,	,	PUNCT
dpc-4489	40	16	which	which	PRON
dpc-4489	40	17	we	we	PRON
dpc-4489	40	18	believe	believe	VERB
dpc-4489	40	19	indicate	indicate	VERB
dpc-4489	40	20	panoptosis	panoptosis	NOUN
dpc-4489	40	21	,	,	PUNCT
dpc-4489	40	22	in	in	ADP
dpc-4489	40	23	psoriasis	psoriasis	NOUN
dpc-4489	40	24	’s	’s	PART
dpc-4489	40	25	pathogenesis	pathogenesis	NOUN
dpc-4489	40	26	and	and	CCONJ
dpc-4489	40	27	diagnosis	diagnosis	NOUN
dpc-4489	40	28	.	.	PUNCT
dpc-4489	41	1	methods	method	NOUN
dpc-4489	41	2	our	our	PRON
dpc-4489	41	3	study	study	NOUN
dpc-4489	41	4	included	include	VERB
dpc-4489	41	5	patients	patient	NOUN
dpc-4489	41	6	diagnosed	diagnose	VERB
dpc-4489	41	7	with	with	ADP
dpc-4489	41	8	psoriasis	psoriasis	NOUN
dpc-4489	41	9	and	and	CCONJ
dpc-4489	41	10	psoriasiform	psoriasiform	NOUN
dpc-4489	41	11	spongiotic	spongiotic	PROPN
dpc-4489	41	12	dermatitis	dermatitis	PROPN
dpc-4489	41	13	who	who	PRON
dpc-4489	41	14	were	be	AUX
dpc-4489	41	15	monitored	monitor	VERB
dpc-4489	41	16	at	at	ADP
dpc-4489	41	17	our	our	PRON
dpc-4489	41	18	hospital	hospital	NOUN
dpc-4489	41	19	’s	’s	PART
dpc-4489	41	20	dermatology	dermatology	NOUN
dpc-4489	41	21	clinic	clinic	NOUN
dpc-4489	41	22	from	from	ADP
dpc-4489	41	23	september	september	PROPN
dpc-4489	41	24	2021	2021	NUM
dpc-4489	41	25	to	to	ADP
dpc-4489	41	26	december	december	PROPN
dpc-4489	41	27	2022	2022	NUM
dpc-4489	41	28	.	.	PUNCT
dpc-4489	42	1	we	we	PRON
dpc-4489	42	2	recruited	recruit	VERB
dpc-4489	42	3	135	135	NUM
dpc-4489	42	4	patients	patient	NOUN
dpc-4489	42	5	diagnosed	diagnose	VERB
dpc-4489	42	6	with	with	ADP
dpc-4489	42	7	psoriasis	psoriasis	NOUN
dpc-4489	42	8	,	,	PUNCT
dpc-4489	42	9	57	57	NUM
dpc-4489	42	10	patients	patient	NOUN
dpc-4489	42	11	with	with	ADP
dpc-4489	42	12	psoriasiform	psoriasiform	PROPN
dpc-4489	42	13	spongiotic	spongiotic	PROPN
dpc-4489	42	14	dermatitis	dermatitis	PROPN
dpc-4489	42	15	,	,	PUNCT
dpc-4489	42	16	and	and	CCONJ
dpc-4489	42	17	71	71	NUM
dpc-4489	42	18	individuals	individual	NOUN
dpc-4489	42	19	with	with	ADP
dpc-4489	42	20	normal	normal	ADJ
dpc-4489	42	21	skin	skin	NOUN
dpc-4489	42	22	who	who	PRON
dpc-4489	42	23	were	be	AUX
dpc-4489	42	24	matched	match	VERB
dpc-4489	42	25	for	for	ADP
dpc-4489	42	26	age	age	NOUN
dpc-4489	42	27	and	and	CCONJ
dpc-4489	42	28	gender	gender	NOUN
dpc-4489	42	29	.	.	PUNCT
dpc-4489	43	1	psoriasis	psoriasis	NOUN
dpc-4489	43	2	and	and	CCONJ
dpc-4489	43	3	psoriasiform	psoriasiform	NOUN
dpc-4489	43	4	spongiotic	spongiotic	ADJ
dpc-4489	43	5	dermatitis	dermatitis	PROPN
dpc-4489	43	6	skin	skin	NOUN
dpc-4489	43	7	biopsies	biopsy	NOUN
dpc-4489	43	8	were	be	AUX
dpc-4489	43	9	compiled	compile	VERB
dpc-4489	43	10	from	from	ADP
dpc-4489	43	11	archival	archival	NOUN
dpc-4489	43	12	specimens	specimen	NOUN
dpc-4489	43	13	,	,	PUNCT
dpc-4489	43	14	whereas	whereas	SCONJ
dpc-4489	43	15	normal	normal	ADJ
dpc-4489	43	16	skin	skin	NOUN
dpc-4489	43	17	biopsies	biopsy	NOUN
dpc-4489	43	18	were	be	AUX
dpc-4489	43	19	prospectively	prospectively	ADV
dpc-4489	43	20	obtained	obtain	VERB
dpc-4489	43	21	as	as	ADP
dpc-4489	43	22	a	a	DET
dpc-4489	43	23	control	control	NOUN
dpc-4489	43	24	group	group	NOUN
dpc-4489	43	25	.	.	PUNCT
dpc-4489	44	1	the	the	DET
dpc-4489	44	2	samples	sample	NOUN
dpc-4489	44	3	of	of	ADP
dpc-4489	44	4	the	the	DET
dpc-4489	44	5	control	control	NOUN
dpc-4489	44	6	group	group	NOUN
dpc-4489	44	7	were	be	AUX
dpc-4489	44	8	obtained	obtain	VERB
dpc-4489	44	9	from	from	ADP
dpc-4489	44	10	the	the	DET
dpc-4489	44	11	skin	skin	NOUN
dpc-4489	44	12	tissue	tissue	NOUN
dpc-4489	44	13	materials	material	NOUN
dpc-4489	44	14	accepted	accept	VERB
dpc-4489	44	15	to	to	ADP
dpc-4489	44	16	the	the	DET
dpc-4489	44	17	pathology	pathology	NOUN
dpc-4489	44	18	laboratory	laboratory	NOUN
dpc-4489	44	19	that	that	PRON
dpc-4489	44	20	did	do	AUX
dpc-4489	44	21	not	not	PART
dpc-4489	44	22	contain	contain	VERB
dpc-4489	44	23	any	any	DET
dpc-4489	44	24	skin	skin	NOUN
dpc-4489	44	25	lesions	lesion	NOUN
dpc-4489	44	26	.	.	PUNCT
dpc-4489	45	1	for	for	ADP
dpc-4489	45	2	the	the	DET
dpc-4489	45	3	group	group	NOUN
dpc-4489	45	4	of	of	ADP
dpc-4489	45	5	patients	patient	NOUN
dpc-4489	45	6	with	with	ADP
dpc-4489	45	7	psoriasis	psoriasis	NOUN
dpc-4489	45	8	and	and	CCONJ
dpc-4489	45	9	psoriasiform	psoriasiform	NOUN
dpc-4489	45	10	spongiotic	spongiotic	PROPN
dpc-4489	45	11	dermatitis	dermatitis	PROPN
dpc-4489	45	12	,	,	PUNCT
dpc-4489	45	13	no	no	DET
dpc-4489	45	14	systemic	systemic	ADJ
dpc-4489	45	15	drugs	drug	NOUN
dpc-4489	45	16	,	,	PUNCT
dpc-4489	45	17	phototherapy	phototherapy	NOUN
dpc-4489	45	18	,	,	PUNCT
dpc-4489	45	19	or	or	CCONJ
dpc-4489	45	20	externally	externally	ADV
dpc-4489	45	21	applied	apply	VERB
dpc-4489	45	22	drugs	drug	NOUN
dpc-4489	45	23	were	be	AUX
dpc-4489	45	24	administered	administer	VERB
dpc-4489	45	25	in	in	ADP
dpc-4489	45	26	the	the	DET
dpc-4489	45	27	month	month	NOUN
dpc-4489	45	28	prior	prior	ADV
dpc-4489	45	29	to	to	ADP
dpc-4489	45	30	sample	sample	NOUN
dpc-4489	45	31	collection	collection	NOUN
dpc-4489	45	32	.	.	PUNCT
dpc-4489	46	1	the	the	DET
dpc-4489	46	2	patients	patient	NOUN
dpc-4489	46	3	’	'	PUNCT
dpc-4489	46	4	records	record	NOUN
dpc-4489	46	5	contained	contain	VERB
dpc-4489	46	6	systematically	systematically	ADV
dpc-4489	46	7	organized	organize	VERB
dpc-4489	46	8	data	datum	NOUN
dpc-4489	46	9	,	,	PUNCT
dpc-4489	46	10	including	include	VERB
dpc-4489	46	11	age	age	NOUN
dpc-4489	46	12	,	,	PUNCT
dpc-4489	46	13	gender	gender	NOUN
dpc-4489	46	14	,	,	PUNCT
dpc-4489	46	15	family	family	NOUN
dpc-4489	46	16	history	history	NOUN
dpc-4489	46	17	,	,	PUNCT
dpc-4489	46	18	clinical	clinical	ADJ
dpc-4489	46	19	type(s	type(s	NOUN
dpc-4489	46	20	)	)	PUNCT
dpc-4489	46	21	of	of	ADP
dpc-4489	46	22	psoriasis	psoriasis	NOUN
dpc-4489	46	23	,	,	PUNCT
dpc-4489	46	24	specific	specific	ADJ
dpc-4489	46	25	areas	area	NOUN
dpc-4489	46	26	affected	affect	VERB
dpc-4489	46	27	(	(	PUNCT
dpc-4489	46	28	e.g.	e.g.	ADV
dpc-4489	46	29	,	,	PUNCT
dpc-4489	46	30	scalp	scalp	NOUN
dpc-4489	46	31	,	,	PUNCT
dpc-4489	46	32	nails	nail	NOUN
dpc-4489	46	33	,	,	PUNCT
dpc-4489	46	34	face	face	NOUN
dpc-4489	46	35	,	,	PUNCT
dpc-4489	46	36	genital	genital	ADJ
dpc-4489	46	37	area	area	NOUN
dpc-4489	46	38	,	,	PUNCT
dpc-4489	46	39	inverse	inverse	NOUN
dpc-4489	46	40	area	area	NOUN
dpc-4489	46	41	,	,	PUNCT
dpc-4489	46	42	and	and	CCONJ
dpc-4489	46	43	joints	joint	NOUN
dpc-4489	46	44	)	)	PUNCT
dpc-4489	46	45	,	,	PUNCT
dpc-4489	46	46	duration	duration	NOUN
dpc-4489	46	47	of	of	ADP
dpc-4489	46	48	disease	disease	NOUN
dpc-4489	46	49	,	,	PUNCT
dpc-4489	46	50	and	and	CCONJ
dpc-4489	46	51	details	detail	NOUN
dpc-4489	46	52	about	about	ADP
dpc-4489	46	53	the	the	DET
dpc-4489	46	54	biopsy	biopsy	NOUN
dpc-4489	46	55	’s	’s	PART
dpc-4489	46	56	location	location	NOUN
dpc-4489	46	57	.	.	PUNCT
dpc-4489	47	1	the	the	DET
dpc-4489	47	2	psoriasis	psoriasis	NOUN
dpc-4489	47	3	area	area	NOUN
dpc-4489	47	4	and	and	CCONJ
dpc-4489	47	5	severity	severity	NOUN
dpc-4489	47	6	index	index	NOUN
dpc-4489	47	7	(	(	PUNCT
dpc-4489	47	8	pasi	pasi	NOUN
dpc-4489	47	9	)	)	PUNCT
dpc-4489	47	10	was	be	AUX
dpc-4489	47	11	used	use	VERB
dpc-4489	47	12	to	to	PART
dpc-4489	47	13	assess	assess	VERB
dpc-4489	47	14	the	the	DET
dpc-4489	47	15	severity	severity	NOUN
dpc-4489	47	16	of	of	ADP
dpc-4489	47	17	the	the	DET
dpc-4489	47	18	disease	disease	NOUN
dpc-4489	47	19	.	.	PUNCT
dpc-4489	48	1	samples	sample	NOUN
dpc-4489	48	2	of	of	ADP
dpc-4489	48	3	psoriasis	psoriasis	NOUN
dpc-4489	48	4	,	,	PUNCT
dpc-4489	48	5	psoriasiform	psoriasiform	NOUN
dpc-4489	48	6	spongiotic	spongiotic	PROPN
dpc-4489	48	7	dermatitis	dermatitis	PROPN
dpc-4489	48	8	,	,	PUNCT
dpc-4489	48	9	and	and	CCONJ
dpc-4489	48	10	normal	normal	ADJ
dpc-4489	48	11	skin	skin	NOUN
dpc-4489	48	12	were	be	AUX
dpc-4489	48	13	analyzed	analyze	VERB
dpc-4489	48	14	.	.	PUNCT
dpc-4489	49	1	slides	slide	NOUN
dpc-4489	49	2	stained	stain	VERB
dpc-4489	49	3	with	with	ADP
dpc-4489	49	4	hematoxylin	hematoxylin	NOUN
dpc-4489	49	5	and	and	CCONJ
dpc-4489	49	6	eosin	eosin	NOUN
dpc-4489	49	7	were	be	AUX
dpc-4489	49	8	used	use	VERB
dpc-4489	49	9	to	to	PART
dpc-4489	49	10	examine	examine	VERB
dpc-4489	49	11	necrotic	necrotic	ADJ
dpc-4489	49	12	keratinocytes	keratinocyte	NOUN
dpc-4489	49	13	,	,	PUNCT
dpc-4489	49	14	which	which	PRON
dpc-4489	49	15	were	be	AUX
dpc-4489	49	16	characterized	characterize	VERB
dpc-4489	49	17	as	as	ADP
dpc-4489	49	18	intraepidermal	intraepidermal	ADJ
dpc-4489	49	19	cells	cell	NOUN
dpc-4489	49	20	with	with	ADP
dpc-4489	49	21	pyknotic	pyknotic	ADJ
dpc-4489	49	22	nuclei	nucleus	NOUN
dpc-4489	49	23	and	and	CCONJ
dpc-4489	49	24	hypereosinophilic	hypereosinophilic	ADJ
dpc-4489	49	25	cytoplasm	cytoplasm	NOUN
dpc-4489	49	26	.	.	PUNCT
dpc-4489	50	1	the	the	DET
dpc-4489	50	2	total	total	ADJ
dpc-4489	50	3	number	number	NOUN
dpc-4489	50	4	of	of	ADP
dpc-4489	50	5	necrotic	necrotic	ADJ
dpc-4489	50	6	keratinocytes	keratinocyte	NOUN
dpc-4489	50	7	present	present	ADJ
dpc-4489	50	8	in	in	ADP
dpc-4489	50	9	three	three	NUM
dpc-4489	50	10	consecutive	consecutive	ADJ
dpc-4489	50	11	sections	section	NOUN
dpc-4489	50	12	was	be	AUX
dpc-4489	50	13	calculated	calculate	VERB
dpc-4489	50	14	,	,	PUNCT
dpc-4489	50	15	and	and	CCONJ
dpc-4489	50	16	each	each	DET
dpc-4489	50	17	necrotic	necrotic	ADJ
dpc-4489	50	18	keratinocyte	keratinocyte	NOUN
dpc-4489	50	19	within	within	ADP
dpc-4489	50	20	the	the	DET
dpc-4489	50	21	epidermis	epidermis	NOUN
dpc-4489	50	22	was	be	AUX
dpc-4489	50	23	noted	note	VERB
dpc-4489	50	24	as	as	ADP
dpc-4489	50	25	being	be	AUX
dpc-4489	50	26	located	locate	VERB
dpc-4489	50	27	in	in	ADP
dpc-4489	50	28	the	the	DET
dpc-4489	50	29	lower	low	ADJ
dpc-4489	50	30	third	third	ADJ
dpc-4489	50	31	,	,	PUNCT
dpc-4489	50	32	middle	middle	ADJ
dpc-4489	50	33	third	third	ADJ
dpc-4489	50	34	,	,	PUNCT
dpc-4489	50	35	or	or	CCONJ
dpc-4489	50	36	upper	upper	ADJ
dpc-4489	50	37	third	third	NOUN
dpc-4489	50	38	.	.	PUNCT
dpc-4489	51	1	the	the	DET
dpc-4489	51	2	research	research	NOUN
dpc-4489	51	3	protocols	protocol	NOUN
dpc-4489	51	4	followed	follow	VERB
dpc-4489	51	5	the	the	DET
dpc-4489	51	6	principles	principle	NOUN
dpc-4489	51	7	of	of	ADP
dpc-4489	51	8	the	the	DET
dpc-4489	51	9	declaration	declaration	NOUN
dpc-4489	51	10	of	of	ADP
dpc-4489	51	11	helsinki	helsinki	PROPN
dpc-4489	51	12	,	,	PUNCT
dpc-4489	51	13	while	while	SCONJ
dpc-4489	51	14	an	an	DET
dpc-4489	51	15	ethics	ethic	NOUN
dpc-4489	51	16	committee	committee	NOUN
dpc-4489	51	17	of	of	ADP
dpc-4489	51	18	a	a	DET
dpc-4489	51	19	tertiary	tertiary	ADJ
dpc-4489	51	20	hospital	hospital	NOUN
dpc-4489	51	21	approved	approve	VERB
dpc-4489	51	22	the	the	DET
dpc-4489	51	23	study	study	NOUN
dpc-4489	51	24	(	(	PUNCT
dpc-4489	51	25	ethical	ethical	ADJ
dpc-4489	51	26	approval	approval	NOUN
dpc-4489	51	27	no	no	INTJ
dpc-4489	51	28	.	.	PUNCT
dpc-4489	51	29	:	:	PUNCT
dpc-4489	52	1	19.04.2021	19.04.2021	NUM
dpc-4489	52	2	-	-	SYM
dpc-4489	52	3	109/01	109/01	NUM
dpc-4489	52	4	)	)	PUNCT
dpc-4489	52	5	.	.	PUNCT
dpc-4489	53	1	the	the	DET
dpc-4489	53	2	collected	collect	VERB
dpc-4489	53	3	data	datum	NOUN
dpc-4489	53	4	were	be	AUX
dpc-4489	53	5	transferred	transfer	VERB
dpc-4489	53	6	to	to	ADP
dpc-4489	53	7	a	a	DET
dpc-4489	53	8	computer	computer	NOUN
dpc-4489	53	9	and	and	CCONJ
dpc-4489	53	10	analyzed	analyze	VERB
dpc-4489	53	11	using	use	VERB
dpc-4489	53	12	spss	spss	PROPN
dpc-4489	53	13	(	(	PUNCT
dpc-4489	53	14	version	version	NOUN
dpc-4489	53	15	15.0	15.0	NUM
dpc-4489	53	16	)	)	PUNCT
dpc-4489	53	17	.	.	PUNCT
dpc-4489	54	1	the	the	DET
dpc-4489	54	2	normal	normal	ADJ
dpc-4489	54	3	distribution	distribution	NOUN
dpc-4489	54	4	of	of	ADP
dpc-4489	54	5	the	the	DET
dpc-4489	54	6	data	datum	NOUN
dpc-4489	54	7	was	be	AUX
dpc-4489	54	8	assessed	assess	VERB
dpc-4489	54	9	using	use	VERB
dpc-4489	54	10	the	the	DET
dpc-4489	54	11	kolmogorov	kolmogorov	ADJ
dpc-4489	54	12	–	–	PUNCT
dpc-4489	54	13	smirnov	smirnov	ADJ
dpc-4489	54	14	test	test	NOUN
dpc-4489	54	15	.	.	PUNCT
dpc-4489	55	1	for	for	ADP
dpc-4489	55	2	data	datum	NOUN
dpc-4489	55	3	that	that	PRON
dpc-4489	55	4	did	do	AUX
dpc-4489	55	5	not	not	PART
dpc-4489	55	6	follow	follow	VERB
dpc-4489	55	7	a	a	DET
dpc-4489	55	8	normal	normal	ADJ
dpc-4489	55	9	distribution	distribution	NOUN
dpc-4489	55	10	,	,	PUNCT
dpc-4489	55	11	analysis	analysis	NOUN
dpc-4489	55	12	was	be	AUX
dpc-4489	55	13	performed	perform	VERB
dpc-4489	55	14	using	use	VERB
dpc-4489	55	15	the	the	DET
dpc-4489	55	16	mann	mann	PROPN
dpc-4489	55	17	–	–	PUNCT
dpc-4489	55	18	whitney	whitney	PROPN
dpc-4489	55	19	u	u	PROPN
dpc-4489	55	20	test	test	NOUN
dpc-4489	55	21	,	,	PUNCT
dpc-4489	55	22	kruskal	kruskal	PROPN
dpc-4489	55	23	–	–	PUNCT
dpc-4489	55	24	wallis	wallis	PROPN
dpc-4489	55	25	test	test	NOUN
dpc-4489	55	26	,	,	PUNCT
dpc-4489	55	27	spearman	spearman	NOUN
dpc-4489	55	28	’s	’s	PART
dpc-4489	55	29	correlation	correlation	NOUN
dpc-4489	55	30	test	test	NOUN
dpc-4489	55	31	,	,	PUNCT
dpc-4489	55	32	and	and	CCONJ
dpc-4489	55	33	logistic	logistic	ADJ
dpc-4489	55	34	regression	regression	NOUN
dpc-4489	55	35	analyses	analysis	NOUN
dpc-4489	55	36	.	.	PUNCT
dpc-4489	56	1	results	result	VERB
dpc-4489	56	2	the	the	DET
dpc-4489	56	3	group	group	NOUN
dpc-4489	56	4	of	of	ADP
dpc-4489	56	5	patients	patient	NOUN
dpc-4489	56	6	with	with	ADP
dpc-4489	56	7	psoriasis	psoriasis	NOUN
dpc-4489	56	8	included	include	VERB
dpc-4489	56	9	87	87	NUM
dpc-4489	56	10	males	male	NOUN
dpc-4489	56	11	and	and	CCONJ
dpc-4489	56	12	48	48	NUM
dpc-4489	56	13	females	female	NOUN
dpc-4489	56	14	,	,	PUNCT
dpc-4489	56	15	the	the	DET
dpc-4489	56	16	group	group	NOUN
dpc-4489	56	17	of	of	ADP
dpc-4489	56	18	patients	patient	NOUN
dpc-4489	56	19	with	with	ADP
dpc-4489	56	20	psoriasiform	psoriasiform	PROPN
dpc-4489	56	21	spongiotic	spongiotic	PROPN
dpc-4489	56	22	dermatitis	dermatitis	PROPN
dpc-4489	56	23	had	have	VERB
dpc-4489	56	24	36	36	NUM
dpc-4489	56	25	males	male	NOUN
dpc-4489	56	26	and	and	CCONJ
dpc-4489	56	27	21	21	NUM
dpc-4489	56	28	females	female	NOUN
dpc-4489	56	29	,	,	PUNCT
dpc-4489	56	30	and	and	CCONJ
dpc-4489	56	31	the	the	DET
dpc-4489	56	32	control	control	NOUN
dpc-4489	56	33	group	group	NOUN
dpc-4489	56	34	consisted	consist	VERB
dpc-4489	56	35	of	of	ADP
dpc-4489	56	36	45	45	NUM
dpc-4489	56	37	males	male	NOUN
dpc-4489	56	38	and	and	CCONJ
dpc-4489	56	39	26	26	NUM
dpc-4489	56	40	females	female	NOUN
dpc-4489	56	41	.	.	PUNCT
dpc-4489	57	1	statistical	statistical	ADJ
dpc-4489	57	2	analysis	analysis	NOUN
dpc-4489	57	3	showed	show	VERB
dpc-4489	57	4	that	that	SCONJ
dpc-4489	57	5	all	all	DET
dpc-4489	57	6	three	three	NUM
dpc-4489	57	7	groups	group	NOUN
dpc-4489	57	8	were	be	AUX
dpc-4489	57	9	comparable	comparable	ADJ
dpc-4489	57	10	.	.	PUNCT
dpc-4489	58	1	original	original	ADJ
dpc-4489	58	2	article	article	NOUN
dpc-4489	58	3	|	|	ADV
dpc-4489	58	4	dermatol	dermatol	ADJ
dpc-4489	58	5	pract	pract	NOUN
dpc-4489	58	6	concept	concept	NOUN
dpc-4489	58	7	.	.	PUNCT
dpc-4489	59	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	59	2	3	3	NUM
dpc-4489	59	3	the	the	DET
dpc-4489	59	4	average	average	ADJ
dpc-4489	59	5	age	age	NOUN
dpc-4489	59	6	of	of	ADP
dpc-4489	59	7	patients	patient	NOUN
dpc-4489	59	8	with	with	ADP
dpc-4489	59	9	psoriasis	psoriasis	NOUN
dpc-4489	59	10	was	be	AUX
dpc-4489	59	11	44.7	44.7	NUM
dpc-4489	59	12	years	year	NOUN
dpc-4489	59	13	(	(	PUNCT
dpc-4489	59	14	age	age	NOUN
dpc-4489	59	15	range	range	NOUN
dpc-4489	59	16	:	:	PUNCT
dpc-4489	59	17	11–85	11–85	NUM
dpc-4489	59	18	years	year	NOUN
dpc-4489	59	19	)	)	PUNCT
dpc-4489	59	20	,	,	PUNCT
dpc-4489	59	21	of	of	ADP
dpc-4489	59	22	patients	patient	NOUN
dpc-4489	59	23	with	with	ADP
dpc-4489	59	24	psoriasiform	psoriasiform	PROPN
dpc-4489	59	25	spongiotic	spongiotic	PROPN
dpc-4489	59	26	dermatitis	dermatitis	PROPN
dpc-4489	59	27	was	be	AUX
dpc-4489	59	28	49.19	49.19	NUM
dpc-4489	59	29	years	year	NOUN
dpc-4489	59	30	(	(	PUNCT
dpc-4489	59	31	age	age	NOUN
dpc-4489	59	32	range	range	NOUN
dpc-4489	59	33	:	:	PUNCT
dpc-4489	59	34	17–83	17–83	NUM
dpc-4489	59	35	years	year	NOUN
dpc-4489	59	36	)	)	PUNCT
dpc-4489	59	37	,	,	PUNCT
dpc-4489	59	38	and	and	CCONJ
dpc-4489	59	39	of	of	ADP
dpc-4489	59	40	the	the	DET
dpc-4489	59	41	control	control	NOUN
dpc-4489	59	42	group	group	NOUN
dpc-4489	59	43	was	be	AUX
dpc-4489	59	44	46.79	46.79	NUM
dpc-4489	59	45	years	year	NOUN
dpc-4489	59	46	(	(	PUNCT
dpc-4489	59	47	age	age	NOUN
dpc-4489	59	48	range	range	NOUN
dpc-4489	59	49	:	:	PUNCT
dpc-4489	59	50	11–83	11–83	NUM
dpc-4489	59	51	years	year	NOUN
dpc-4489	59	52	)	)	PUNCT
dpc-4489	59	53	.	.	PUNCT
dpc-4489	60	1	no	no	DET
dpc-4489	60	2	statistically	statistically	ADV
dpc-4489	60	3	significant	significant	ADJ
dpc-4489	60	4	difference	difference	NOUN
dpc-4489	60	5	in	in	ADP
dpc-4489	60	6	age	age	NOUN
dpc-4489	60	7	emerged	emerge	VERB
dpc-4489	60	8	between	between	ADP
dpc-4489	60	9	the	the	DET
dpc-4489	60	10	three	three	NUM
dpc-4489	60	11	groups	group	NOUN
dpc-4489	60	12	.	.	PUNCT
dpc-4489	61	1	the	the	DET
dpc-4489	61	2	general	general	ADJ
dpc-4489	61	3	characteristics	characteristic	NOUN
dpc-4489	61	4	of	of	ADP
dpc-4489	61	5	the	the	DET
dpc-4489	61	6	study	study	NOUN
dpc-4489	61	7	group	group	NOUN
dpc-4489	61	8	are	be	AUX
dpc-4489	61	9	presented	present	VERB
dpc-4489	61	10	in	in	ADP
dpc-4489	61	11	table	table	NOUN
dpc-4489	61	12	1	1	NUM
dpc-4489	61	13	.	.	PUNCT
dpc-4489	62	1	we	we	PRON
dpc-4489	62	2	evaluated	evaluate	VERB
dpc-4489	62	3	the	the	DET
dpc-4489	62	4	quantities	quantity	NOUN
dpc-4489	62	5	of	of	ADP
dpc-4489	62	6	necrotic	necrotic	ADJ
dpc-4489	62	7	keratinocytes	keratinocyte	NOUN
dpc-4489	62	8	in	in	ADP
dpc-4489	62	9	the	the	DET
dpc-4489	62	10	upper	upper	ADJ
dpc-4489	62	11	,	,	PUNCT
dpc-4489	62	12	middle	middle	ADJ
dpc-4489	62	13	,	,	PUNCT
dpc-4489	62	14	and	and	CCONJ
dpc-4489	62	15	lower	low	ADJ
dpc-4489	62	16	thirds	third	NOUN
dpc-4489	62	17	of	of	ADP
dpc-4489	62	18	the	the	DET
dpc-4489	62	19	epidermis	epidermis	NOUN
dpc-4489	62	20	.	.	PUNCT
dpc-4489	63	1	when	when	SCONJ
dpc-4489	63	2	assessing	assess	VERB
dpc-4489	63	3	the	the	DET
dpc-4489	63	4	total	total	ADJ
dpc-4489	63	5	number	number	NOUN
dpc-4489	63	6	of	of	ADP
dpc-4489	63	7	necrotic	necrotic	ADJ
dpc-4489	63	8	keratinocytes	keratinocyte	NOUN
dpc-4489	63	9	and	and	CCONJ
dpc-4489	63	10	the	the	DET
dpc-4489	63	11	number	number	NOUN
dpc-4489	63	12	of	of	ADP
dpc-4489	63	13	necrotic	necrotic	ADJ
dpc-4489	63	14	keratinocytes	keratinocyte	NOUN
dpc-4489	63	15	in	in	ADP
dpc-4489	63	16	each	each	PRON
dpc-4489	63	17	of	of	ADP
dpc-4489	63	18	the	the	DET
dpc-4489	63	19	three	three	NUM
dpc-4489	63	20	epidermal	epidermal	ADJ
dpc-4489	63	21	regions	region	NOUN
dpc-4489	63	22	in	in	ADP
dpc-4489	63	23	patients	patient	NOUN
dpc-4489	63	24	with	with	ADP
dpc-4489	63	25	psoriasis	psoriasis	NOUN
dpc-4489	63	26	(	(	PUNCT
dpc-4489	63	27	figure	figure	NOUN
dpc-4489	63	28	1	1	NUM
dpc-4489	63	29	)	)	PUNCT
dpc-4489	63	30	,	,	PUNCT
dpc-4489	63	31	a	a	DET
dpc-4489	63	32	significant	significant	ADJ
dpc-4489	63	33	difference	difference	NOUN
dpc-4489	63	34	arose	arise	VERB
dpc-4489	63	35	between	between	ADP
dpc-4489	63	36	the	the	DET
dpc-4489	63	37	psoriasiform	psoriasiform	NOUN
dpc-4489	63	38	spongiotic	spongiotic	PROPN
dpc-4489	63	39	dermatitis	dermatitis	PROPN
dpc-4489	63	40	(	(	PUNCT
dpc-4489	63	41	p	p	X
dpc-4489	63	42	<	<	X
dpc-4489	63	43	.001	.001	NUM
dpc-4489	63	44	)	)	PUNCT
dpc-4489	63	45	(	(	PUNCT
dpc-4489	63	46	figure	figure	NOUN
dpc-4489	63	47	2	2	NUM
dpc-4489	63	48	)	)	PUNCT
dpc-4489	63	49	and	and	CCONJ
dpc-4489	63	50	control	control	NOUN
dpc-4489	63	51	groups	group	NOUN
dpc-4489	63	52	(	(	PUNCT
dpc-4489	63	53	p	p	X
dpc-4489	63	54	<	<	X
dpc-4489	63	55	.001	.001	NUM
dpc-4489	63	56	)	)	PUNCT
dpc-4489	63	57	(	(	PUNCT
dpc-4489	63	58	figure	figure	NOUN
dpc-4489	63	59	3	3	NUM
dpc-4489	63	60	)	)	PUNCT
dpc-4489	63	61	.	.	PUNCT
dpc-4489	64	1	the	the	DET
dpc-4489	64	2	results	result	NOUN
dpc-4489	64	3	of	of	ADP
dpc-4489	64	4	our	our	PRON
dpc-4489	64	5	quantitative	quantitative	ADJ
dpc-4489	64	6	analysis	analysis	NOUN
dpc-4489	64	7	of	of	ADP
dpc-4489	64	8	necrotic	necrotic	ADJ
dpc-4489	64	9	keratinocytes	keratinocyte	NOUN
dpc-4489	64	10	in	in	ADP
dpc-4489	64	11	the	the	DET
dpc-4489	64	12	psoriasis	psoriasis	NOUN
dpc-4489	64	13	,	,	PUNCT
dpc-4489	64	14	psoriasiform	psoriasiform	NOUN
dpc-4489	64	15	spongiotic	spongiotic	PROPN
dpc-4489	64	16	dermatitis	dermatitis	PROPN
dpc-4489	64	17	,	,	PUNCT
dpc-4489	64	18	and	and	CCONJ
dpc-4489	64	19	control	control	NOUN
dpc-4489	64	20	groups	group	NOUN
dpc-4489	64	21	appear	appear	VERB
dpc-4489	64	22	in	in	ADP
dpc-4489	64	23	table	table	NOUN
dpc-4489	64	24	2	2	NUM
dpc-4489	64	25	,	,	PUNCT
dpc-4489	64	26	while	while	SCONJ
dpc-4489	64	27	table	table	NOUN
dpc-4489	64	28	 	 	SPACE
dpc-4489	64	29	3	3	NUM
dpc-4489	64	30	presents	present	VERB
dpc-4489	64	31	the	the	DET
dpc-4489	64	32	quantities	quantity	NOUN
dpc-4489	64	33	of	of	ADP
dpc-4489	64	34	necrotic	necrotic	ADJ
dpc-4489	64	35	keratinocytes	keratinocyte	NOUN
dpc-4489	64	36	based	base	VERB
dpc-4489	64	37	on	on	ADP
dpc-4489	64	38	their	their	PRON
dpc-4489	64	39	locations	location	NOUN
dpc-4489	64	40	in	in	ADP
dpc-4489	64	41	the	the	DET
dpc-4489	64	42	epidermis	epidermis	NOUN
dpc-4489	64	43	for	for	ADP
dpc-4489	64	44	all	all	DET
dpc-4489	64	45	three	three	NUM
dpc-4489	64	46	groups	group	NOUN
dpc-4489	64	47	.	.	PUNCT
dpc-4489	65	1	no	no	DET
dpc-4489	65	2	significant	significant	ADJ
dpc-4489	65	3	relationship	relationship	NOUN
dpc-4489	65	4	surfaced	surface	VERB
dpc-4489	65	5	between	between	ADP
dpc-4489	65	6	the	the	DET
dpc-4489	65	7	involvement	involvement	NOUN
dpc-4489	65	8	of	of	ADP
dpc-4489	65	9	specific	specific	ADJ
dpc-4489	65	10	areas	area	NOUN
dpc-4489	65	11	and	and	CCONJ
dpc-4489	65	12	the	the	DET
dpc-4489	65	13	number	number	NOUN
dpc-4489	65	14	of	of	ADP
dpc-4489	65	15	necrotic	necrotic	ADJ
dpc-4489	65	16	keratinocytes	keratinocyte	NOUN
dpc-4489	65	17	in	in	ADP
dpc-4489	65	18	the	the	DET
dpc-4489	65	19	psoriasis	psoriasis	NOUN
dpc-4489	65	20	group	group	NOUN
dpc-4489	65	21	(	(	PUNCT
dpc-4489	65	22	p	p	X
dpc-4489	65	23	>	>	X
dpc-4489	65	24	.05	.05	NUM
dpc-4489	65	25	)	)	PUNCT
dpc-4489	65	26	.	.	PUNCT
dpc-4489	66	1	similarly	similarly	ADV
dpc-4489	66	2	,	,	PUNCT
dpc-4489	66	3	no	no	DET
dpc-4489	66	4	significant	significant	ADJ
dpc-4489	66	5	association	association	NOUN
dpc-4489	66	6	was	be	AUX
dpc-4489	66	7	observed	observe	VERB
dpc-4489	66	8	between	between	ADP
dpc-4489	66	9	the	the	DET
dpc-4489	66	10	presence	presence	NOUN
dpc-4489	66	11	or	or	CCONJ
dpc-4489	66	12	absence	absence	NOUN
dpc-4489	66	13	of	of	ADP
dpc-4489	66	14	a	a	DET
dpc-4489	66	15	family	family	NOUN
dpc-4489	66	16	history	history	NOUN
dpc-4489	66	17	of	of	ADP
dpc-4489	66	18	psoriasis	psoriasis	NOUN
dpc-4489	66	19	and	and	CCONJ
dpc-4489	66	20	the	the	DET
dpc-4489	66	21	number	number	NOUN
dpc-4489	66	22	of	of	ADP
dpc-4489	66	23	necrotic	necrotic	ADJ
dpc-4489	66	24	keratinocytes	keratinocyte	NOUN
dpc-4489	66	25	(	(	PUNCT
dpc-4489	66	26	p	p	X
dpc-4489	66	27	>	>	X
dpc-4489	66	28	.05	.05	NUM
dpc-4489	66	29	)	)	PUNCT
dpc-4489	66	30	.	.	PUNCT
dpc-4489	67	1	the	the	DET
dpc-4489	67	2	duration	duration	NOUN
dpc-4489	67	3	of	of	ADP
dpc-4489	67	4	the	the	DET
dpc-4489	67	5	disease	disease	NOUN
dpc-4489	67	6	also	also	ADV
dpc-4489	67	7	showed	show	VERB
dpc-4489	67	8	no	no	DET
dpc-4489	67	9	significant	significant	ADJ
dpc-4489	67	10	relationship	relationship	NOUN
dpc-4489	67	11	with	with	ADP
dpc-4489	67	12	the	the	DET
dpc-4489	67	13	number	number	NOUN
dpc-4489	67	14	of	of	ADP
dpc-4489	67	15	necrotic	necrotic	ADJ
dpc-4489	67	16	keratinocytes	keratinocyte	NOUN
dpc-4489	67	17	(	(	PUNCT
dpc-4489	67	18	p	p	X
dpc-4489	67	19	>	>	X
dpc-4489	67	20	.05	.05	NUM
dpc-4489	67	21	)	)	PUNCT
dpc-4489	67	22	.	.	PUNCT
dpc-4489	68	1	among	among	ADP
dpc-4489	68	2	patients	patient	NOUN
dpc-4489	68	3	with	with	ADP
dpc-4489	68	4	psoriasis	psoriasis	NOUN
dpc-4489	68	5	,	,	PUNCT
dpc-4489	68	6	the	the	DET
dpc-4489	68	7	quantity	quantity	NOUN
dpc-4489	68	8	of	of	ADP
dpc-4489	68	9	necrotic	necrotic	ADJ
dpc-4489	68	10	keratinocytes	keratinocyte	NOUN
dpc-4489	68	11	was	be	AUX
dpc-4489	68	12	significantly	significantly	ADV
dpc-4489	68	13	higher	high	ADJ
dpc-4489	68	14	in	in	ADP
dpc-4489	68	15	each	each	PRON
dpc-4489	68	16	of	of	ADP
dpc-4489	68	17	the	the	DET
dpc-4489	68	18	three	three	NUM
dpc-4489	68	19	regions	region	NOUN
dpc-4489	68	20	of	of	ADP
dpc-4489	68	21	the	the	DET
dpc-4489	68	22	epidermis	epidermis	NOUN
dpc-4489	68	23	than	than	ADP
dpc-4489	68	24	among	among	ADP
dpc-4489	68	25	patients	patient	NOUN
dpc-4489	68	26	with	with	ADP
dpc-4489	68	27	psoriasiform	psoriasiform	PROPN
dpc-4489	68	28	spongiotic	spongiotic	PROPN
dpc-4489	68	29	dermatitis	dermatitis	PROPN
dpc-4489	68	30	(	(	PUNCT
dpc-4489	68	31	p	p	X
dpc-4489	68	32	<	<	X
dpc-4489	68	33	.001	.001	NUM
dpc-4489	68	34	)	)	PUNCT
dpc-4489	68	35	.	.	PUNCT
dpc-4489	69	1	a	a	DET
dpc-4489	69	2	significant	significant	ADJ
dpc-4489	69	3	difference	difference	NOUN
dpc-4489	69	4	was	be	AUX
dpc-4489	69	5	also	also	ADV
dpc-4489	69	6	observed	observe	VERB
dpc-4489	69	7	between	between	ADP
dpc-4489	69	8	the	the	DET
dpc-4489	69	9	psoriasiform	psoriasiform	NOUN
dpc-4489	69	10	spongiotic	spongiotic	PROPN
dpc-4489	69	11	dermatitis	dermatitis	PROPN
dpc-4489	69	12	and	and	CCONJ
dpc-4489	69	13	control	control	NOUN
dpc-4489	69	14	groups	group	NOUN
dpc-4489	69	15	in	in	ADP
dpc-4489	69	16	terms	term	NOUN
dpc-4489	69	17	of	of	ADP
dpc-4489	69	18	the	the	DET
dpc-4489	69	19	quantity	quantity	NOUN
dpc-4489	69	20	of	of	ADP
dpc-4489	69	21	necrotic	necrotic	ADJ
dpc-4489	69	22	keratinocytes	keratinocyte	NOUN
dpc-4489	69	23	in	in	ADP
dpc-4489	69	24	the	the	DET
dpc-4489	69	25	upper	upper	ADJ
dpc-4489	69	26	epidermis	epidermis	NOUN
dpc-4489	69	27	(	(	PUNCT
dpc-4489	69	28	p	p	X
dpc-4489	69	29	<	<	X
dpc-4489	69	30	.001	.001	NUM
dpc-4489	69	31	)	)	PUNCT
dpc-4489	69	32	.	.	PUNCT
dpc-4489	70	1	however	however	ADV
dpc-4489	70	2	,	,	PUNCT
dpc-4489	70	3	no	no	DET
dpc-4489	70	4	significant	significant	ADJ
dpc-4489	70	5	differences	difference	NOUN
dpc-4489	70	6	were	be	AUX
dpc-4489	70	7	found	find	VERB
dpc-4489	70	8	in	in	ADP
dpc-4489	70	9	the	the	DET
dpc-4489	70	10	quantities	quantity	NOUN
dpc-4489	70	11	of	of	ADP
dpc-4489	70	12	necrotic	necrotic	ADJ
dpc-4489	70	13	keratinocytes	keratinocyte	NOUN
dpc-4489	70	14	in	in	ADP
dpc-4489	70	15	the	the	DET
dpc-4489	70	16	middle	middle	NOUN
dpc-4489	70	17	(	(	PUNCT
dpc-4489	70	18	p	p	NOUN
dpc-4489	70	19	=	=	NOUN
dpc-4489	70	20	.184	.184	NUM
dpc-4489	70	21	)	)	PUNCT
dpc-4489	70	22	and	and	CCONJ
dpc-4489	70	23	lower	low	ADJ
dpc-4489	70	24	thirds	third	NOUN
dpc-4489	70	25	of	of	ADP
dpc-4489	70	26	the	the	DET
dpc-4489	70	27	epidermis	epidermis	NOUN
dpc-4489	70	28	(	(	PUNCT
dpc-4489	70	29	p	p	NOUN
dpc-4489	70	30	=	=	NOUN
dpc-4489	70	31	.479	.479	NUM
dpc-4489	70	32	)	)	PUNCT
dpc-4489	70	33	.	.	PUNCT
dpc-4489	71	1	the	the	DET
dpc-4489	71	2	results	result	NOUN
dpc-4489	71	3	of	of	ADP
dpc-4489	71	4	logistic	logistic	ADJ
dpc-4489	71	5	regression	regression	NOUN
dpc-4489	71	6	analyses	analysis	NOUN
dpc-4489	71	7	showed	show	VERB
dpc-4489	71	8	that	that	SCONJ
dpc-4489	71	9	individuals	individual	NOUN
dpc-4489	71	10	with	with	ADP
dpc-4489	71	11	psoriasis	psoriasis	NOUN
dpc-4489	71	12	were	be	AUX
dpc-4489	71	13	923	923	NUM
dpc-4489	71	14	times	time	NOUN
dpc-4489	71	15	more	more	ADV
dpc-4489	71	16	likely	likely	ADJ
dpc-4489	71	17	to	to	PART
dpc-4489	71	18	have	have	VERB
dpc-4489	71	19	necrotic	necrotic	ADJ
dpc-4489	71	20	keratinocytes	keratinocyte	NOUN
dpc-4489	71	21	,	,	PUNCT
dpc-4489	71	22	whereas	whereas	SCONJ
dpc-4489	71	23	ones	one	NOUN
dpc-4489	71	24	with	with	ADP
dpc-4489	71	25	psoriasiform	psoriasiform	PROPN
dpc-4489	71	26	spongiotic	spongiotic	PROPN
dpc-4489	71	27	dermatitis	dermatitis	PROPN
dpc-4489	71	28	were	be	AUX
dpc-4489	71	29	5.4	5.4	NUM
dpc-4489	71	30	times	time	NOUN
dpc-4489	71	31	more	more	ADV
dpc-4489	71	32	likely	likely	ADJ
dpc-4489	71	33	to	to	PART
dpc-4489	71	34	have	have	VERB
dpc-4489	71	35	necrotic	necrotic	ADJ
dpc-4489	71	36	keratinocytes	keratinocyte	NOUN
dpc-4489	71	37	than	than	ADP
dpc-4489	71	38	patients	patient	NOUN
dpc-4489	71	39	without	without	ADP
dpc-4489	71	40	those	those	DET
dpc-4489	71	41	conditions	condition	NOUN
dpc-4489	71	42	.	.	PUNCT
dpc-4489	72	1	table	table	NOUN
dpc-4489	72	2	1	1	NUM
dpc-4489	72	3	.	.	PUNCT
dpc-4489	73	1	general	general	ADJ
dpc-4489	73	2	characteristics	characteristic	NOUN
dpc-4489	73	3	of	of	ADP
dpc-4489	73	4	the	the	DET
dpc-4489	73	5	study	study	NOUN
dpc-4489	73	6	group	group	NOUN
dpc-4489	73	7	.	.	PUNCT
dpc-4489	74	1	characteristics	characteristic	NOUN
dpc-4489	74	2	psoriasis	psoriasis	NOUN
dpc-4489	74	3	(	(	PUNCT
dpc-4489	74	4	n	n	CCONJ
dpc-4489	74	5	)	)	PUNCT
dpc-4489	74	6	n=135	n=135	PART
dpc-4489	74	7	psoriasiform	psoriasiform	PROPN
dpc-4489	74	8	spongiotic	spongiotic	PROPN
dpc-4489	74	9	dermatitis	dermatitis	PROPN
dpc-4489	74	10	(	(	PUNCT
dpc-4489	74	11	n	n	CCONJ
dpc-4489	74	12	)	)	PUNCT
dpc-4489	74	13	n=57	n=57	NOUN
dpc-4489	74	14	control	control	NOUN
dpc-4489	74	15	(	(	PUNCT
dpc-4489	74	16	n	n	CCONJ
dpc-4489	74	17	)	)	PUNCT
dpc-4489	74	18	n=71	n=71	NOUN
dpc-4489	74	19	sex	sex	NOUN
dpc-4489	74	20	87	87	NUM
dpc-4489	74	21	m	m	NUM
dpc-4489	74	22	48	48	NUM
dpc-4489	74	23	f	f	NUM
dpc-4489	74	24	36	36	NUM
dpc-4489	74	25	m	m	NUM
dpc-4489	74	26	21	21	NUM
dpc-4489	74	27	f	f	NUM
dpc-4489	74	28	45	45	NUM
dpc-4489	74	29	m	m	NUM
dpc-4489	74	30	26	26	NUM
dpc-4489	74	31	f	f	PROPN
dpc-4489	74	32	biopsy	biopsy	NOUN
dpc-4489	74	33	site	site	NOUN
dpc-4489	74	34	lower	low	ADJ
dpc-4489	74	35	extremity	extremity	NOUN
dpc-4489	74	36	upper	upper	ADJ
dpc-4489	74	37	extremity	extremity	NOUN
dpc-4489	74	38	scalp	scalp	NOUN
dpc-4489	74	39	back	back	ADV
dpc-4489	74	40	chest	chest	NOUN
dpc-4489	74	41	abdomen	abdomen	VERB
dpc-4489	74	42	52	52	NUM
dpc-4489	74	43	36	36	NUM
dpc-4489	74	44	5	5	NUM
dpc-4489	74	45	23	23	NUM
dpc-4489	74	46	2	2	NUM
dpc-4489	74	47	17	17	NUM
dpc-4489	74	48	22	22	NUM
dpc-4489	74	49	24	24	NUM
dpc-4489	74	50	3	3	NUM
dpc-4489	74	51	6	6	NUM
dpc-4489	74	52	2	2	NUM
dpc-4489	74	53	20	20	NUM
dpc-4489	74	54	19	19	NUM
dpc-4489	74	55	4	4	NUM
dpc-4489	74	56	12	12	NUM
dpc-4489	74	57	16	16	NUM
dpc-4489	74	58	age	age	NOUN
dpc-4489	74	59	,	,	PUNCT
dpc-4489	74	60	years	year	VERB
dpc-4489	74	61	44.7	44.7	NUM
dpc-4489	74	62	49.9	49.9	NUM
dpc-4489	74	63	46.79	46.79	NUM
dpc-4489	74	64	family	family	NOUN
dpc-4489	74	65	history	history	NOUN
dpc-4489	75	1	yes	yes	INTJ
dpc-4489	75	2	no	no	DET
dpc-4489	75	3	39	39	NUM
dpc-4489	75	4	96	96	NUM
dpc-4489	75	5	clinical	clinical	ADJ
dpc-4489	75	6	type	type	NOUN
dpc-4489	75	7	plaque	plaque	NOUN
dpc-4489	75	8	guttate	guttate	NOUN
dpc-4489	75	9	126	126	NUM
dpc-4489	75	10	9	9	NUM
dpc-4489	75	11	specific	specific	ADJ
dpc-4489	75	12	area	area	NOUN
dpc-4489	75	13	involvement	involvement	NOUN
dpc-4489	75	14	scalp	scalp	NOUN
dpc-4489	75	15	nail	nail	NOUN
dpc-4489	75	16	face	face	VERB
dpc-4489	75	17	genital	genital	ADJ
dpc-4489	75	18	area	area	NOUN
dpc-4489	75	19	joint	joint	ADJ
dpc-4489	75	20	inverse	inverse	NOUN
dpc-4489	75	21	area	area	NOUN
dpc-4489	75	22	96	96	NUM
dpc-4489	75	23	65	65	NUM
dpc-4489	75	24	44	44	NUM
dpc-4489	75	25	52	52	NUM
dpc-4489	75	26	17	17	NUM
dpc-4489	75	27	28	28	NUM
dpc-4489	75	28	disease	disease	NOUN
dpc-4489	75	29	duration	duration	NOUN
dpc-4489	75	30	,	,	PUNCT
dpc-4489	75	31	months	month	NOUN
dpc-4489	75	32	(	(	PUNCT
dpc-4489	75	33	mean	mean	NOUN
dpc-4489	75	34	)	)	PUNCT
dpc-4489	75	35	(	(	PUNCT
dpc-4489	75	36	min	min	NOUN
dpc-4489	75	37	-	-	PUNCT
dpc-4489	75	38	max	max	NOUN
dpc-4489	75	39	)	)	PUNCT
dpc-4489	75	40	137.88	137.88	NUM
dpc-4489	75	41	(	(	PUNCT
dpc-4489	75	42	1	1	NUM
dpc-4489	75	43	-	-	SYM
dpc-4489	75	44	660	660	NUM
dpc-4489	75	45	)	)	PUNCT
dpc-4489	75	46	171,32	171,32	NUM
dpc-4489	75	47	(	(	PUNCT
dpc-4489	75	48	1	1	NUM
dpc-4489	75	49	-	-	NUM
dpc-4489	75	50	708	708	NUM
dpc-4489	75	51	)	)	PUNCT
dpc-4489	75	52	pasi	pasi	NOUN
dpc-4489	75	53	,	,	PUNCT
dpc-4489	75	54	mean	mean	INTJ
dpc-4489	75	55	(	(	PUNCT
dpc-4489	75	56	min	min	NOUN
dpc-4489	75	57	-	-	PUNCT
dpc-4489	75	58	max	max	NOUN
dpc-4489	75	59	)	)	PUNCT
dpc-4489	75	60	9.559	9.559	NUM
dpc-4489	75	61	(	(	PUNCT
dpc-4489	75	62	0.6	0.6	NUM
dpc-4489	75	63	-	-	SYM
dpc-4489	75	64	55	55	NUM
dpc-4489	75	65	)	)	PUNCT
dpc-4489	75	66	m	m	PROPN
dpc-4489	76	1	=	=	NOUN
dpc-4489	76	2	male	male	NOUN
dpc-4489	76	3	;	;	PUNCT
dpc-4489	76	4	f	f	NOUN
dpc-4489	76	5	=	=	SYM
dpc-4489	76	6	female	female	NOUN
dpc-4489	76	7	;	;	PUNCT
dpc-4489	76	8	pasi	pasi	NOUN
dpc-4489	76	9	=	=	SYM
dpc-4489	76	10	psoriasis	psoriasis	NOUN
dpc-4489	76	11	area	area	NOUN
dpc-4489	76	12	severity	severity	PROPN
dpc-4489	76	13	index	index	NOUN
dpc-4489	76	14	.	.	PUNCT
dpc-4489	77	1	4	4	NUM
dpc-4489	77	2	original	original	ADJ
dpc-4489	77	3	article	article	NOUN
dpc-4489	77	4	|	|	ADV
dpc-4489	77	5	dermatol	dermatol	ADJ
dpc-4489	77	6	pract	pract	NOUN
dpc-4489	77	7	concept	concept	NOUN
dpc-4489	77	8	.	.	PUNCT
dpc-4489	78	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	78	2	figure	figure	NOUN
dpc-4489	78	3	1	1	NUM
dpc-4489	78	4	.	.	PUNCT
dpc-4489	79	1	(	(	PUNCT
dpc-4489	79	2	a	a	X
dpc-4489	79	3	)	)	PUNCT
dpc-4489	79	4	necrotic	necrotic	ADJ
dpc-4489	79	5	keratinocytes	keratinocyte	NOUN
dpc-4489	79	6	(	(	PUNCT
dpc-4489	79	7	black	black	ADJ
dpc-4489	79	8	arrows	arrow	NOUN
dpc-4489	79	9	)	)	PUNCT
dpc-4489	79	10	in	in	ADP
dpc-4489	79	11	upper	upper	ADJ
dpc-4489	79	12	and	and	CCONJ
dpc-4489	79	13	middle	middle	ADJ
dpc-4489	79	14	epidermis	epidermis	NOUN
dpc-4489	79	15	in	in	ADP
dpc-4489	79	16	psoriasis	psoriasis	NOUN
dpc-4489	79	17	patient	patient	NOUN
dpc-4489	79	18	(	(	PUNCT
dpc-4489	79	19	pasi	pasi	NOUN
dpc-4489	79	20	:	:	PUNCT
dpc-4489	79	21	27.5	27.5	NUM
dpc-4489	79	22	;	;	PUNCT
dpc-4489	79	23	h&e	h&e	PROPN
dpc-4489	79	24	,	,	PUNCT
dpc-4489	79	25	×200	×200	PROPN
dpc-4489	79	26	)	)	PUNCT
dpc-4489	79	27	.	.	PUNCT
dpc-4489	80	1	(	(	PUNCT
dpc-4489	80	2	b	b	X
dpc-4489	80	3	)	)	PUNCT
dpc-4489	80	4	necrotic	necrotic	ADJ
dpc-4489	80	5	keratinocyte	keratinocyte	NOUN
dpc-4489	80	6	(	(	PUNCT
dpc-4489	80	7	black	black	ADJ
dpc-4489	80	8	arrow	arrow	NOUN
dpc-4489	80	9	)	)	PUNCT
dpc-4489	80	10	in	in	ADP
dpc-4489	80	11	upper	upper	ADJ
dpc-4489	80	12	epidermis	epidermis	NOUN
dpc-4489	80	13	in	in	ADP
dpc-4489	80	14	psoriasis	psoriasis	NOUN
dpc-4489	80	15	patient	patient	NOUN
dpc-4489	80	16	(	(	PUNCT
dpc-4489	80	17	pasi	pasi	NOUN
dpc-4489	80	18	:	:	PUNCT
dpc-4489	80	19	2	2	NUM
dpc-4489	80	20	;	;	PUNCT
dpc-4489	80	21	h&e	h&e	PROPN
dpc-4489	80	22	,	,	PUNCT
dpc-4489	80	23	×200	×200	PROPN
dpc-4489	80	24	)	)	PUNCT
dpc-4489	80	25	.	.	PUNCT
dpc-4489	81	1	figure	figure	NOUN
dpc-4489	81	2	2	2	NUM
dpc-4489	81	3	.	.	PUNCT
dpc-4489	82	1	(	(	PUNCT
dpc-4489	82	2	a	a	PRON
dpc-4489	82	3	)	)	PUNCT
dpc-4489	82	4	psoriasiform	psoriasiform	NOUN
dpc-4489	82	5	spongiotic	spongiotic	PROPN
dpc-4489	82	6	dermatitis	dermatitis	PROPN
dpc-4489	82	7	without	without	ADP
dpc-4489	82	8	necrotic	necrotic	ADJ
dpc-4489	82	9	keratinocytes	keratinocyte	NOUN
dpc-4489	82	10	(	(	PUNCT
dpc-4489	82	11	h&e	h&e	PROPN
dpc-4489	82	12	,	,	PUNCT
dpc-4489	82	13	×200	×200	PROPN
dpc-4489	82	14	)	)	PUNCT
dpc-4489	82	15	.	.	PUNCT
dpc-4489	83	1	(	(	PUNCT
dpc-4489	83	2	b	b	X
dpc-4489	83	3	)	)	PUNCT
dpc-4489	83	4	necrotic	necrotic	ADJ
dpc-4489	83	5	keratinocyte	keratinocyte	NOUN
dpc-4489	83	6	(	(	PUNCT
dpc-4489	83	7	black	black	ADJ
dpc-4489	83	8	arrow	arrow	NOUN
dpc-4489	83	9	)	)	PUNCT
dpc-4489	83	10	in	in	ADP
dpc-4489	83	11	middle	middle	ADJ
dpc-4489	83	12	epidermis	epidermis	NOUN
dpc-4489	83	13	in	in	ADP
dpc-4489	83	14	psoriasiform	psoriasiform	PROPN
dpc-4489	83	15	spongiotic	spongiotic	PROPN
dpc-4489	83	16	dermatitis	dermatitis	PROPN
dpc-4489	83	17	patient	patient	NOUN
dpc-4489	83	18	(	(	PUNCT
dpc-4489	83	19	h&e	h&e	PROPN
dpc-4489	83	20	,	,	PUNCT
dpc-4489	83	21	×200	×200	PROPN
dpc-4489	83	22	)	)	PUNCT
dpc-4489	83	23	.	.	PUNCT
dpc-4489	84	1	figure	figure	VERB
dpc-4489	84	2	3	3	NUM
dpc-4489	84	3	.	.	PUNCT
dpc-4489	85	1	(	(	PUNCT
dpc-4489	85	2	a	a	X
dpc-4489	85	3	)	)	PUNCT
dpc-4489	85	4	normal	normal	ADJ
dpc-4489	85	5	skin	skin	NOUN
dpc-4489	85	6	without	without	ADP
dpc-4489	85	7	necrotic	necrotic	ADJ
dpc-4489	85	8	keratinocytes	keratinocyte	NOUN
dpc-4489	85	9	(	(	PUNCT
dpc-4489	85	10	h&e	h&e	PROPN
dpc-4489	85	11	,	,	PUNCT
dpc-4489	85	12	×200	×200	PROPN
dpc-4489	85	13	)	)	PUNCT
dpc-4489	85	14	.	.	PUNCT
dpc-4489	86	1	(	(	PUNCT
dpc-4489	86	2	b	b	X
dpc-4489	86	3	)	)	PUNCT
dpc-4489	86	4	necrotic	necrotic	ADJ
dpc-4489	86	5	keratinocyte	keratinocyte	NOUN
dpc-4489	86	6	(	(	PUNCT
dpc-4489	86	7	black	black	ADJ
dpc-4489	86	8	arrow	arrow	NOUN
dpc-4489	86	9	)	)	PUNCT
dpc-4489	86	10	in	in	ADP
dpc-4489	86	11	middle	middle	ADJ
dpc-4489	86	12	epidermis	epidermis	NOUN
dpc-4489	86	13	in	in	ADP
dpc-4489	86	14	normal	normal	ADJ
dpc-4489	86	15	skin	skin	NOUN
dpc-4489	86	16	(	(	PUNCT
dpc-4489	86	17	h&e	h&e	PROPN
dpc-4489	86	18	,	,	PUNCT
dpc-4489	86	19	×200	×200	PROPN
dpc-4489	86	20	)	)	PUNCT
dpc-4489	86	21	.	.	PUNCT
dpc-4489	87	1	table	table	NOUN
dpc-4489	87	2	2	2	NUM
dpc-4489	87	3	:	:	PUNCT
dpc-4489	87	4	quantitative	quantitative	ADJ
dpc-4489	87	5	analysis	analysis	NOUN
dpc-4489	87	6	of	of	ADP
dpc-4489	87	7	necrotic	necrotic	ADJ
dpc-4489	87	8	keratinocyte	keratinocyte	NOUN
dpc-4489	87	9	(	(	PUNCT
dpc-4489	87	10	nk	nk	PROPN
dpc-4489	87	11	)	)	PUNCT
dpc-4489	87	12	in	in	ADP
dpc-4489	87	13	psoriasis	psoriasis	NOUN
dpc-4489	87	14	,	,	PUNCT
dpc-4489	87	15	psoriasiform	psoriasiform	NOUN
dpc-4489	87	16	spongiotic	spongiotic	PROPN
dpc-4489	87	17	dermatitis	dermatitis	PROPN
dpc-4489	87	18	,	,	PUNCT
dpc-4489	87	19	and	and	CCONJ
dpc-4489	87	20	control	control	NOUN
dpc-4489	87	21	.	.	PUNCT
dpc-4489	88	1	psoriasis	psoriasis	NOUN
dpc-4489	88	2	psoriasiform	psoriasiform	NOUN
dpc-4489	88	3	spongiotic	spongiotic	PROPN
dpc-4489	88	4	dermatitis	dermatitis	PROPN
dpc-4489	88	5	control	control	NOUN
dpc-4489	88	6	p	p	ADJ
dpc-4489	88	7	-	-	PUNCT
dpc-4489	88	8	value	value	NOUN
dpc-4489	88	9	total	total	ADJ
dpc-4489	88	10	number	number	NOUN
dpc-4489	88	11	of	of	ADP
dpc-4489	88	12	cases	case	NOUN
dpc-4489	88	13	135	135	NUM
dpc-4489	88	14	57	57	NUM
dpc-4489	88	15	71	71	NUM
dpc-4489	88	16	cases	case	NOUN
dpc-4489	88	17	with	with	ADP
dpc-4489	88	18	nk	nk	PROPN
dpc-4489	88	19	134	134	NUM
dpc-4489	88	20	25	25	NUM
dpc-4489	88	21	9	9	NUM
dpc-4489	88	22	percentage	percentage	NOUN
dpc-4489	88	23	(	(	PUNCT
dpc-4489	88	24	%	%	NOUN
dpc-4489	88	25	)	)	PUNCT
dpc-4489	88	26	99.3	99.3	NUM
dpc-4489	88	27	%	%	NOUN
dpc-4489	88	28	43.9	43.9	NUM
dpc-4489	88	29	%	%	NOUN
dpc-4489	88	30	12.7	12.7	NUM
dpc-4489	88	31	%	%	NOUN
dpc-4489	88	32	<	<	X
dpc-4489	88	33	.001	.001	NUM
dpc-4489	88	34	mean	mean	ADJ
dpc-4489	88	35	number	number	NOUN
dpc-4489	88	36	of	of	ADP
dpc-4489	88	37	nk	nk	PROPN
dpc-4489	88	38	5.27	5.27	NUM
dpc-4489	88	39	0.58	0.58	NUM
dpc-4489	88	40	0.13	0.13	NUM
dpc-4489	88	41	<	<	X
dpc-4489	88	42	.001	.001	NUM
dpc-4489	88	43	(	(	PUNCT
dpc-4489	88	44	note	note	NOUN
dpc-4489	88	45	:	:	PUNCT
dpc-4489	88	46	kruskal	kruskal	PROPN
dpc-4489	88	47	-	-	PUNCT
dpc-4489	88	48	wallis	wallis	PROPN
dpc-4489	88	49	test	test	NOUN
dpc-4489	88	50	was	be	AUX
dpc-4489	88	51	used	use	VERB
dpc-4489	88	52	for	for	ADP
dpc-4489	88	53	analysis	analysis	NOUN
dpc-4489	88	54	)	)	PUNCT
dpc-4489	88	55	in	in	ADP
dpc-4489	88	56	the	the	DET
dpc-4489	88	57	psoriasis	psoriasis	NOUN
dpc-4489	88	58	group	group	NOUN
dpc-4489	88	59	,	,	PUNCT
dpc-4489	88	60	a	a	DET
dpc-4489	88	61	strong	strong	ADJ
dpc-4489	88	62	,	,	PUNCT
dpc-4489	88	63	significant	significant	ADJ
dpc-4489	88	64	correlation	correlation	NOUN
dpc-4489	88	65	was	be	AUX
dpc-4489	88	66	observed	observe	VERB
dpc-4489	88	67	between	between	ADP
dpc-4489	88	68	pasi	pasi	NOUN
dpc-4489	88	69	score	score	NOUN
dpc-4489	88	70	and	and	CCONJ
dpc-4489	88	71	the	the	DET
dpc-4489	88	72	total	total	ADJ
dpc-4489	88	73	number	number	NOUN
dpc-4489	88	74	of	of	ADP
dpc-4489	88	75	necrotic	necrotic	ADJ
dpc-4489	88	76	keratinocytes	keratinocyte	NOUN
dpc-4489	88	77	(	(	PUNCT
dpc-4489	88	78	r	r	NOUN
dpc-4489	88	79	=	=	SYM
dpc-4489	88	80	.72	.72	NUM
dpc-4489	88	81	)	)	PUNCT
dpc-4489	88	82	.	.	PUNCT
dpc-4489	89	1	when	when	SCONJ
dpc-4489	89	2	that	that	DET
dpc-4489	89	3	correlation	correlation	NOUN
dpc-4489	89	4	was	be	AUX
dpc-4489	89	5	evaluated	evaluate	VERB
dpc-4489	89	6	separately	separately	ADV
dpc-4489	89	7	for	for	ADP
dpc-4489	89	8	each	each	PRON
dpc-4489	89	9	of	of	ADP
dpc-4489	89	10	the	the	DET
dpc-4489	89	11	three	three	NUM
dpc-4489	89	12	region	region	NOUN
dpc-4489	89	13	of	of	ADP
dpc-4489	89	14	the	the	DET
dpc-4489	89	15	epidermis	epidermis	NOUN
dpc-4489	89	16	,	,	PUNCT
dpc-4489	89	17	a	a	DET
dpc-4489	89	18	strong	strong	ADJ
dpc-4489	89	19	,	,	PUNCT
dpc-4489	89	20	significant	significant	ADJ
dpc-4489	89	21	correlation	correlation	NOUN
dpc-4489	89	22	also	also	ADV
dpc-4489	89	23	emerged	emerge	VERB
dpc-4489	89	24	between	between	ADP
dpc-4489	89	25	the	the	DET
dpc-4489	89	26	number	number	NOUN
dpc-4489	89	27	of	of	ADP
dpc-4489	89	28	necrotic	necrotic	ADJ
dpc-4489	89	29	keratinocytes	keratinocyte	NOUN
dpc-4489	89	30	in	in	ADP
dpc-4489	89	31	the	the	DET
dpc-4489	89	32	upper	upper	ADJ
dpc-4489	89	33	epidermis	epidermis	NOUN
dpc-4489	89	34	and	and	CCONJ
dpc-4489	89	35	pasi	pasi	NOUN
dpc-4489	89	36	score	score	NOUN
dpc-4489	89	37	(	(	PUNCT
dpc-4489	89	38	r	r	NOUN
dpc-4489	89	39	=	=	PUNCT
dpc-4489	89	40	.618	.618	NUM
dpc-4489	89	41	)	)	PUNCT
dpc-4489	89	42	.	.	PUNCT
dpc-4489	90	1	a	a	DET
dpc-4489	90	2	significant	significant	ADJ
dpc-4489	90	3	correlation	correlation	NOUN
dpc-4489	90	4	was	be	AUX
dpc-4489	90	5	also	also	ADV
dpc-4489	90	6	observed	observe	VERB
dpc-4489	90	7	between	between	ADP
dpc-4489	90	8	pasi	pasi	NOUN
dpc-4489	90	9	score	score	NOUN
dpc-4489	90	10	and	and	CCONJ
dpc-4489	90	11	the	the	DET
dpc-4489	90	12	total	total	ADJ
dpc-4489	90	13	number	number	NOUN
dpc-4489	90	14	original	original	ADJ
dpc-4489	90	15	article	article	NOUN
dpc-4489	90	16	|	|	ADV
dpc-4489	90	17	dermatol	dermatol	ADJ
dpc-4489	90	18	pract	pract	NOUN
dpc-4489	90	19	concept	concept	NOUN
dpc-4489	90	20	.	.	PUNCT
dpc-4489	91	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	91	2	5	5	NUM
dpc-4489	91	3	specimens	specimen	NOUN
dpc-4489	91	4	from	from	ADP
dpc-4489	91	5	individuals	individual	NOUN
dpc-4489	91	6	with	with	ADP
dpc-4489	91	7	psoriasis	psoriasis	NOUN
dpc-4489	91	8	and	and	CCONJ
dpc-4489	91	9	eczematous	eczematous	ADJ
dpc-4489	91	10	dermatitis	dermatitis	NOUN
dpc-4489	91	11	exhibit	exhibit	VERB
dpc-4489	91	12	clear	clear	ADV
dpc-4489	91	13	-	-	PUNCT
dpc-4489	91	14	cut	cut	VERB
dpc-4489	91	15	features	feature	NOUN
dpc-4489	91	16	,	,	PUNCT
dpc-4489	91	17	a	a	DET
dpc-4489	91	18	notable	notable	ADJ
dpc-4489	91	19	proportion	proportion	NOUN
dpc-4489	91	20	presents	present	VERB
dpc-4489	91	21	with	with	ADP
dpc-4489	91	22	clinicopathologic	clinicopathologic	ADJ
dpc-4489	91	23	overlap	overlap	NOUN
dpc-4489	91	24	,	,	PUNCT
dpc-4489	91	25	which	which	PRON
dpc-4489	91	26	leads	lead	VERB
dpc-4489	91	27	to	to	ADP
dpc-4489	91	28	challenges	challenge	NOUN
dpc-4489	91	29	with	with	ADP
dpc-4489	91	30	diagnosis	diagnosis	NOUN
dpc-4489	91	31	[	[	X
dpc-4489	91	32	12	12	NUM
dpc-4489	91	33	]	]	PUNCT
dpc-4489	91	34	.	.	PUNCT
dpc-4489	92	1	recently	recently	ADV
dpc-4489	92	2	,	,	PUNCT
dpc-4489	92	3	the	the	DET
dpc-4489	92	4	significance	significance	NOUN
dpc-4489	92	5	of	of	ADP
dpc-4489	92	6	necrotic	necrotic	ADJ
dpc-4489	92	7	keratinocytes	keratinocyte	NOUN
dpc-4489	92	8	in	in	ADP
dpc-4489	92	9	diagnosing	diagnose	VERB
dpc-4489	92	10	psoriasis	psoriasis	NOUN
dpc-4489	92	11	has	have	AUX
dpc-4489	92	12	been	be	AUX
dpc-4489	92	13	emphasized	emphasize	VERB
dpc-4489	92	14	in	in	ADP
dpc-4489	92	15	pathological	pathological	ADJ
dpc-4489	92	16	studies	study	NOUN
dpc-4489	92	17	[	[	X
dpc-4489	92	18	8,13	8,13	NUM
dpc-4489	92	19	]	]	PUNCT
dpc-4489	92	20	.	.	PUNCT
dpc-4489	93	1	in	in	ADP
dpc-4489	93	2	a	a	DET
dpc-4489	93	3	study	study	NOUN
dpc-4489	93	4	by	by	ADP
dpc-4489	93	5	cloutier	cloutier	PROPN
dpc-4489	93	6	et	et	PROPN
dpc-4489	93	7	al	al	PROPN
dpc-4489	93	8	.	.	PROPN
dpc-4489	93	9	,	,	PUNCT
dpc-4489	93	10	for	for	ADP
dpc-4489	93	11	example	example	NOUN
dpc-4489	93	12	,	,	PUNCT
dpc-4489	93	13	necrotic	necrotic	ADJ
dpc-4489	93	14	keratinocytes	keratinocyte	NOUN
dpc-4489	93	15	were	be	AUX
dpc-4489	93	16	found	find	VERB
dpc-4489	93	17	to	to	PART
dpc-4489	93	18	be	be	AUX
dpc-4489	93	19	valuable	valuable	ADJ
dpc-4489	93	20	in	in	ADP
dpc-4489	93	21	differentiating	differentiate	VERB
dpc-4489	93	22	psoriasis	psoriasis	NOUN
dpc-4489	93	23	from	from	ADP
dpc-4489	93	24	psoriasiform	psoriasiform	PROPN
dpc-4489	93	25	spongiotic	spongiotic	PROPN
dpc-4489	93	26	dermatitis	dermatitis	PROPN
dpc-4489	93	27	,	,	PUNCT
dpc-4489	93	28	which	which	PRON
dpc-4489	93	29	shares	share	VERB
dpc-4489	93	30	similar	similar	ADJ
dpc-4489	93	31	histopathological	histopathological	ADJ
dpc-4489	93	32	and	and	CCONJ
dpc-4489	93	33	clinical	clinical	ADJ
dpc-4489	93	34	features	feature	NOUN
dpc-4489	93	35	with	with	ADP
dpc-4489	93	36	psoriasis	psoriasis	NOUN
dpc-4489	93	37	[	[	X
dpc-4489	93	38	8	8	NUM
dpc-4489	93	39	]	]	PUNCT
dpc-4489	93	40	.	.	PUNCT
dpc-4489	94	1	in	in	ADP
dpc-4489	94	2	our	our	PRON
dpc-4489	94	3	study	study	NOUN
dpc-4489	94	4	,	,	PUNCT
dpc-4489	94	5	we	we	PRON
dpc-4489	94	6	quantitatively	quantitatively	ADV
dpc-4489	94	7	evaluated	evaluate	VERB
dpc-4489	94	8	necrotic	necrotic	ADJ
dpc-4489	94	9	keratinocytes	keratinocyte	NOUN
dpc-4489	94	10	in	in	ADP
dpc-4489	94	11	three	three	NUM
dpc-4489	94	12	groups	group	NOUN
dpc-4489	94	13	:	:	PUNCT
dpc-4489	94	14	patients	patient	NOUN
dpc-4489	94	15	with	with	ADP
dpc-4489	94	16	psoriasis	psoriasis	NOUN
dpc-4489	94	17	,	,	PUNCT
dpc-4489	94	18	patients	patient	NOUN
dpc-4489	94	19	with	with	ADP
dpc-4489	94	20	psoriasiform	psoriasiform	PROPN
dpc-4489	94	21	spongiotic	spongiotic	PROPN
dpc-4489	94	22	dermatitis	dermatitis	PROPN
dpc-4489	94	23	,	,	PUNCT
dpc-4489	94	24	and	and	CCONJ
dpc-4489	94	25	normal	normal	ADJ
dpc-4489	94	26	skin	skin	NOUN
dpc-4489	94	27	of	of	ADP
dpc-4489	94	28	the	the	DET
dpc-4489	94	29	control	control	NOUN
dpc-4489	94	30	group	group	NOUN
dpc-4489	94	31	.	.	PUNCT
dpc-4489	95	1	our	our	PRON
dpc-4489	95	2	results	result	NOUN
dpc-4489	95	3	showed	show	VERB
dpc-4489	95	4	that	that	SCONJ
dpc-4489	95	5	the	the	DET
dpc-4489	95	6	psoriasis	psoriasis	NOUN
dpc-4489	95	7	group	group	NOUN
dpc-4489	95	8	had	have	VERB
dpc-4489	95	9	a	a	DET
dpc-4489	95	10	significantly	significantly	ADV
dpc-4489	95	11	higher	high	ADJ
dpc-4489	95	12	total	total	ADJ
dpc-4489	95	13	number	number	NOUN
dpc-4489	95	14	of	of	ADP
dpc-4489	95	15	necrotic	necrotic	ADJ
dpc-4489	95	16	keratinocytes	keratinocyte	NOUN
dpc-4489	95	17	than	than	ADP
dpc-4489	95	18	both	both	CCONJ
dpc-4489	95	19	the	the	DET
dpc-4489	95	20	psoriasiform	psoriasiform	NOUN
dpc-4489	95	21	spongiotic	spongiotic	PROPN
dpc-4489	95	22	dermatitis	dermatitis	PROPN
dpc-4489	95	23	and	and	CCONJ
dpc-4489	95	24	control	control	NOUN
dpc-4489	95	25	groups	group	NOUN
dpc-4489	95	26	.	.	PUNCT
dpc-4489	96	1	those	those	DET
dpc-4489	96	2	findings	finding	NOUN
dpc-4489	96	3	are	be	AUX
dpc-4489	96	4	consistent	consistent	ADJ
dpc-4489	96	5	with	with	ADP
dpc-4489	96	6	the	the	DET
dpc-4489	96	7	results	result	NOUN
dpc-4489	96	8	of	of	ADP
dpc-4489	96	9	cloutier	cloutier	PROPN
dpc-4489	96	10	et	et	PROPN
dpc-4489	96	11	al	al	PROPN
dpc-4489	96	12	.	.	PROPN
dpc-4489	96	13	,	,	PUNCT
dpc-4489	96	14	who	who	PRON
dpc-4489	96	15	also	also	ADV
dpc-4489	96	16	found	find	VERB
dpc-4489	96	17	significant	significant	ADJ
dpc-4489	96	18	results	result	NOUN
dpc-4489	96	19	among	among	ADP
dpc-4489	96	20	patients	patient	NOUN
dpc-4489	96	21	with	with	ADP
dpc-4489	96	22	psoriasis	psoriasis	NOUN
dpc-4489	96	23	[	[	X
dpc-4489	96	24	8	8	NUM
dpc-4489	96	25	]	]	PUNCT
dpc-4489	96	26	.	.	PUNCT
dpc-4489	97	1	the	the	DET
dpc-4489	97	2	increased	increase	VERB
dpc-4489	97	3	necrotic	necrotic	ADJ
dpc-4489	97	4	keratinocytes	keratinocyte	NOUN
dpc-4489	97	5	that	that	PRON
dpc-4489	97	6	we	we	PRON
dpc-4489	97	7	observed	observe	VERB
dpc-4489	97	8	in	in	ADP
dpc-4489	97	9	patients	patient	NOUN
dpc-4489	97	10	with	with	ADP
dpc-4489	97	11	psoriasis	psoriasis	NOUN
dpc-4489	97	12	in	in	ADP
dpc-4489	97	13	our	our	PRON
dpc-4489	97	14	study	study	NOUN
dpc-4489	97	15	will	will	AUX
dpc-4489	97	16	be	be	AUX
dpc-4489	97	17	useful	useful	ADJ
dpc-4489	97	18	in	in	ADP
dpc-4489	97	19	differentiating	differentiate	VERB
dpc-4489	97	20	spongiotic	spongiotic	ADJ
dpc-4489	97	21	psoriasiform	psoriasiform	NOUN
dpc-4489	97	22	dermatitis	dermatitis	PROPN
dpc-4489	97	23	,	,	PUNCT
dpc-4489	97	24	which	which	PRON
dpc-4489	97	25	has	have	VERB
dpc-4489	97	26	clinical	clinical	ADJ
dpc-4489	97	27	and	and	CCONJ
dpc-4489	97	28	histopathological	histopathological	ADJ
dpc-4489	97	29	features	feature	NOUN
dpc-4489	97	30	similar	similar	ADJ
dpc-4489	97	31	to	to	ADP
dpc-4489	97	32	psoriasis	psoriasis	NOUN
dpc-4489	97	33	’s	’s	NOUN
dpc-4489	97	34	.	.	PUNCT
dpc-4489	98	1	of	of	ADP
dpc-4489	98	2	necrotic	necrotic	ADJ
dpc-4489	98	3	keratinocytes	keratinocyte	NOUN
dpc-4489	98	4	in	in	ADP
dpc-4489	98	5	the	the	DET
dpc-4489	98	6	middle	middle	ADJ
dpc-4489	98	7	epidermis	epidermis	NOUN
dpc-4489	98	8	(	(	PUNCT
dpc-4489	98	9	r	r	NOUN
dpc-4489	98	10	=	=	NOUN
dpc-4489	98	11	.235	.235	NUM
dpc-4489	98	12	)	)	PUNCT
dpc-4489	98	13	.	.	PUNCT
dpc-4489	99	1	however	however	ADV
dpc-4489	99	2	,	,	PUNCT
dpc-4489	99	3	no	no	DET
dpc-4489	99	4	significant	significant	ADJ
dpc-4489	99	5	correlation	correlation	NOUN
dpc-4489	99	6	was	be	AUX
dpc-4489	99	7	found	find	VERB
dpc-4489	99	8	between	between	ADP
dpc-4489	99	9	the	the	DET
dpc-4489	99	10	number	number	NOUN
dpc-4489	99	11	of	of	ADP
dpc-4489	99	12	necrotic	necrotic	ADJ
dpc-4489	99	13	keratinocytes	keratinocyte	NOUN
dpc-4489	99	14	in	in	ADP
dpc-4489	99	15	the	the	DET
dpc-4489	99	16	lower	low	ADJ
dpc-4489	99	17	epidermis	epidermis	NOUN
dpc-4489	99	18	and	and	CCONJ
dpc-4489	99	19	pasi	pasi	NOUN
dpc-4489	99	20	score	score	NOUN
dpc-4489	99	21	.	.	PUNCT
dpc-4489	100	1	the	the	DET
dpc-4489	100	2	correlation	correlation	NOUN
dpc-4489	100	3	between	between	ADP
dpc-4489	100	4	the	the	DET
dpc-4489	100	5	total	total	ADJ
dpc-4489	100	6	number	number	NOUN
dpc-4489	100	7	of	of	ADP
dpc-4489	100	8	necrotic	necrotic	ADJ
dpc-4489	100	9	keratinocytes	keratinocyte	NOUN
dpc-4489	100	10	and	and	CCONJ
dpc-4489	100	11	pasi	pasi	NOUN
dpc-4489	100	12	score	score	NOUN
dpc-4489	100	13	is	be	AUX
dpc-4489	100	14	illustrated	illustrate	VERB
dpc-4489	100	15	in	in	ADP
dpc-4489	100	16	figure	figure	NOUN
dpc-4489	100	17	4	4	NUM
dpc-4489	100	18	.	.	PUNCT
dpc-4489	100	19	discussion	discussion	NOUN
dpc-4489	100	20	psoriasis	psoriasis	NOUN
dpc-4489	100	21	is	be	AUX
dpc-4489	100	22	a	a	DET
dpc-4489	100	23	chronic	chronic	ADJ
dpc-4489	100	24	inflammatory	inflammatory	ADJ
dpc-4489	100	25	skin	skin	NOUN
dpc-4489	100	26	disorder	disorder	NOUN
dpc-4489	100	27	characterized	characterize	VERB
dpc-4489	100	28	by	by	ADP
dpc-4489	100	29	the	the	DET
dpc-4489	100	30	hyperproliferation	hyperproliferation	NOUN
dpc-4489	100	31	and	and	CCONJ
dpc-4489	100	32	impaired	impaired	ADJ
dpc-4489	100	33	maturation	maturation	NOUN
dpc-4489	100	34	of	of	ADP
dpc-4489	100	35	keratinocytes	keratinocyte	NOUN
dpc-4489	100	36	,	,	PUNCT
dpc-4489	100	37	the	the	DET
dpc-4489	100	38	increased	increase	VERB
dpc-4489	100	39	infiltration	infiltration	NOUN
dpc-4489	100	40	of	of	ADP
dpc-4489	100	41	immune	immune	ADJ
dpc-4489	100	42	cells	cell	NOUN
dpc-4489	100	43	and	and	CCONJ
dpc-4489	100	44	blood	blood	NOUN
dpc-4489	100	45	vessel	vessel	NOUN
dpc-4489	100	46	formation	formation	NOUN
dpc-4489	100	47	,	,	PUNCT
dpc-4489	100	48	and	and	CCONJ
dpc-4489	100	49	the	the	DET
dpc-4489	100	50	accumulation	accumulation	NOUN
dpc-4489	100	51	of	of	ADP
dpc-4489	100	52	proinflammatory	proinflammatory	ADJ
dpc-4489	100	53	cytokines	cytokine	NOUN
dpc-4489	101	1	[	[	X
dpc-4489	101	2	3	3	NUM
dpc-4489	101	3	]	]	PUNCT
dpc-4489	101	4	.	.	PUNCT
dpc-4489	102	1	the	the	DET
dpc-4489	102	2	diagnosis	diagnosis	NOUN
dpc-4489	102	3	of	of	ADP
dpc-4489	102	4	psoriasis	psoriasis	NOUN
dpc-4489	102	5	is	be	AUX
dpc-4489	102	6	supported	support	VERB
dpc-4489	102	7	both	both	CCONJ
dpc-4489	102	8	clinically	clinically	ADV
dpc-4489	102	9	and	and	CCONJ
dpc-4489	102	10	histopathologically	histopathologically	ADV
dpc-4489	102	11	[	[	X
dpc-4489	102	12	9	9	NUM
dpc-4489	102	13	]	]	PUNCT
dpc-4489	102	14	,	,	PUNCT
dpc-4489	102	15	while	while	SCONJ
dpc-4489	102	16	the	the	DET
dpc-4489	102	17	disease	disease	NOUN
dpc-4489	102	18	’s	’s	PART
dpc-4489	102	19	severity	severity	NOUN
dpc-4489	102	20	is	be	AUX
dpc-4489	102	21	determined	determine	VERB
dpc-4489	102	22	using	use	VERB
dpc-4489	102	23	various	various	ADJ
dpc-4489	102	24	parameters	parameter	NOUN
dpc-4489	102	25	,	,	PUNCT
dpc-4489	102	26	with	with	ADP
dpc-4489	102	27	pasi	pasi	NOUN
dpc-4489	102	28	score	score	NOUN
dpc-4489	102	29	being	be	AUX
dpc-4489	102	30	a	a	DET
dpc-4489	102	31	primary	primary	ADJ
dpc-4489	102	32	indicator	indicator	NOUN
dpc-4489	102	33	[	[	X
dpc-4489	102	34	10	10	NUM
dpc-4489	102	35	]	]	PUNCT
dpc-4489	102	36	.	.	PUNCT
dpc-4489	103	1	pathologists	pathologist	NOUN
dpc-4489	103	2	usually	usually	ADV
dpc-4489	103	3	refer	refer	VERB
dpc-4489	103	4	to	to	ADP
dpc-4489	103	5	textbook	textbook	NOUN
dpc-4489	103	6	descriptions	description	NOUN
dpc-4489	103	7	of	of	ADP
dpc-4489	103	8	psoriasis	psoriasis	NOUN
dpc-4489	103	9	,	,	PUNCT
dpc-4489	103	10	which	which	PRON
dpc-4489	103	11	emphasize	emphasize	VERB
dpc-4489	103	12	the	the	DET
dpc-4489	103	13	disease	disease	NOUN
dpc-4489	103	14	’s	’s	PART
dpc-4489	103	15	important	important	ADJ
dpc-4489	103	16	histological	histological	ADJ
dpc-4489	103	17	characteristics	characteristic	NOUN
dpc-4489	103	18	such	such	ADJ
dpc-4489	103	19	as	as	ADP
dpc-4489	103	20	acanthosis	acanthosis	NOUN
dpc-4489	103	21	,	,	PUNCT
dpc-4489	103	22	parakeratosis	parakeratosis	NOUN
dpc-4489	103	23	,	,	PUNCT
dpc-4489	103	24	reduced	reduce	VERB
dpc-4489	103	25	stratum	stratum	PROPN
dpc-4489	103	26	granulosum	granulosum	NOUN
dpc-4489	103	27	,	,	PUNCT
dpc-4489	103	28	the	the	DET
dpc-4489	103	29	presence	presence	NOUN
dpc-4489	103	30	of	of	ADP
dpc-4489	103	31	neutrophils	neutrophil	NOUN
dpc-4489	103	32	in	in	ADP
dpc-4489	103	33	the	the	DET
dpc-4489	103	34	superficial	superficial	ADJ
dpc-4489	103	35	epidermis	epidermis	NOUN
dpc-4489	103	36	and	and	CCONJ
dpc-4489	103	37	stratum	stratum	PROPN
dpc-4489	103	38	corneum	corneum	NOUN
dpc-4489	103	39	,	,	PUNCT
dpc-4489	103	40	and	and	CCONJ
dpc-4489	103	41	increased	increase	VERB
dpc-4489	103	42	vascularity	vascularity	NOUN
dpc-4489	103	43	in	in	ADP
dpc-4489	103	44	the	the	DET
dpc-4489	103	45	papillary	papillary	ADJ
dpc-4489	103	46	dermis	dermis	NOUN
dpc-4489	104	1	[	[	X
dpc-4489	104	2	11	11	NUM
dpc-4489	104	3	]	]	PUNCT
dpc-4489	104	4	.	.	PUNCT
dpc-4489	105	1	while	while	SCONJ
dpc-4489	105	2	most	most	ADJ
dpc-4489	105	3	biopsy	biopsy	ADJ
dpc-4489	105	4	table	table	NOUN
dpc-4489	105	5	3	3	X
dpc-4489	105	6	.	.	PUNCT
dpc-4489	105	7	necrotic	necrotic	ADJ
dpc-4489	105	8	keratinocyte	keratinocyte	NOUN
dpc-4489	105	9	(	(	PUNCT
dpc-4489	105	10	nk	nk	PROPN
dpc-4489	105	11	)	)	PUNCT
dpc-4489	105	12	quantities	quantity	NOUN
dpc-4489	105	13	based	base	VERB
dpc-4489	105	14	on	on	ADP
dpc-4489	105	15	epidermal	epidermal	ADJ
dpc-4489	105	16	locations	location	NOUN
dpc-4489	105	17	in	in	ADP
dpc-4489	105	18	all	all	DET
dpc-4489	105	19	study	study	NOUN
dpc-4489	105	20	groups	group	NOUN
dpc-4489	105	21	.	.	PUNCT
dpc-4489	106	1	study	study	NOUN
dpc-4489	106	2	group	group	NOUN
dpc-4489	106	3	psoriasis	psoriasis	NOUN
dpc-4489	106	4	psoriasiform	psoriasiform	NOUN
dpc-4489	106	5	spongiotic	spongiotic	PROPN
dpc-4489	106	6	dermatitis	dermatitis	PROPN
dpc-4489	106	7	control	control	NOUN
dpc-4489	106	8	total	total	ADJ
dpc-4489	106	9	number	number	NOUN
dpc-4489	106	10	of	of	ADP
dpc-4489	106	11	nk	nk	PROPN
dpc-4489	106	12	712	712	NUM
dpc-4489	106	13	33	33	NUM
dpc-4489	106	14	9	9	NUM
dpc-4489	106	15	nk	nk	NOUN
dpc-4489	106	16	in	in	ADP
dpc-4489	106	17	upper	upper	ADJ
dpc-4489	106	18	epidermis	epidermis	NOUN
dpc-4489	106	19	,	,	PUNCT
dpc-4489	106	20	n	n	CCONJ
dpc-4489	106	21	(	(	PUNCT
dpc-4489	106	22	%	%	INTJ
dpc-4489	106	23	)	)	PUNCT
dpc-4489	106	24	552	552	NUM
dpc-4489	106	25	(	(	PUNCT
dpc-4489	106	26	77.5	77.5	NUM
dpc-4489	106	27	%	%	NOUN
dpc-4489	106	28	)	)	PUNCT
dpc-4489	106	29	23	23	NUM
dpc-4489	106	30	(	(	PUNCT
dpc-4489	106	31	69.7	69.7	NUM
dpc-4489	106	32	%	%	NOUN
dpc-4489	106	33	)	)	PUNCT
dpc-4489	106	34	3	3	NUM
dpc-4489	106	35	(	(	PUNCT
dpc-4489	106	36	33.3	33.3	NUM
dpc-4489	106	37	%	%	NOUN
dpc-4489	106	38	)	)	PUNCT
dpc-4489	106	39	nk	nk	PROPN
dpc-4489	106	40	in	in	ADP
dpc-4489	106	41	middle	middle	ADJ
dpc-4489	106	42	epidermis	epidermis	NOUN
dpc-4489	106	43	,	,	PUNCT
dpc-4489	106	44	n	n	CCONJ
dpc-4489	106	45	(	(	PUNCT
dpc-4489	106	46	%	%	INTJ
dpc-4489	106	47	)	)	PUNCT
dpc-4489	106	48	77	77	NUM
dpc-4489	106	49	(	(	PUNCT
dpc-4489	106	50	10.8	10.8	NUM
dpc-4489	106	51	%	%	NOUN
dpc-4489	106	52	)	)	PUNCT
dpc-4489	106	53	7	7	NUM
dpc-4489	106	54	(	(	PUNCT
dpc-4489	106	55	21.2	21.2	NUM
dpc-4489	106	56	%	%	NOUN
dpc-4489	106	57	)	)	PUNCT
dpc-4489	106	58	4	4	NUM
dpc-4489	106	59	(	(	PUNCT
dpc-4489	106	60	44.4	44.4	NUM
dpc-4489	106	61	%	%	NOUN
dpc-4489	106	62	)	)	PUNCT
dpc-4489	106	63	nk	nk	PROPN
dpc-4489	106	64	in	in	ADP
dpc-4489	106	65	lower	low	ADJ
dpc-4489	106	66	epidermis	epidermis	NOUN
dpc-4489	106	67	,	,	PUNCT
dpc-4489	106	68	n	n	CCONJ
dpc-4489	106	69	(	(	PUNCT
dpc-4489	106	70	%	%	INTJ
dpc-4489	106	71	)	)	PUNCT
dpc-4489	106	72	83	83	NUM
dpc-4489	106	73	(	(	PUNCT
dpc-4489	106	74	11.7	11.7	NUM
dpc-4489	106	75	%	%	NOUN
dpc-4489	106	76	)	)	PUNCT
dpc-4489	106	77	3	3	NUM
dpc-4489	106	78	(	(	PUNCT
dpc-4489	106	79	9.1	9.1	NUM
dpc-4489	106	80	%	%	NOUN
dpc-4489	106	81	)	)	PUNCT
dpc-4489	106	82	2	2	NUM
dpc-4489	106	83	(	(	PUNCT
dpc-4489	106	84	22.2	22.2	NUM
dpc-4489	106	85	%	%	NOUN
dpc-4489	106	86	)	)	PUNCT
dpc-4489	106	87	(	(	PUNCT
dpc-4489	106	88	note	note	NOUN
dpc-4489	106	89	:	:	PUNCT
dpc-4489	106	90	kruskal	kruskal	PROPN
dpc-4489	106	91	-	-	PUNCT
dpc-4489	106	92	wallis	wallis	PROPN
dpc-4489	106	93	test	test	NOUN
dpc-4489	106	94	was	be	AUX
dpc-4489	106	95	used	use	VERB
dpc-4489	106	96	for	for	ADP
dpc-4489	106	97	analysis	analysis	NOUN
dpc-4489	106	98	)	)	PUNCT
dpc-4489	106	99	figure	figure	NOUN
dpc-4489	106	100	4	4	NUM
dpc-4489	106	101	:	:	PUNCT
dpc-4489	106	102	the	the	DET
dpc-4489	106	103	correlation	correlation	NOUN
dpc-4489	106	104	between	between	ADP
dpc-4489	106	105	the	the	DET
dpc-4489	106	106	total	total	ADJ
dpc-4489	106	107	number	number	NOUN
dpc-4489	106	108	of	of	ADP
dpc-4489	106	109	necrotic	necrotic	ADJ
dpc-4489	106	110	keratinocytes	keratinocyte	NOUN
dpc-4489	106	111	and	and	CCONJ
dpc-4489	106	112	pasi	pasi	NOUN
dpc-4489	106	113	(	(	PUNCT
dpc-4489	106	114	note	note	NOUN
dpc-4489	106	115	:	:	PUNCT
dpc-4489	106	116	spearman	spearman	NOUN
dpc-4489	106	117	’s	’s	PART
dpc-4489	106	118	correlation	correlation	NOUN
dpc-4489	106	119	test	test	NOUN
dpc-4489	106	120	was	be	AUX
dpc-4489	106	121	used	use	VERB
dpc-4489	106	122	for	for	ADP
dpc-4489	106	123	analysis	analysis	NOUN
dpc-4489	106	124	)	)	PUNCT
dpc-4489	106	125	6	6	NUM
dpc-4489	106	126	original	original	ADJ
dpc-4489	106	127	article	article	NOUN
dpc-4489	106	128	|	|	ADV
dpc-4489	106	129	dermatol	dermatol	ADJ
dpc-4489	106	130	pract	pract	NOUN
dpc-4489	106	131	concept	concept	NOUN
dpc-4489	106	132	.	.	PUNCT
dpc-4489	107	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	107	2	between	between	ADP
dpc-4489	107	3	panoptosis	panoptosis	NOUN
dpc-4489	107	4	and	and	CCONJ
dpc-4489	107	5	the	the	DET
dpc-4489	107	6	development	development	NOUN
dpc-4489	107	7	of	of	ADP
dpc-4489	107	8	psoriasis	psoriasis	NOUN
dpc-4489	108	1	and	and	CCONJ
dpc-4489	108	2	observed	observe	VERB
dpc-4489	108	3	the	the	DET
dpc-4489	108	4	activation	activation	NOUN
dpc-4489	108	5	of	of	ADP
dpc-4489	108	6	pyroptosisand	pyroptosisand	NOUN
dpc-4489	108	7	apoptosis	apoptosis	NOUN
dpc-4489	108	8	signaling	signal	VERB
dpc-4489	108	9	pathways	pathway	NOUN
dpc-4489	109	1	[	[	X
dpc-4489	109	2	5	5	NUM
dpc-4489	109	3	]	]	PUNCT
dpc-4489	109	4	.	.	PUNCT
dpc-4489	110	1	similarly	similarly	ADV
dpc-4489	110	2	,	,	PUNCT
dpc-4489	110	3	hu	hu	PROPN
dpc-4489	110	4	et	et	PROPN
dpc-4489	110	5	al	al	PROPN
dpc-4489	110	6	.	.	PROPN
dpc-4489	110	7	identified	identify	VERB
dpc-4489	110	8	the	the	DET
dpc-4489	110	9	high	high	ADJ
dpc-4489	110	10	activity	activity	NOUN
dpc-4489	110	11	of	of	ADP
dpc-4489	110	12	the	the	DET
dpc-4489	110	13	panoptosis	panoptosis	NOUN
dpc-4489	110	14	pathway	pathway	NOUN
dpc-4489	110	15	in	in	ADP
dpc-4489	110	16	psoriatic	psoriatic	ADJ
dpc-4489	110	17	lesions	lesion	NOUN
dpc-4489	110	18	[	[	X
dpc-4489	110	19	7	7	NUM
dpc-4489	110	20	]	]	PUNCT
dpc-4489	110	21	.	.	PUNCT
dpc-4489	111	1	in	in	ADP
dpc-4489	111	2	another	another	DET
dpc-4489	111	3	study	study	NOUN
dpc-4489	111	4	,	,	PUNCT
dpc-4489	111	5	duan	duan	PROPN
dpc-4489	111	6	et	et	PROPN
dpc-4489	111	7	al	al	PROPN
dpc-4489	111	8	.	.	PROPN
dpc-4489	111	9	found	find	VERB
dpc-4489	111	10	results	result	NOUN
dpc-4489	111	11	suggesting	suggest	VERB
dpc-4489	111	12	that	that	PRON
dpc-4489	111	13	necroptosis	necroptosis	NOUN
dpc-4489	111	14	in	in	ADP
dpc-4489	111	15	keratinocytes	keratinocyte	NOUN
dpc-4489	111	16	triggers	trigger	VERB
dpc-4489	111	17	psoriatic	psoriatic	ADJ
dpc-4489	111	18	inflammation	inflammation	NOUN
dpc-4489	111	19	,	,	PUNCT
dpc-4489	111	20	which	which	PRON
dpc-4489	111	21	disrupts	disrupt	VERB
dpc-4489	111	22	the	the	DET
dpc-4489	111	23	epidermal	epidermal	ADJ
dpc-4489	111	24	barrier	barrier	NOUN
dpc-4489	111	25	and	and	CCONJ
dpc-4489	111	26	thereby	thereby	ADV
dpc-4489	111	27	exposes	expose	VERB
dpc-4489	111	28	keratinocytes	keratinocyte	NOUN
dpc-4489	111	29	to	to	ADP
dpc-4489	111	30	harmful	harmful	ADJ
dpc-4489	111	31	stimuli	stimulus	NOUN
dpc-4489	111	32	and	and	CCONJ
dpc-4489	111	33	causes	cause	VERB
dpc-4489	111	34	extensive	extensive	ADJ
dpc-4489	111	35	necroptosis	necroptosis	NOUN
dpc-4489	111	36	.	.	PUNCT
dpc-4489	112	1	programmed	program	VERB
dpc-4489	112	2	necrosis	necrosis	NOUN
dpc-4489	112	3	-	-	PUNCT
dpc-4489	112	4	related	relate	VERB
dpc-4489	112	5	proteins	protein	NOUN
dpc-4489	112	6	are	be	AUX
dpc-4489	112	7	primarily	primarily	ADV
dpc-4489	112	8	expressed	express	VERB
dpc-4489	112	9	in	in	ADP
dpc-4489	112	10	the	the	DET
dpc-4489	112	11	epidermis	epidermis	NOUN
dpc-4489	112	12	,	,	PUNCT
dpc-4489	112	13	particularly	particularly	ADV
dpc-4489	112	14	in	in	ADP
dpc-4489	112	15	keratinocytes	keratinocyte	NOUN
dpc-4489	112	16	.	.	PUNCT
dpc-4489	113	1	immunofluorescence	immunofluorescence	NOUN
dpc-4489	113	2	and	and	CCONJ
dpc-4489	113	3	the	the	DET
dpc-4489	113	4	immunohistochemical	immunohistochemical	ADJ
dpc-4489	113	5	labeling	labeling	NOUN
dpc-4489	113	6	of	of	ADP
dpc-4489	113	7	tunel	tunel	NOUN
dpc-4489	113	8	,	,	PUNCT
dpc-4489	113	9	active	active	ADJ
dpc-4489	113	10	caspase-3	caspase-3	PROPN
dpc-4489	113	11	,	,	PUNCT
dpc-4489	113	12	ripk1	ripk1	NOUN
dpc-4489	113	13	,	,	PUNCT
dpc-4489	113	14	and	and	CCONJ
dpc-4489	113	15	mlkl	mlkl	VERB
dpc-4489	113	16	indicate	indicate	VERB
dpc-4489	113	17	that	that	DET
dpc-4489	113	18	necroptosis	necroptosis	NOUN
dpc-4489	113	19	primarily	primarily	ADV
dpc-4489	113	20	occurs	occur	VERB
dpc-4489	113	21	in	in	ADP
dpc-4489	113	22	the	the	DET
dpc-4489	113	23	upper	upper	ADJ
dpc-4489	113	24	epidermis	epidermis	NOUN
dpc-4489	113	25	in	in	ADP
dpc-4489	113	26	mice	mouse	NOUN
dpc-4489	113	27	,	,	PUNCT
dpc-4489	113	28	as	as	SCONJ
dpc-4489	113	29	is	be	AUX
dpc-4489	113	30	consistent	consistent	ADJ
dpc-4489	113	31	with	with	ADP
dpc-4489	113	32	results	result	NOUN
dpc-4489	113	33	in	in	ADP
dpc-4489	113	34	patients	patient	NOUN
dpc-4489	113	35	with	with	ADP
dpc-4489	113	36	psoriasis	psoriasis	NOUN
dpc-4489	113	37	[	[	X
dpc-4489	113	38	3	3	NUM
dpc-4489	113	39	]	]	PUNCT
dpc-4489	113	40	.	.	PUNCT
dpc-4489	114	1	furthermore	furthermore	ADV
dpc-4489	114	2	,	,	PUNCT
dpc-4489	114	3	cloutier	cloutier	PROPN
dpc-4489	114	4	et	et	PROPN
dpc-4489	114	5	al	al	PROPN
dpc-4489	114	6	.	.	PROPN
dpc-4489	114	7	reported	report	VERB
dpc-4489	114	8	that	that	SCONJ
dpc-4489	114	9	89	89	NUM
dpc-4489	114	10	%	%	NOUN
dpc-4489	114	11	of	of	ADP
dpc-4489	114	12	necrotic	necrotic	ADJ
dpc-4489	114	13	keratinocytes	keratinocyte	NOUN
dpc-4489	114	14	in	in	ADP
dpc-4489	114	15	patients	patient	NOUN
dpc-4489	114	16	with	with	ADP
dpc-4489	114	17	psoriasis	psoriasis	NOUN
dpc-4489	114	18	were	be	AUX
dpc-4489	114	19	located	locate	VERB
dpc-4489	114	20	in	in	ADP
dpc-4489	114	21	the	the	DET
dpc-4489	114	22	upper	upper	ADJ
dpc-4489	114	23	two	two	NUM
dpc-4489	114	24	-	-	PUNCT
dpc-4489	114	25	thirds	third	NOUN
dpc-4489	114	26	of	of	ADP
dpc-4489	114	27	the	the	DET
dpc-4489	114	28	epidermis	epidermis	NOUN
dpc-4489	115	1	[	[	X
dpc-4489	115	2	8	8	NUM
dpc-4489	115	3	]	]	PUNCT
dpc-4489	115	4	.	.	PUNCT
dpc-4489	116	1	in	in	ADP
dpc-4489	116	2	our	our	PRON
dpc-4489	116	3	study	study	NOUN
dpc-4489	116	4	,	,	PUNCT
dpc-4489	116	5	88.3	88.3	NUM
dpc-4489	116	6	%	%	NOUN
dpc-4489	116	7	of	of	ADP
dpc-4489	116	8	necrotic	necrotic	ADJ
dpc-4489	116	9	keratinocytes	keratinocyte	NOUN
dpc-4489	116	10	,	,	PUNCT
dpc-4489	116	11	which	which	PRON
dpc-4489	116	12	we	we	PRON
dpc-4489	116	13	believe	believe	VERB
dpc-4489	116	14	may	may	AUX
dpc-4489	116	15	indicate	indicate	VERB
dpc-4489	116	16	panoptosis	panoptosis	NOUN
dpc-4489	116	17	,	,	PUNCT
dpc-4489	116	18	were	be	AUX
dpc-4489	116	19	located	locate	VERB
dpc-4489	116	20	in	in	ADP
dpc-4489	116	21	the	the	DET
dpc-4489	116	22	upper	upper	ADJ
dpc-4489	116	23	two	two	NUM
dpc-4489	116	24	-	-	PUNCT
dpc-4489	116	25	thirds	third	NOUN
dpc-4489	116	26	of	of	ADP
dpc-4489	116	27	the	the	DET
dpc-4489	116	28	epidermis	epidermis	NOUN
dpc-4489	116	29	,	,	PUNCT
dpc-4489	116	30	which	which	PRON
dpc-4489	116	31	supports	support	VERB
dpc-4489	116	32	the	the	DET
dpc-4489	116	33	findings	finding	NOUN
dpc-4489	116	34	of	of	ADP
dpc-4489	116	35	both	both	DET
dpc-4489	116	36	duan	duan	PROPN
dpc-4489	116	37	et	et	PROPN
dpc-4489	116	38	al	al	PROPN
dpc-4489	116	39	.	.	PROPN
dpc-4489	116	40	and	and	CCONJ
dpc-4489	116	41	cloutier	cloutier	PROPN
dpc-4489	116	42	et	et	PROPN
dpc-4489	116	43	al	al	PROPN
dpc-4489	116	44	.	.	PUNCT
dpc-4489	117	1	[	[	X
dpc-4489	117	2	3,8	3,8	NUM
dpc-4489	117	3	]	]	PUNCT
dpc-4489	117	4	.	.	PUNCT
dpc-4489	118	1	the	the	DET
dpc-4489	118	2	literature	literature	NOUN
dpc-4489	118	3	outlines	outline	VERB
dpc-4489	118	4	the	the	DET
dpc-4489	118	5	involvement	involvement	NOUN
dpc-4489	118	6	of	of	ADP
dpc-4489	118	7	panoptosis	panoptosis	NOUN
dpc-4489	118	8	in	in	ADP
dpc-4489	118	9	psoriasis	psoriasis	NOUN
dpc-4489	118	10	’s	’s	PART
dpc-4489	118	11	pathogenesis	pathogenesis	NOUN
dpc-4489	118	12	and	and	CCONJ
dpc-4489	118	13	,	,	PUNCT
dpc-4489	118	14	on	on	ADP
dpc-4489	118	15	that	that	DET
dpc-4489	118	16	count	count	NOUN
dpc-4489	118	17	,	,	PUNCT
dpc-4489	118	18	indicates	indicate	VERB
dpc-4489	118	19	that	that	SCONJ
dpc-4489	118	20	elevated	elevated	ADJ
dpc-4489	118	21	levels	level	NOUN
dpc-4489	118	22	of	of	ADP
dpc-4489	118	23	circulating	circulate	VERB
dpc-4489	118	24	cytokines	cytokine	NOUN
dpc-4489	118	25	such	such	ADJ
dpc-4489	118	26	as	as	ADP
dpc-4489	118	27	tnf	tnf	PROPN
dpc-4489	118	28	and	and	CCONJ
dpc-4489	118	29	ifn	ifn	PROPN
dpc-4489	118	30	-	-	PUNCT
dpc-4489	118	31	γ	γ	NOUN
dpc-4489	118	32	can	can	AUX
dpc-4489	118	33	synergistically	synergistically	ADV
dpc-4489	118	34	induce	induce	VERB
dpc-4489	118	35	panoptosis	panoptosis	NOUN
dpc-4489	118	36	.	.	PUNCT
dpc-4489	119	1	panoptosis	panoptosis	NOUN
dpc-4489	119	2	entails	entail	VERB
dpc-4489	119	3	the	the	DET
dpc-4489	119	4	activation	activation	NOUN
dpc-4489	119	5	of	of	ADP
dpc-4489	119	6	molecules	molecule	NOUN
dpc-4489	119	7	associated	associate	VERB
dpc-4489	119	8	with	with	ADP
dpc-4489	119	9	pyroptosis	pyroptosis	NOUN
dpc-4489	119	10	(	(	PUNCT
dpc-4489	119	11	i.e.	i.e.	X
dpc-4489	119	12	,	,	PUNCT
dpc-4489	119	13	gsdmd	gsdmd	ADJ
dpc-4489	119	14	)	)	PUNCT
dpc-4489	119	15	,	,	PUNCT
dpc-4489	119	16	apoptosis	apoptosis	NOUN
dpc-4489	119	17	(	(	PUNCT
dpc-4489	119	18	i.e.	i.e.	X
dpc-4489	119	19	,	,	PUNCT
dpc-4489	119	20	casp8/3/7	casp8/3/7	NOUN
dpc-4489	119	21	)	)	PUNCT
dpc-4489	119	22	,	,	PUNCT
dpc-4489	119	23	and	and	CCONJ
dpc-4489	119	24	necroptosis	necroptosis	NOUN
dpc-4489	119	25	(	(	PUNCT
dpc-4489	119	26	i.e.	i.e.	X
dpc-4489	119	27	,	,	PUNCT
dpc-4489	119	28	pmlkl	pmlkl	NOUN
dpc-4489	119	29	)	)	PUNCT
dpc-4489	119	30	.	.	PUNCT
dpc-4489	120	1	furthermore	furthermore	ADV
dpc-4489	120	2	,	,	PUNCT
dpc-4489	120	3	those	those	DET
dpc-4489	120	4	cytokines	cytokine	NOUN
dpc-4489	120	5	can	can	AUX
dpc-4489	120	6	activate	activate	VERB
dpc-4489	120	7	jak	jak	PROPN
dpc-4489	120	8	/	/	SYM
dpc-4489	120	9	stat1	stat1	PROPN
dpc-4489	120	10	/	/	SYM
dpc-4489	120	11	irf1	irf1	NOUN
dpc-4489	120	12	signaling	signaling	ADJ
dpc-4489	120	13	and	and	CCONJ
dpc-4489	120	14	nitric	nitric	ADJ
dpc-4489	120	15	oxide	oxide	NOUN
dpc-4489	120	16	production	production	NOUN
dpc-4489	120	17	,	,	PUNCT
dpc-4489	120	18	which	which	PRON
dpc-4489	120	19	augments	augment	VERB
dpc-4489	120	20	casp8	casp8	PROPN
dpc-4489	120	21	/	/	SYM
dpc-4489	120	22	fadd	fadd	NOUN
dpc-4489	120	23	-	-	PUNCT
dpc-4489	120	24	mediated	mediate	VERB
dpc-4489	120	25	panoptosis	panoptosis	NOUN
dpc-4489	120	26	.	.	PUNCT
dpc-4489	121	1	that	that	DET
dpc-4489	121	2	process	process	NOUN
dpc-4489	121	3	leads	lead	VERB
dpc-4489	121	4	to	to	ADP
dpc-4489	121	5	excessive	excessive	ADJ
dpc-4489	121	6	cytokine	cytokine	NOUN
dpc-4489	121	7	production	production	NOUN
dpc-4489	121	8	,	,	PUNCT
dpc-4489	121	9	which	which	PRON
dpc-4489	121	10	results	result	VERB
dpc-4489	121	11	in	in	ADP
dpc-4489	121	12	a	a	DET
dpc-4489	121	13	cytokine	cytokine	ADJ
dpc-4489	121	14	storm	storm	NOUN
dpc-4489	121	15	that	that	PRON
dpc-4489	121	16	may	may	AUX
dpc-4489	121	17	perpetuate	perpetuate	VERB
dpc-4489	121	18	a	a	DET
dpc-4489	121	19	positive	positive	ADJ
dpc-4489	121	20	feedback	feedback	NOUN
dpc-4489	121	21	loop	loop	NOUN
dpc-4489	121	22	in	in	ADP
dpc-4489	121	23	psoriasis	psoriasis	NOUN
dpc-4489	121	24	’s	’s	PART
dpc-4489	121	25	progression	progression	NOUN
dpc-4489	122	1	[	[	X
dpc-4489	122	2	7	7	NUM
dpc-4489	122	3	]	]	PUNCT
dpc-4489	122	4	.	.	PUNCT
dpc-4489	123	1	furthermore	furthermore	ADV
dpc-4489	123	2	,	,	PUNCT
dpc-4489	123	3	the	the	DET
dpc-4489	123	4	il-23/	il-23/	NOUN
dpc-4489	123	5	il-17	il-17	NUM
dpc-4489	123	6	axis	axis	NOUN
dpc-4489	123	7	is	be	AUX
dpc-4489	123	8	closely	closely	ADV
dpc-4489	123	9	associated	associate	VERB
dpc-4489	123	10	with	with	ADP
dpc-4489	123	11	the	the	DET
dpc-4489	123	12	panoptosome	panoptosome	NOUN
dpc-4489	123	13	complex	complex	NOUN
dpc-4489	123	14	.	.	PUNCT
dpc-4489	124	1	taken	take	VERB
dpc-4489	124	2	together	together	ADV
dpc-4489	124	3	,	,	PUNCT
dpc-4489	124	4	those	those	DET
dpc-4489	124	5	findings	finding	NOUN
dpc-4489	124	6	suggest	suggest	VERB
dpc-4489	124	7	that	that	SCONJ
dpc-4489	124	8	panoptosis	panoptosis	NOUN
dpc-4489	124	9	may	may	AUX
dpc-4489	124	10	be	be	AUX
dpc-4489	124	11	intricately	intricately	ADV
dpc-4489	124	12	linked	link	VERB
dpc-4489	124	13	to	to	ADP
dpc-4489	124	14	psoriasis	psoriasis	NOUN
dpc-4489	124	15	’s	’s	PART
dpc-4489	124	16	pathogenesis	pathogenesis	NOUN
dpc-4489	125	1	[	[	X
dpc-4489	125	2	5	5	NUM
dpc-4489	125	3	]	]	PUNCT
dpc-4489	125	4	.	.	PUNCT
dpc-4489	126	1	we	we	PRON
dpc-4489	126	2	additionally	additionally	ADV
dpc-4489	126	3	found	find	VERB
dpc-4489	126	4	a	a	DET
dpc-4489	126	5	statistically	statistically	ADV
dpc-4489	126	6	significant	significant	ADJ
dpc-4489	126	7	correlation	correlation	NOUN
dpc-4489	126	8	between	between	ADP
dpc-4489	126	9	the	the	DET
dpc-4489	126	10	total	total	ADJ
dpc-4489	126	11	count	count	NOUN
dpc-4489	126	12	of	of	ADP
dpc-4489	126	13	necrotic	necrotic	ADJ
dpc-4489	126	14	keratinocytes	keratinocyte	NOUN
dpc-4489	126	15	and	and	CCONJ
dpc-4489	126	16	pasi	pasi	NOUN
dpc-4489	126	17	score	score	NOUN
dpc-4489	126	18	,	,	PUNCT
dpc-4489	126	19	an	an	DET
dpc-4489	126	20	indicator	indicator	NOUN
dpc-4489	126	21	of	of	ADP
dpc-4489	126	22	psoriasis	psoriasis	NOUN
dpc-4489	126	23	’s	’s	PART
dpc-4489	126	24	severity	severity	NOUN
dpc-4489	126	25	.	.	PUNCT
dpc-4489	127	1	our	our	PRON
dpc-4489	127	2	results	result	NOUN
dpc-4489	127	3	showing	show	VERB
dpc-4489	127	4	significantly	significantly	ADV
dpc-4489	127	5	increased	increase	VERB
dpc-4489	127	6	necrotic	necrotic	ADJ
dpc-4489	127	7	keratinocytes	keratinocyte	NOUN
dpc-4489	127	8	in	in	ADP
dpc-4489	127	9	patients	patient	NOUN
dpc-4489	127	10	with	with	ADP
dpc-4489	127	11	psoriasis	psoriasis	NOUN
dpc-4489	127	12	and	and	CCONJ
dpc-4489	127	13	their	their	PRON
dpc-4489	127	14	correlation	correlation	NOUN
dpc-4489	127	15	with	with	ADP
dpc-4489	127	16	pasi	pasi	NOUN
dpc-4489	127	17	might	might	AUX
dpc-4489	127	18	be	be	AUX
dpc-4489	127	19	an	an	DET
dpc-4489	127	20	additional	additional	ADJ
dpc-4489	127	21	support	support	NOUN
dpc-4489	127	22	for	for	ADP
dpc-4489	127	23	studies	study	NOUN
dpc-4489	127	24	showing	show	VERB
dpc-4489	127	25	the	the	DET
dpc-4489	127	26	relationship	relationship	NOUN
dpc-4489	127	27	between	between	ADP
dpc-4489	127	28	necrotic	necrotic	ADJ
dpc-4489	127	29	keratinocytes	keratinocyte	NOUN
dpc-4489	127	30	in	in	ADP
dpc-4489	127	31	psoriasis	psoriasis	NOUN
dpc-4489	127	32	known	know	VERB
dpc-4489	127	33	as	as	ADP
dpc-4489	127	34	panoptosis	panoptosis	NOUN
dpc-4489	127	35	.	.	PUNCT
dpc-4489	128	1	to	to	ADP
dpc-4489	128	2	our	our	PRON
dpc-4489	128	3	knowledge	knowledge	NOUN
dpc-4489	128	4	,	,	PUNCT
dpc-4489	128	5	our	our	PRON
dpc-4489	128	6	study	study	NOUN
dpc-4489	128	7	was	be	AUX
dpc-4489	128	8	the	the	DET
dpc-4489	128	9	first	first	ADJ
dpc-4489	128	10	to	to	PART
dpc-4489	128	11	provide	provide	VERB
dpc-4489	128	12	evidence	evidence	NOUN
dpc-4489	128	13	supporting	support	VERB
dpc-4489	128	14	previous	previous	ADJ
dpc-4489	128	15	animal	animal	NOUN
dpc-4489	128	16	and	and	CCONJ
dpc-4489	128	17	human	human	ADJ
dpc-4489	128	18	studies	study	NOUN
dpc-4489	128	19	on	on	ADP
dpc-4489	128	20	panoptosis	panoptosis	NOUN
dpc-4489	128	21	’s	’s	PART
dpc-4489	128	22	role	role	NOUN
dpc-4489	128	23	in	in	ADP
dpc-4489	128	24	psoriasis	psoriasis	NOUN
dpc-4489	128	25	by	by	ADP
dpc-4489	128	26	showing	show	VERB
dpc-4489	128	27	its	its	PRON
dpc-4489	128	28	relationship	relationship	NOUN
dpc-4489	128	29	with	with	ADP
dpc-4489	128	30	clinical	clinical	ADJ
dpc-4489	128	31	severity	severity	NOUN
dpc-4489	128	32	.	.	PUNCT
dpc-4489	129	1	hu	hu	PROPN
dpc-4489	129	2	et	et	PROPN
dpc-4489	129	3	al	al	PROPN
dpc-4489	129	4	.	.	PROPN
dpc-4489	129	5	conducted	conduct	VERB
dpc-4489	129	6	a	a	DET
dpc-4489	129	7	study	study	NOUN
dpc-4489	129	8	to	to	PART
dpc-4489	129	9	investigate	investigate	VERB
dpc-4489	129	10	the	the	DET
dpc-4489	129	11	diverse	diverse	ADJ
dpc-4489	129	12	functions	function	NOUN
dpc-4489	129	13	of	of	ADP
dpc-4489	129	14	hub	hub	NOUN
dpc-4489	129	15	genes	gene	NOUN
dpc-4489	129	16	involved	involve	VERB
dpc-4489	129	17	in	in	ADP
dpc-4489	129	18	panoptosis	panoptosis	NOUN
dpc-4489	129	19	for	for	ADP
dpc-4489	129	20	drug	drug	NOUN
dpc-4489	129	21	prediction	prediction	NOUN
dpc-4489	129	22	.	.	PUNCT
dpc-4489	130	1	based	base	VERB
dpc-4489	130	2	on	on	ADP
dpc-4489	130	3	their	their	PRON
dpc-4489	130	4	experimental	experimental	ADJ
dpc-4489	130	5	data	datum	NOUN
dpc-4489	130	6	,	,	PUNCT
dpc-4489	130	7	they	they	PRON
dpc-4489	130	8	found	find	VERB
dpc-4489	130	9	that	that	SCONJ
dpc-4489	130	10	disulfiram	disulfiram	NOUN
dpc-4489	130	11	,	,	PUNCT
dpc-4489	130	12	a	a	DET
dpc-4489	130	13	predicted	predict	VERB
dpc-4489	130	14	drug	drug	NOUN
dpc-4489	130	15	,	,	PUNCT
dpc-4489	130	16	showed	show	VERB
dpc-4489	130	17	a	a	DET
dpc-4489	130	18	significant	significant	ADJ
dpc-4489	130	19	ameliorative	ameliorative	ADJ
dpc-4489	130	20	effect	effect	NOUN
dpc-4489	130	21	on	on	ADP
dpc-4489	130	22	imq	imq	NOUN
dpc-4489	130	23	-	-	PUNCT
dpc-4489	130	24	mediated	mediate	VERB
dpc-4489	130	25	psoriatic	psoriatic	ADJ
dpc-4489	130	26	lesions	lesion	NOUN
dpc-4489	130	27	.	.	PUNCT
dpc-4489	131	1	they	they	PRON
dpc-4489	131	2	also	also	ADV
dpc-4489	131	3	observed	observe	VERB
dpc-4489	131	4	that	that	SCONJ
dpc-4489	131	5	disulfiram	disulfiram	NOUN
dpc-4489	131	6	treatment	treatment	NOUN
dpc-4489	131	7	,	,	PUNCT
dpc-4489	131	8	acting	act	VERB
dpc-4489	131	9	as	as	ADP
dpc-4489	131	10	an	an	DET
dpc-4489	131	11	antagonist	antagonist	NOUN
dpc-4489	131	12	of	of	ADP
dpc-4489	131	13	when	when	SCONJ
dpc-4489	131	14	comparing	compare	VERB
dpc-4489	131	15	the	the	DET
dpc-4489	131	16	quantitative	quantitative	ADJ
dpc-4489	131	17	values	value	NOUN
dpc-4489	131	18	of	of	ADP
dpc-4489	131	19	necrotic	necrotic	ADJ
dpc-4489	131	20	keratinocytes	keratinocyte	NOUN
dpc-4489	131	21	between	between	ADP
dpc-4489	131	22	the	the	DET
dpc-4489	131	23	groups	group	NOUN
dpc-4489	131	24	in	in	ADP
dpc-4489	131	25	our	our	PRON
dpc-4489	131	26	study	study	NOUN
dpc-4489	131	27	,	,	PUNCT
dpc-4489	131	28	we	we	PRON
dpc-4489	131	29	found	find	VERB
dpc-4489	131	30	that	that	SCONJ
dpc-4489	131	31	the	the	DET
dpc-4489	131	32	mean	mean	ADJ
dpc-4489	131	33	number	number	NOUN
dpc-4489	131	34	of	of	ADP
dpc-4489	131	35	necrotic	necrotic	ADJ
dpc-4489	131	36	keratinocytes	keratinocyte	NOUN
dpc-4489	131	37	was	be	AUX
dpc-4489	131	38	10	10	NUM
dpc-4489	131	39	and	and	CCONJ
dpc-4489	131	40	50	50	NUM
dpc-4489	131	41	times	time	NOUN
dpc-4489	131	42	higher	high	ADJ
dpc-4489	131	43	in	in	ADP
dpc-4489	131	44	the	the	DET
dpc-4489	131	45	psoriasis	psoriasis	NOUN
dpc-4489	131	46	group	group	NOUN
dpc-4489	131	47	than	than	ADP
dpc-4489	131	48	in	in	ADP
dpc-4489	131	49	the	the	DET
dpc-4489	131	50	psoriasiform	psoriasiform	NOUN
dpc-4489	131	51	spongiotic	spongiotic	PROPN
dpc-4489	131	52	dermatitis	dermatitis	PROPN
dpc-4489	131	53	and	and	CCONJ
dpc-4489	131	54	control	control	NOUN
dpc-4489	131	55	groups	group	NOUN
dpc-4489	131	56	,	,	PUNCT
dpc-4489	131	57	respectively	respectively	ADV
dpc-4489	131	58	.	.	PUNCT
dpc-4489	132	1	by	by	ADP
dpc-4489	132	2	contrast	contrast	NOUN
dpc-4489	132	3	,	,	PUNCT
dpc-4489	132	4	cloutier	cloutier	PROPN
dpc-4489	132	5	et	et	PROPN
dpc-4489	132	6	al	al	PROPN
dpc-4489	132	7	.	.	PROPN
dpc-4489	132	8	reported	report	VERB
dpc-4489	132	9	a	a	DET
dpc-4489	132	10	mean	mean	ADJ
dpc-4489	132	11	number	number	NOUN
dpc-4489	132	12	of	of	ADP
dpc-4489	132	13	necrotic	necrotic	ADJ
dpc-4489	132	14	keratinocytes	keratinocyte	NOUN
dpc-4489	132	15	in	in	ADP
dpc-4489	132	16	the	the	DET
dpc-4489	132	17	psoriasis	psoriasis	NOUN
dpc-4489	132	18	group	group	NOUN
dpc-4489	132	19	that	that	PRON
dpc-4489	132	20	was	be	AUX
dpc-4489	132	21	1.5	1.5	NUM
dpc-4489	132	22	and	and	CCONJ
dpc-4489	132	23	7.5	7.5	NUM
dpc-4489	132	24	times	time	NOUN
dpc-4489	132	25	higher	high	ADJ
dpc-4489	132	26	than	than	ADP
dpc-4489	132	27	in	in	ADP
dpc-4489	132	28	the	the	DET
dpc-4489	132	29	psoriasiform	psoriasiform	NOUN
dpc-4489	132	30	spongiotic	spongiotic	PROPN
dpc-4489	132	31	dermatitis	dermatitis	PROPN
dpc-4489	132	32	and	and	CCONJ
dpc-4489	132	33	control	control	NOUN
dpc-4489	132	34	groups	group	NOUN
dpc-4489	132	35	,	,	PUNCT
dpc-4489	132	36	respectively	respectively	ADV
dpc-4489	132	37	[	[	X
dpc-4489	132	38	8	8	NUM
dpc-4489	132	39	]	]	PUNCT
dpc-4489	132	40	.	.	PUNCT
dpc-4489	133	1	even	even	ADV
dpc-4489	133	2	so	so	ADV
dpc-4489	133	3	,	,	PUNCT
dpc-4489	133	4	our	our	PRON
dpc-4489	133	5	study	study	NOUN
dpc-4489	133	6	and	and	CCONJ
dpc-4489	133	7	cloutier	cloutier	NOUN
dpc-4489	133	8	et	et	PROPN
dpc-4489	133	9	al	al	PROPN
dpc-4489	133	10	.	.	PROPN
dpc-4489	133	11	’s	’	VERB
dpc-4489	133	12	both	both	PRON
dpc-4489	133	13	revealed	reveal	VERB
dpc-4489	133	14	similar	similar	ADJ
dpc-4489	133	15	results	result	NOUN
dpc-4489	133	16	in	in	ADP
dpc-4489	133	17	terms	term	NOUN
dpc-4489	133	18	of	of	ADP
dpc-4489	133	19	mean	mean	ADJ
dpc-4489	133	20	necrotic	necrotic	ADJ
dpc-4489	133	21	keratinocytes	keratinocyte	NOUN
dpc-4489	133	22	when	when	SCONJ
dpc-4489	133	23	the	the	DET
dpc-4489	133	24	psoriasiform	psoriasiform	NOUN
dpc-4489	133	25	spongiotic	spongiotic	PROPN
dpc-4489	133	26	dermatitis	dermatitis	PROPN
dpc-4489	133	27	and	and	CCONJ
dpc-4489	133	28	control	control	NOUN
dpc-4489	133	29	groups	group	NOUN
dpc-4489	133	30	were	be	AUX
dpc-4489	133	31	compared	compare	VERB
dpc-4489	133	32	.	.	PUNCT
dpc-4489	134	1	according	accord	VERB
dpc-4489	134	2	to	to	ADP
dpc-4489	134	3	the	the	DET
dpc-4489	134	4	findings	finding	NOUN
dpc-4489	134	5	of	of	ADP
dpc-4489	134	6	both	both	DET
dpc-4489	134	7	studies	study	NOUN
dpc-4489	134	8	,	,	PUNCT
dpc-4489	134	9	the	the	DET
dpc-4489	134	10	mean	mean	ADJ
dpc-4489	134	11	number	number	NOUN
dpc-4489	134	12	of	of	ADP
dpc-4489	134	13	necrotic	necrotic	ADJ
dpc-4489	134	14	keratinocytes	keratinocyte	NOUN
dpc-4489	134	15	was	be	AUX
dpc-4489	134	16	approximately	approximately	ADV
dpc-4489	134	17	4.5	4.5	NUM
dpc-4489	134	18	times	time	NOUN
dpc-4489	134	19	higher	high	ADJ
dpc-4489	134	20	in	in	ADP
dpc-4489	134	21	the	the	DET
dpc-4489	134	22	psoriasiform	psoriasiform	NOUN
dpc-4489	134	23	spongiotic	spongiotic	PROPN
dpc-4489	134	24	dermatitis	dermatitis	PROPN
dpc-4489	134	25	group	group	NOUN
dpc-4489	134	26	than	than	ADP
dpc-4489	134	27	in	in	ADP
dpc-4489	134	28	the	the	DET
dpc-4489	134	29	control	control	NOUN
dpc-4489	134	30	group	group	NOUN
dpc-4489	134	31	[	[	X
dpc-4489	134	32	8	8	NUM
dpc-4489	134	33	]	]	PUNCT
dpc-4489	134	34	.	.	PUNCT
dpc-4489	135	1	the	the	DET
dpc-4489	135	2	discrepancy	discrepancy	NOUN
dpc-4489	135	3	in	in	ADP
dpc-4489	135	4	the	the	DET
dpc-4489	135	5	psoriasis	psoriasis	NOUN
dpc-4489	135	6	group	group	NOUN
dpc-4489	135	7	could	could	AUX
dpc-4489	135	8	be	be	AUX
dpc-4489	135	9	attributed	attribute	VERB
dpc-4489	135	10	to	to	ADP
dpc-4489	135	11	the	the	DET
dpc-4489	135	12	fact	fact	NOUN
dpc-4489	135	13	that	that	SCONJ
dpc-4489	135	14	the	the	DET
dpc-4489	135	15	mean	mean	ADJ
dpc-4489	135	16	pasi	pasi	NOUN
dpc-4489	135	17	values	value	NOUN
dpc-4489	135	18	of	of	ADP
dpc-4489	135	19	the	the	DET
dpc-4489	135	20	patients	patient	NOUN
dpc-4489	135	21	with	with	ADP
dpc-4489	135	22	psoriasis	psoriasis	NOUN
dpc-4489	135	23	in	in	ADP
dpc-4489	135	24	our	our	PRON
dpc-4489	135	25	study	study	NOUN
dpc-4489	135	26	were	be	AUX
dpc-4489	135	27	as	as	ADV
dpc-4489	135	28	high	high	ADJ
dpc-4489	135	29	as	as	ADP
dpc-4489	135	30	9.6	9.6	NUM
dpc-4489	135	31	.	.	PUNCT
dpc-4489	136	1	by	by	ADP
dpc-4489	136	2	contrast	contrast	NOUN
dpc-4489	136	3	,	,	PUNCT
dpc-4489	136	4	pasi	pasi	ADJ
dpc-4489	136	5	values	value	NOUN
dpc-4489	136	6	were	be	AUX
dpc-4489	136	7	not	not	PART
dpc-4489	136	8	evaluated	evaluate	VERB
dpc-4489	136	9	by	by	ADP
dpc-4489	136	10	cloutier	cloutier	PROPN
dpc-4489	136	11	et	et	PROPN
dpc-4489	136	12	al	al	PROPN
dpc-4489	136	13	.	.	PUNCT
dpc-4489	137	1	[	[	X
dpc-4489	137	2	8	8	NUM
dpc-4489	137	3	]	]	PUNCT
dpc-4489	137	4	.	.	PUNCT
dpc-4489	138	1	psoriasis	psoriasis	NOUN
dpc-4489	138	2	is	be	AUX
dpc-4489	138	3	characterized	characterize	VERB
dpc-4489	138	4	by	by	ADP
dpc-4489	138	5	persistent	persistent	ADJ
dpc-4489	138	6	inflammation	inflammation	NOUN
dpc-4489	138	7	,	,	PUNCT
dpc-4489	138	8	which	which	PRON
dpc-4489	138	9	leads	lead	VERB
dpc-4489	138	10	to	to	ADP
dpc-4489	138	11	the	the	DET
dpc-4489	138	12	uncontrolled	uncontrolled	ADJ
dpc-4489	138	13	proliferation	proliferation	NOUN
dpc-4489	138	14	and	and	CCONJ
dpc-4489	138	15	impaired	impaired	ADJ
dpc-4489	138	16	differentiation	differentiation	NOUN
dpc-4489	138	17	of	of	ADP
dpc-4489	138	18	keratinocytes	keratinocyte	NOUN
dpc-4489	138	19	[	[	X
dpc-4489	138	20	14	14	NUM
dpc-4489	138	21	]	]	PUNCT
dpc-4489	138	22	.	.	PUNCT
dpc-4489	139	1	in	in	ADP
dpc-4489	139	2	our	our	PRON
dpc-4489	139	3	study	study	NOUN
dpc-4489	139	4	,	,	PUNCT
dpc-4489	139	5	we	we	PRON
dpc-4489	139	6	reviewed	review	VERB
dpc-4489	139	7	the	the	DET
dpc-4489	139	8	literature	literature	NOUN
dpc-4489	139	9	to	to	PART
dpc-4489	139	10	understand	understand	VERB
dpc-4489	139	11	the	the	DET
dpc-4489	139	12	role	role	NOUN
dpc-4489	139	13	of	of	ADP
dpc-4489	139	14	necrotic	necrotic	ADJ
dpc-4489	139	15	keratinocytes	keratinocyte	NOUN
dpc-4489	139	16	,	,	PUNCT
dpc-4489	139	17	which	which	PRON
dpc-4489	139	18	were	be	AUX
dpc-4489	139	19	increased	increase	VERB
dpc-4489	139	20	in	in	ADP
dpc-4489	139	21	the	the	DET
dpc-4489	139	22	skin	skin	NOUN
dpc-4489	139	23	biopsies	biopsy	NOUN
dpc-4489	139	24	of	of	ADP
dpc-4489	139	25	patients	patient	NOUN
dpc-4489	139	26	with	with	ADP
dpc-4489	139	27	psoriasis	psoriasis	NOUN
dpc-4489	139	28	,	,	PUNCT
dpc-4489	139	29	in	in	ADP
dpc-4489	139	30	the	the	DET
dpc-4489	139	31	development	development	NOUN
dpc-4489	139	32	of	of	ADP
dpc-4489	139	33	the	the	DET
dpc-4489	139	34	disease	disease	NOUN
dpc-4489	139	35	,	,	PUNCT
dpc-4489	139	36	largely	largely	ADV
dpc-4489	139	37	because	because	SCONJ
dpc-4489	139	38	our	our	PRON
dpc-4489	139	39	findings	finding	NOUN
dpc-4489	139	40	showed	show	VERB
dpc-4489	139	41	the	the	DET
dpc-4489	139	42	opposite	opposite	NOUN
dpc-4489	139	43	based	base	VERB
dpc-4489	139	44	on	on	ADP
dpc-4489	139	45	decreased	decrease	VERB
dpc-4489	139	46	apoptosis	apoptosis	NOUN
dpc-4489	139	47	in	in	ADP
dpc-4489	139	48	keratinocytes	keratinocyte	NOUN
dpc-4489	139	49	in	in	ADP
dpc-4489	139	50	psoriasis	psoriasis	NOUN
dpc-4489	139	51	[	[	X
dpc-4489	139	52	15	15	NUM
dpc-4489	139	53	]	]	PUNCT
dpc-4489	139	54	.	.	PUNCT
dpc-4489	140	1	our	our	PRON
dpc-4489	140	2	literature	literature	PROPN
dpc-4489	140	3	review	review	NOUN
dpc-4489	140	4	identified	identify	VERB
dpc-4489	140	5	several	several	ADJ
dpc-4489	140	6	recently	recently	ADV
dpc-4489	140	7	published	publish	VERB
dpc-4489	140	8	articles	article	NOUN
dpc-4489	140	9	implicating	implicate	VERB
dpc-4489	140	10	panoptosis	panoptosis	NOUN
dpc-4489	140	11	,	,	PUNCT
dpc-4489	140	12	a	a	DET
dpc-4489	140	13	phenomenon	phenomenon	NOUN
dpc-4489	140	14	newly	newly	ADV
dpc-4489	140	15	described	describe	VERB
dpc-4489	140	16	kanneganti	kanneganti	PROPN
dpc-4489	140	17	et	et	PROPN
dpc-4489	140	18	al	al	PROPN
dpc-4489	140	19	.	.	PROPN
dpc-4489	141	1	in	in	ADP
dpc-4489	141	2	2019	2019	NUM
dpc-4489	141	3	[	[	X
dpc-4489	141	4	16	16	NUM
dpc-4489	141	5	]	]	X
dpc-4489	141	6	,	,	PUNCT
dpc-4489	141	7	in	in	ADP
dpc-4489	141	8	psoriasis	psoriasis	NOUN
dpc-4489	141	9	’s	’s	PART
dpc-4489	141	10	pathogenesis	pathogenesis	NOUN
dpc-4489	141	11	[	[	X
dpc-4489	141	12	4	4	NUM
dpc-4489	141	13	,	,	PUNCT
dpc-4489	141	14	5	5	NUM
dpc-4489	141	15	,	,	PUNCT
dpc-4489	141	16	7	7	NUM
dpc-4489	141	17	]	]	PUNCT
dpc-4489	141	18	.	.	PUNCT
dpc-4489	142	1	panoptosis	panoptosis	NOUN
dpc-4489	142	2	is	be	AUX
dpc-4489	142	3	an	an	DET
dpc-4489	142	4	inflammatory	inflammatory	ADJ
dpc-4489	142	5	pcd	pcd	NOUN
dpc-4489	142	6	pathway	pathway	NOUN
dpc-4489	142	7	regulated	regulate	VERB
dpc-4489	142	8	by	by	ADP
dpc-4489	142	9	the	the	DET
dpc-4489	142	10	panoptosome	panoptosome	NOUN
dpc-4489	142	11	complex	complex	NOUN
dpc-4489	142	12	,	,	PUNCT
dpc-4489	142	13	which	which	PRON
dpc-4489	142	14	combines	combine	VERB
dpc-4489	142	15	features	feature	NOUN
dpc-4489	142	16	of	of	ADP
dpc-4489	142	17	pyroptosis	pyroptosis	NOUN
dpc-4489	142	18	,	,	PUNCT
dpc-4489	142	19	apoptosis	apoptosis	NOUN
dpc-4489	142	20	,	,	PUNCT
dpc-4489	142	21	and	and	CCONJ
dpc-4489	142	22	necroptosis	necroptosis	NOUN
dpc-4489	142	23	and	and	CCONJ
dpc-4489	142	24	involves	involve	VERB
dpc-4489	142	25	essential	essential	ADJ
dpc-4489	142	26	molecules	molecule	NOUN
dpc-4489	142	27	from	from	ADP
dpc-4489	142	28	those	those	DET
dpc-4489	142	29	three	three	NUM
dpc-4489	142	30	pathways	pathway	NOUN
dpc-4489	143	1	[	[	X
dpc-4489	143	2	5	5	NUM
dpc-4489	143	3	]	]	PUNCT
dpc-4489	143	4	.	.	PUNCT
dpc-4489	144	1	pyroptosis	pyroptosis	NOUN
dpc-4489	144	2	is	be	AUX
dpc-4489	144	3	executed	execute	VERB
dpc-4489	144	4	by	by	ADP
dpc-4489	144	5	gasdermin	gasdermin	ADJ
dpc-4489	144	6	family	family	NOUN
dpc-4489	144	7	members	member	NOUN
dpc-4489	144	8	through	through	ADP
dpc-4489	144	9	the	the	DET
dpc-4489	144	10	inflammasome	inflammasome	NOUN
dpc-4489	144	11	activation	activation	NOUN
dpc-4489	144	12	-	-	PUNCT
dpc-4489	144	13	mediated	mediate	VERB
dpc-4489	144	14	caspase-1	caspase-1	NOUN
dpc-4489	144	15	cleavage	cleavage	NOUN
dpc-4489	144	16	of	of	ADP
dpc-4489	144	17	gasdermin	gasdermin	ADJ
dpc-4489	144	18	d	d	PROPN
dpc-4489	144	19	(	(	PUNCT
dpc-4489	144	20	gsdmd	gsdmd	NOUN
dpc-4489	144	21	)	)	PUNCT
dpc-4489	144	22	,	,	PUNCT
dpc-4489	144	23	caspase-11/4/5or	caspase-11/4/5or	PROPN
dpc-4489	144	24	caspase-8	caspase-8	NOUN
dpc-4489	144	25	-	-	PUNCT
dpc-4489	144	26	mediated	mediate	VERB
dpc-4489	144	27	cleavage	cleavage	NOUN
dpc-4489	144	28	of	of	ADP
dpc-4489	144	29	gsdmd	gsdmd	NOUN
dpc-4489	144	30	,	,	PUNCT
dpc-4489	144	31	caspase-3	caspase-3	NUM
dpc-4489	144	32	-	-	PUNCT
dpc-4489	144	33	mediated	mediate	VERB
dpc-4489	144	34	cleavage	cleavage	NOUN
dpc-4489	144	35	of	of	ADP
dpc-4489	144	36	gasdermin	gasdermin	NOUN
dpc-4489	144	37	e	e	NOUN
dpc-4489	144	38	,	,	PUNCT
dpc-4489	144	39	or	or	CCONJ
dpc-4489	144	40	granzyme	granzyme	VERB
dpc-4489	144	41	a	a	DET
dpc-4489	144	42	-	-	PUNCT
dpc-4489	144	43	mediated	mediate	VERB
dpc-4489	144	44	cleavage	cleavage	NOUN
dpc-4489	144	45	of	of	ADP
dpc-4489	144	46	gasdermin	gasdermin	PROPN
dpc-4489	144	47	b.	b.	PROPN
dpc-4489	144	48	by	by	ADP
dpc-4489	144	49	contrast	contrast	NOUN
dpc-4489	144	50	,	,	PUNCT
dpc-4489	144	51	apoptosis	apoptosis	NOUN
dpc-4489	144	52	is	be	AUX
dpc-4489	144	53	executed	execute	VERB
dpc-4489	144	54	by	by	ADP
dpc-4489	144	55	caspase-3	caspase-3	NUM
dpc-4489	144	56	and	and	CCONJ
dpc-4489	144	57	7	7	NUM
dpc-4489	144	58	following	follow	VERB
dpc-4489	144	59	the	the	DET
dpc-4489	144	60	activation	activation	NOUN
dpc-4489	144	61	of	of	ADP
dpc-4489	144	62	upstream	upstream	ADJ
dpc-4489	144	63	initiator	initiator	NOUN
dpc-4489	144	64	caspases	caspase	NOUN
dpc-4489	144	65	caspase-8/10	caspase-8/10	ADJ
dpc-4489	144	66	or	or	CCONJ
dpc-4489	144	67	-9	-9	INTJ
dpc-4489	144	68	.	.	PUNCT
dpc-4489	145	1	last	last	ADJ
dpc-4489	145	2	,	,	PUNCT
dpc-4489	145	3	necroptosis	necroptosis	NOUN
dpc-4489	145	4	is	be	AUX
dpc-4489	145	5	executed	execute	VERB
dpc-4489	145	6	by	by	ADP
dpc-4489	145	7	mixed	mixed	ADJ
dpc-4489	145	8	lineage	lineage	NOUN
dpc-4489	145	9	kinase	kinase	NOUN
dpc-4489	145	10	-	-	PUNCT
dpc-4489	145	11	like	like	ADJ
dpc-4489	145	12	(	(	PUNCT
dpc-4489	145	13	mlkl	mlkl	NOUN
dpc-4489	145	14	)	)	PUNCT
dpc-4489	145	15	oligomerization	oligomerization	NOUN
dpc-4489	145	16	mediated	mediate	VERB
dpc-4489	145	17	by	by	ADP
dpc-4489	145	18	receptor	receptor	NOUN
dpc-4489	145	19	-	-	PUNCT
dpc-4489	145	20	interacting	interact	VERB
dpc-4489	145	21	serine	serine	ADJ
dpc-4489	145	22	threonine	threonine	NOUN
dpc-4489	145	23	kinase-3	kinase-3	PROPN
dpc-4489	145	24	[	[	X
dpc-4489	145	25	17	17	NUM
dpc-4489	145	26	]	]	PUNCT
dpc-4489	145	27	.	.	PUNCT
dpc-4489	146	1	previous	previous	ADJ
dpc-4489	146	2	studies	study	NOUN
dpc-4489	146	3	have	have	AUX
dpc-4489	146	4	linked	link	VERB
dpc-4489	146	5	panoptosis	panoptosis	NOUN
dpc-4489	146	6	’s	’s	PART
dpc-4489	146	7	components	component	NOUN
dpc-4489	146	8	to	to	ADP
dpc-4489	146	9	the	the	DET
dpc-4489	146	10	pathogenesis	pathogenesis	NOUN
dpc-4489	146	11	of	of	ADP
dpc-4489	146	12	psoriasis	psoriasis	NOUN
dpc-4489	146	13	[	[	X
dpc-4489	146	14	3–5,7,18,19	3–5,7,18,19	NUM
dpc-4489	146	15	]	]	PUNCT
dpc-4489	146	16	.	.	PUNCT
dpc-4489	147	1	for	for	ADP
dpc-4489	147	2	example	example	NOUN
dpc-4489	147	3	,	,	PUNCT
dpc-4489	147	4	one	one	NUM
dpc-4489	147	5	study	study	NOUN
dpc-4489	147	6	showed	show	VERB
dpc-4489	147	7	that	that	SCONJ
dpc-4489	147	8	nlrp3	nlrp3	ADJ
dpc-4489	147	9	inflammasome	inflammasome	NOUN
dpc-4489	147	10	-	-	PUNCT
dpc-4489	147	11	mediated	mediate	VERB
dpc-4489	147	12	pyroptosis	pyroptosis	NOUN
dpc-4489	147	13	was	be	AUX
dpc-4489	147	14	present	present	ADJ
dpc-4489	147	15	in	in	ADP
dpc-4489	147	16	imiquimod	imiquimod	PROPN
dpc-4489	147	17	(	(	PUNCT
dpc-4489	147	18	imq)-induced	imq)-induce	VERB
dpc-4489	147	19	psoriasis	psoriasis	NOUN
dpc-4489	147	20	,	,	PUNCT
dpc-4489	147	21	similar	similar	ADJ
dpc-4489	147	22	to	to	ADP
dpc-4489	147	23	skin	skin	NOUN
dpc-4489	147	24	inflammation	inflammation	NOUN
dpc-4489	147	25	in	in	ADP
dpc-4489	147	26	mice	mouse	NOUN
dpc-4489	147	27	[	[	X
dpc-4489	147	28	18	18	NUM
dpc-4489	147	29	]	]	PUNCT
dpc-4489	147	30	.	.	PUNCT
dpc-4489	148	1	other	other	ADJ
dpc-4489	148	2	studies	study	NOUN
dpc-4489	148	3	have	have	AUX
dpc-4489	148	4	shown	show	VERB
dpc-4489	148	5	that	that	SCONJ
dpc-4489	148	6	the	the	DET
dpc-4489	148	7	tnf	tnf	PROPN
dpc-4489	148	8	-	-	PUNCT
dpc-4489	148	9	α	α	NOUN
dpc-4489	148	10	-	-	PUNCT
dpc-4489	148	11	mediated	mediate	VERB
dpc-4489	148	12	nlrp3	nlrp3	NOUN
dpc-4489	148	13	inflammasome	inflammasome	NOUN
dpc-4489	148	14	contributes	contribute	VERB
dpc-4489	148	15	to	to	ADP
dpc-4489	148	16	systemic	systemic	ADJ
dpc-4489	148	17	inflammation	inflammation	NOUN
dpc-4489	148	18	in	in	ADP
dpc-4489	148	19	patients	patient	NOUN
dpc-4489	148	20	with	with	ADP
dpc-4489	148	21	psoriasis	psoriasis	NOUN
dpc-4489	148	22	[	[	X
dpc-4489	148	23	19	19	NUM
dpc-4489	148	24	]	]	PUNCT
dpc-4489	148	25	.	.	PUNCT
dpc-4489	149	1	meanwhile	meanwhile	ADV
dpc-4489	149	2	,	,	PUNCT
dpc-4489	149	3	lu	lu	PROPN
dpc-4489	149	4	et	et	PROPN
dpc-4489	149	5	al	al	PROPN
dpc-4489	149	6	.	.	PROPN
dpc-4489	149	7	pinpointed	pinpoint	VERB
dpc-4489	149	8	the	the	DET
dpc-4489	149	9	close	close	ADJ
dpc-4489	149	10	association	association	NOUN
dpc-4489	149	11	original	original	ADJ
dpc-4489	149	12	article	article	NOUN
dpc-4489	149	13	|	|	ADV
dpc-4489	149	14	dermatol	dermatol	ADJ
dpc-4489	149	15	pract	pract	NOUN
dpc-4489	149	16	concept	concept	NOUN
dpc-4489	149	17	.	.	PUNCT
dpc-4489	150	1	2024;14(3):e2024213	2024;14(3):e2024213	NUM
dpc-4489	150	2	7	7	NUM
dpc-4489	150	3	therapeutic	therapeutic	ADJ
dpc-4489	150	4	strategies	strategy	NOUN
dpc-4489	150	5	.	.	PUNCT
dpc-4489	151	1	comput	comput	PROPN
dpc-4489	151	2	struct	struct	VERB
dpc-4489	151	3	biotechnol	biotechnol	NOUN
dpc-4489	151	4	j.	j.	PROPN
dpc-4489	151	5	2023;23	2023;23	NUM
dpc-4489	151	6	:	:	PUNCT
dpc-4489	151	7	64	64	NUM
dpc-4489	151	8	-	-	SYM
dpc-4489	151	9	76	76	NUM
dpc-4489	151	10	.	.	PUNCT
dpc-4489	152	1	doi	doi	NOUN
dpc-4489	152	2	:	:	PUNCT
dpc-4489	152	3	10.1016	10.1016	NUM
dpc-4489	152	4	/	/	SYM
dpc-4489	152	5	j.csbj.2023.11.049	j.csbj.2023.11.049	PROPN
dpc-4489	152	6	.	.	PUNCT
dpc-4489	153	1	pmid	pmid	NOUN
dpc-4489	153	2	:	:	PUNCT
dpc-4489	153	3	38125299	38125299	NUM
dpc-4489	153	4	.	.	PUNCT
dpc-4489	154	1	8	8	X
dpc-4489	154	2	.	.	PUNCT
dpc-4489	154	3	cloutier	cloutier	PROPN
dpc-4489	154	4	jm	jm	PROPN
dpc-4489	154	5	,	,	PUNCT
dpc-4489	154	6	hsi	hsi	PROPN
dpc-4489	154	7	a	a	X
dpc-4489	154	8	,	,	PUNCT
dpc-4489	154	9	camacho	camacho	PROPN
dpc-4489	154	10	c	c	PROPN
dpc-4489	154	11	,	,	PUNCT
dpc-4489	154	12	lazova	lazova	VERB
dpc-4489	154	13	r.	r.	PROPN
dpc-4489	154	14	necrotic	necrotic	ADJ
dpc-4489	154	15	keratinocytes	keratinocyte	NOUN
dpc-4489	154	16	are	be	AUX
dpc-4489	154	17	common	common	ADJ
dpc-4489	154	18	in	in	ADP
dpc-4489	154	19	psoriasis	psoriasis	NOUN
dpc-4489	154	20	and	and	CCONJ
dpc-4489	154	21	have	have	VERB
dpc-4489	154	22	a	a	DET
dpc-4489	154	23	predilection	predilection	NOUN
dpc-4489	154	24	to	to	ADP
dpc-4489	154	25	the	the	DET
dpc-4489	154	26	upper	upper	ADJ
dpc-4489	154	27	epidermis	epidermis	NOUN
dpc-4489	154	28	:	:	PUNCT
dpc-4489	154	29	a	a	DET
dpc-4489	154	30	quantitative	quantitative	ADJ
dpc-4489	154	31	and	and	CCONJ
dpc-4489	154	32	comparative	comparative	ADJ
dpc-4489	154	33	analysis	analysis	NOUN
dpc-4489	154	34	.	.	PUNCT
dpc-4489	155	1	am	be	AUX
dpc-4489	155	2	j	j	PROPN
dpc-4489	155	3	dermatopathol	dermatopathol	NOUN
dpc-4489	155	4	.	.	PUNCT
dpc-4489	156	1	2020;42(1):20	2020;42(1):20	NUM
dpc-4489	156	2	-	-	SYM
dpc-4489	156	3	23	23	NUM
dpc-4489	156	4	.	.	PUNCT
dpc-4489	157	1	doi	doi	NOUN
dpc-4489	157	2	:	:	PUNCT
dpc-4489	157	3	10.1097	10.1097	NUM
dpc-4489	157	4	/	/	SYM
dpc-4489	157	5	dad	dad	PROPN
dpc-4489	157	6	.0000000000001444	.0000000000001444	PROPN
dpc-4489	157	7	.	.	PUNCT
dpc-4489	158	1	pmid	pmid	NOUN
dpc-4489	158	2	:	:	PUNCT
dpc-4489	158	3	31094719	31094719	NUM
dpc-4489	158	4	.	.	PUNCT
dpc-4489	159	1	9	9	X
dpc-4489	159	2	.	.	X
dpc-4489	159	3	kim	kim	PROPN
dpc-4489	159	4	by	by	ADP
dpc-4489	159	5	,	,	PUNCT
dpc-4489	159	6	choi	choi	PROPN
dpc-4489	159	7	jw	jw	PROPN
dpc-4489	159	8	,	,	PUNCT
dpc-4489	159	9	kim	kim	PROPN
dpc-4489	159	10	br	br	PROPN
dpc-4489	159	11	,	,	PUNCT
dpc-4489	159	12	youn	youn	PROPN
dpc-4489	159	13	sw	sw	PROPN
dpc-4489	159	14	.	.	PUNCT
dpc-4489	160	1	histopathological	histopathological	PROPN
dpc-4489	160	2	findings	finding	NOUN
dpc-4489	160	3	are	be	AUX
dpc-4489	160	4	associated	associate	VERB
dpc-4489	160	5	with	with	ADP
dpc-4489	160	6	the	the	DET
dpc-4489	160	7	clinical	clinical	ADJ
dpc-4489	160	8	types	type	NOUN
dpc-4489	160	9	of	of	ADP
dpc-4489	160	10	psoriasis	psoriasis	NOUN
dpc-4489	160	11	but	but	CCONJ
dpc-4489	160	12	not	not	PART
dpc-4489	160	13	with	with	ADP
dpc-4489	160	14	the	the	DET
dpc-4489	160	15	corresponding	corresponding	ADJ
dpc-4489	160	16	lesional	lesional	ADJ
dpc-4489	160	17	psoriasis	psoriasis	NOUN
dpc-4489	160	18	severity	severity	NOUN
dpc-4489	160	19	index	index	NOUN
dpc-4489	160	20	.	.	PUNCT
dpc-4489	161	1	ann	ann	PROPN
dpc-4489	161	2	dermatol	dermatol	NOUN
dpc-4489	161	3	.	.	PUNCT
dpc-4489	162	1	2015;27(1):26	2015;27(1):26	NUM
dpc-4489	162	2	-	-	SYM
dpc-4489	162	3	31	31	NUM
dpc-4489	162	4	.	.	PUNCT
dpc-4489	163	1	doi	doi	NOUN
dpc-4489	163	2	:	:	PUNCT
dpc-4489	163	3	10.5021	10.5021	NUM
dpc-4489	163	4	/	/	SYM
dpc-4489	163	5	ad.2015.27.1.26	ad.2015.27.1.26	NOUN
dpc-4489	163	6	.	.	PUNCT
dpc-4489	164	1	pmid	pmid	NOUN
dpc-4489	164	2	:	:	PUNCT
dpc-4489	164	3	25673928	25673928	NUM
dpc-4489	164	4	.	.	PUNCT
dpc-4489	165	1	10	10	NUM
dpc-4489	165	2	.	.	PUNCT
dpc-4489	165	3	žurauskas	žurauskas	PROPN
dpc-4489	165	4	m	m	PROPN
dpc-4489	165	5	,	,	PUNCT
dpc-4489	165	6	barkalifa	barkalifa	PROPN
dpc-4489	165	7	r	r	NOUN
dpc-4489	165	8	,	,	PUNCT
dpc-4489	165	9	alex	alex	PROPN
dpc-4489	165	10	a	a	X
dpc-4489	165	11	,	,	PUNCT
dpc-4489	165	12	et	et	PROPN
dpc-4489	165	13	al	al	PROPN
dpc-4489	165	14	.	.	PUNCT
dpc-4489	166	1	assessing	assess	VERB
dpc-4489	166	2	the	the	DET
dpc-4489	166	3	severity	severity	NOUN
dpc-4489	166	4	of	of	ADP
dpc-4489	166	5	psoriasis	psoriasis	NOUN
dpc-4489	166	6	through	through	ADP
dpc-4489	166	7	multivariate	multivariate	NOUN
dpc-4489	166	8	analysis	analysis	NOUN
dpc-4489	166	9	of	of	ADP
dpc-4489	166	10	optical	optical	ADJ
dpc-4489	166	11	images	image	NOUN
dpc-4489	166	12	from	from	ADP
dpc-4489	166	13	non	non	ADJ
dpc-4489	166	14	-	-	ADJ
dpc-4489	166	15	lesional	lesional	ADJ
dpc-4489	166	16	skin	skin	NOUN
dpc-4489	166	17	.	.	PUNCT
dpc-4489	167	1	sci	sci	PROPN
dpc-4489	167	2	rep	rep	PROPN
dpc-4489	167	3	.	.	PROPN
dpc-4489	167	4	2020;10(1):9154	2020;10(1):9154	PROPN
dpc-4489	167	5	.	.	PUNCT
dpc-4489	168	1	doi	doi	NOUN
dpc-4489	168	2	:	:	PUNCT
dpc-4489	168	3	10.1038	10.1038	NUM
dpc-4489	168	4	/	/	SYM
dpc-4489	169	1	s41598	s41598	PROPN
dpc-4489	169	2	-020	-020	PROPN
dpc-4489	169	3	-	-	PUNCT
dpc-4489	169	4	65689	65689	NUM
dpc-4489	169	5	-	-	SYM
dpc-4489	169	6	4	4	NUM
dpc-4489	169	7	.	.	PUNCT
dpc-4489	170	1	pmid	pmid	NOUN
dpc-4489	170	2	:	:	PUNCT
dpc-4489	170	3	32513976	32513976	NUM
dpc-4489	170	4	.	.	PUNCT
dpc-4489	171	1	11	11	NUM
dpc-4489	171	2	.	.	PUNCT
dpc-4489	172	1	wick	wick	PROPN
dpc-4489	172	2	mr	mr	PROPN
dpc-4489	172	3	.	.	PROPN
dpc-4489	172	4	psoriasiform	psoriasiform	PROPN
dpc-4489	172	5	dermatitides	dermatitide	VERB
dpc-4489	172	6	:	:	PUNCT
dpc-4489	172	7	a	a	DET
dpc-4489	172	8	brief	brief	ADJ
dpc-4489	172	9	review	review	NOUN
dpc-4489	172	10	.	.	PUNCT
dpc-4489	173	1	semin	semin	PROPN
dpc-4489	173	2	diagn	diagn	PROPN
dpc-4489	173	3	pathol	pathol	PROPN
dpc-4489	173	4	.	.	PUNCT
dpc-4489	174	1	2017;34(3):220	2017;34(3):220	NUM
dpc-4489	174	2	-	-	PUNCT
dpc-4489	174	3	225	225	NUM
dpc-4489	174	4	.	.	PUNCT
dpc-4489	175	1	doi	doi	NOUN
dpc-4489	175	2	:	:	PUNCT
dpc-4489	175	3	10.1053	10.1053	NUM
dpc-4489	175	4	/	/	SYM
dpc-4489	175	5	j.semdp	j.semdp	NOUN
dpc-4489	175	6	.2016.12.006	.2016.12.006	PUNCT
dpc-4489	175	7	.	.	PUNCT
dpc-4489	176	1	pmid	pmid	NOUN
dpc-4489	176	2	:	:	PUNCT
dpc-4489	176	3	28094165	28094165	NUM
dpc-4489	176	4	.	.	PUNCT
dpc-4489	177	1	12	12	NUM
dpc-4489	177	2	.	.	PUNCT
dpc-4489	178	1	cohen	cohen	PROPN
dpc-4489	178	2	jn	jn	PROPN
dpc-4489	178	3	,	,	PUNCT
dpc-4489	178	4	bowman	bowman	PROPN
dpc-4489	178	5	s	s	PROPN
dpc-4489	178	6	,	,	PUNCT
dpc-4489	178	7	laszik	laszik	PROPN
dpc-4489	178	8	zg	zg	PROPN
dpc-4489	178	9	,	,	PUNCT
dpc-4489	178	10	north	north	NOUN
dpc-4489	178	11	jp	jp	NOUN
dpc-4489	178	12	.	.	PUNCT
dpc-4489	179	1	clinicopathologic	clinicopathologic	ADJ
dpc-4489	179	2	overlap	overlap	NOUN
dpc-4489	179	3	of	of	ADP
dpc-4489	179	4	psoriasis	psoriasis	NOUN
dpc-4489	179	5	,	,	PUNCT
dpc-4489	179	6	eczema	eczema	NOUN
dpc-4489	179	7	,	,	PUNCT
dpc-4489	179	8	and	and	CCONJ
dpc-4489	179	9	psoriasiform	psoriasiform	NOUN
dpc-4489	179	10	dermatoses	dermatose	VERB
dpc-4489	179	11	:	:	PUNCT
dpc-4489	179	12	a	a	DET
dpc-4489	179	13	retrospective	retrospective	ADJ
dpc-4489	179	14	study	study	NOUN
dpc-4489	179	15	of	of	ADP
dpc-4489	179	16	t	t	PROPN
dpc-4489	179	17	helper	helper	NOUN
dpc-4489	179	18	type	type	NOUN
dpc-4489	179	19	2	2	NUM
dpc-4489	179	20	and	and	CCONJ
dpc-4489	179	21	17	17	NUM
dpc-4489	179	22	subsets	subset	NOUN
dpc-4489	179	23	,	,	PUNCT
dpc-4489	179	24	interleukin	interleukin	NOUN
dpc-4489	179	25	36	36	NUM
dpc-4489	179	26	,	,	PUNCT
dpc-4489	179	27	and	and	CCONJ
dpc-4489	179	28	β	β	X
dpc-4489	179	29	-	-	NOUN
dpc-4489	179	30	defensin	defensin	ADJ
dpc-4489	179	31	2	2	NUM
dpc-4489	179	32	in	in	ADP
dpc-4489	179	33	spongiotic	spongiotic	ADJ
dpc-4489	179	34	psoriasiform	psoriasiform	NOUN
dpc-4489	179	35	dermatitis	dermatitis	PROPN
dpc-4489	179	36	,	,	PUNCT
dpc-4489	179	37	sebopsoriasis	sebopsoriasis	NOUN
dpc-4489	179	38	,	,	PUNCT
dpc-4489	179	39	and	and	CCONJ
dpc-4489	179	40	tumor	tumor	NOUN
dpc-4489	179	41	necrosis	necrosis	NOUN
dpc-4489	179	42	factor	factor	NOUN
dpc-4489	179	43	α	α	NOUN
dpc-4489	179	44	inhibitor	inhibitor	NOUN
dpc-4489	179	45	-	-	PUNCT
dpc-4489	179	46	associated	associate	VERB
dpc-4489	179	47	dermatitis	dermatitis	NOUN
dpc-4489	179	48	.	.	PUNCT
dpc-4489	180	1	j	j	PROPN
dpc-4489	180	2	am	be	AUX
dpc-4489	180	3	acad	acad	ADJ
dpc-4489	180	4	dermatol	dermatol	NOUN
dpc-4489	180	5	.	.	PUNCT
dpc-4489	181	1	2020;82(2):430	2020;82(2):430	PROPN
dpc-4489	181	2	-	-	PUNCT
dpc-4489	181	3	439	439	NUM
dpc-4489	181	4	.	.	PUNCT
dpc-4489	181	5	doi	doi	NOUN
dpc-4489	181	6	:	:	PUNCT
dpc-4489	181	7	10.1016	10.1016	NUM
dpc-4489	181	8	/	/	SYM
dpc-4489	181	9	j.jaad.2019.08.023	j.jaad.2019.08.023	PROPN
dpc-4489	181	10	.	.	PUNCT
dpc-4489	182	1	pmid	pmid	NOUN
dpc-4489	182	2	:	:	PUNCT
dpc-4489	182	3	31859047	31859047	NUM
dpc-4489	182	4	.	.	PUNCT
dpc-4489	183	1	13	13	NUM
dpc-4489	183	2	.	.	PUNCT
dpc-4489	184	1	chau	chau	PROPN
dpc-4489	184	2	t	t	PROPN
dpc-4489	184	3	,	,	PUNCT
dpc-4489	184	4	parsi	parsi	ADJ
dpc-4489	184	5	kk	kk	PROPN
dpc-4489	184	6	,	,	PUNCT
dpc-4489	184	7	ogawa	ogawa	PROPN
dpc-4489	184	8	t	t	PROPN
dpc-4489	184	9	,	,	PUNCT
dpc-4489	184	10	et	et	PROPN
dpc-4489	184	11	al	al	PROPN
dpc-4489	184	12	.	.	PUNCT
dpc-4489	184	13	psoriasis	psoriasis	NOUN
dpc-4489	184	14	or	or	CCONJ
dpc-4489	184	15	not	not	PART
dpc-4489	184	16	?	?	PUNCT
dpc-4489	185	1	review	review	NOUN
dpc-4489	185	2	of	of	ADP
dpc-4489	185	3	51	51	NUM
dpc-4489	185	4	clinically	clinically	ADV
dpc-4489	185	5	confirmed	confirm	VERB
dpc-4489	185	6	cases	case	NOUN
dpc-4489	185	7	reveals	reveal	VERB
dpc-4489	185	8	an	an	DET
dpc-4489	185	9	expanded	expand	VERB
dpc-4489	185	10	histopathologic	histopathologic	NOUN
dpc-4489	185	11	spectrum	spectrum	NOUN
dpc-4489	185	12	of	of	ADP
dpc-4489	185	13	psoriasis	psoriasis	NOUN
dpc-4489	185	14	.	.	PUNCT
dpc-4489	186	1	j	j	PROPN
dpc-4489	186	2	cutan	cutan	PROPN
dpc-4489	186	3	pathol	pathol	NOUN
dpc-4489	186	4	.	.	PUNCT
dpc-4489	187	1	2017;44(12):1018	2017;44(12):1018	NOUN
dpc-4489	187	2	-	-	NOUN
dpc-4489	187	3	1026	1026	NUM
dpc-4489	187	4	.	.	PUNCT
dpc-4489	188	1	doi	doi	NOUN
dpc-4489	188	2	:	:	PUNCT
dpc-4489	188	3	10.1111	10.1111	NUM
dpc-4489	188	4	/	/	SYM
dpc-4489	188	5	cup.13033	cup.13033	PROPN
dpc-4489	188	6	.	.	PUNCT
dpc-4489	189	1	pmid	pmid	NOUN
dpc-4489	189	2	:	:	PUNCT
dpc-4489	189	3	28833447	28833447	NUM
dpc-4489	189	4	.	.	PUNCT
dpc-4489	190	1	14	14	NUM
dpc-4489	190	2	.	.	PUNCT
dpc-4489	191	1	rendon	rendon	PROPN
dpc-4489	191	2	a	a	PRON
dpc-4489	191	3	,	,	PUNCT
dpc-4489	191	4	schäkel	schäkel	PROPN
dpc-4489	191	5	k.	k.	PROPN
dpc-4489	191	6	psoriasis	psoriasis	NOUN
dpc-4489	191	7	pathogenesis	pathogenesis	NOUN
dpc-4489	191	8	and	and	CCONJ
dpc-4489	191	9	treatment	treatment	NOUN
dpc-4489	191	10	.	.	PUNCT
dpc-4489	192	1	int	int	PROPN
dpc-4489	192	2	j	j	PROPN
dpc-4489	192	3	mol	mol	ADP
dpc-4489	192	4	sci	sci	PROPN
dpc-4489	192	5	.	.	PUNCT
dpc-4489	193	1	2019;20(6):1475	2019;20(6):1475	NUM
dpc-4489	193	2	.	.	PUNCT
dpc-4489	194	1	doi	doi	NOUN
dpc-4489	194	2	:	:	PUNCT
dpc-4489	194	3	10.3390	10.3390	NUM
dpc-4489	194	4	/	/	SYM
dpc-4489	194	5	ijms20061475	ijms20061475	PROPN
dpc-4489	194	6	.	.	PUNCT
dpc-4489	195	1	pmid	pmid	NOUN
dpc-4489	195	2	:	:	PUNCT
dpc-4489	195	3	30909615	30909615	NUM
dpc-4489	195	4	.	.	PUNCT
dpc-4489	196	1	15	15	NUM
dpc-4489	196	2	.	.	X
dpc-4489	197	1	krawczyk	krawczyk	NOUN
dpc-4489	197	2	a	a	PRON
dpc-4489	197	3	,	,	PUNCT
dpc-4489	197	4	miśkiewicz	miśkiewicz	PROPN
dpc-4489	197	5	j	j	PROPN
dpc-4489	197	6	,	,	PUNCT
dpc-4489	197	7	strzelec	strzelec	PROPN
dpc-4489	197	8	k	k	PROPN
dpc-4489	197	9	,	,	PUNCT
dpc-4489	197	10	wcisło	wcisło	ADV
dpc-4489	197	11	-	-	PUNCT
dpc-4489	197	12	dziadecka	dziadecka	PROPN
dpc-4489	197	13	d	d	NOUN
dpc-4489	197	14	,	,	PUNCT
dpc-4489	197	15	strzalka	strzalka	NOUN
dpc-4489	197	16	-	-	PUNCT
dpc-4489	197	17	mrozik	mrozik	ADV
dpc-4489	197	18	b.	b.	NOUN
dpc-4489	197	19	apoptosis	apoptosis	NOUN
dpc-4489	197	20	in	in	ADP
dpc-4489	197	21	autoimmunological	autoimmunological	ADJ
dpc-4489	197	22	diseases	disease	NOUN
dpc-4489	197	23	,	,	PUNCT
dpc-4489	197	24	with	with	ADP
dpc-4489	197	25	particular	particular	ADJ
dpc-4489	197	26	consideration	consideration	NOUN
dpc-4489	197	27	of	of	ADP
dpc-4489	197	28	molecular	molecular	ADJ
dpc-4489	197	29	aspects	aspect	NOUN
dpc-4489	197	30	of	of	ADP
dpc-4489	197	31	psoriasis	psoriasis	NOUN
dpc-4489	197	32	.	.	PUNCT
dpc-4489	198	1	med	med	PROPN
dpc-4489	198	2	sci	sci	PROPN
dpc-4489	198	3	monit	monit	PROPN
dpc-4489	198	4	.	.	PUNCT
dpc-4489	199	1	2020;26	2020;26	NUM
dpc-4489	199	2	:	:	PUNCT
dpc-4489	199	3	e922035	e922035	ADJ
dpc-4489	199	4	.	.	PUNCT
dpc-4489	200	1	doi	doi	NOUN
dpc-4489	200	2	:	:	PUNCT
dpc-4489	200	3	10.12659	10.12659	NUM
dpc-4489	200	4	/msm.922035	/msm.922035	NOUN
dpc-4489	200	5	.	.	PUNCT
dpc-4489	201	1	pmid	pmid	NOUN
dpc-4489	201	2	:	:	PUNCT
dpc-4489	201	3	32567582	32567582	NUM
dpc-4489	201	4	.	.	PUNCT
dpc-4489	202	1	16	16	NUM
dpc-4489	202	2	.	.	PUNCT
dpc-4489	203	1	malireddi	malireddi	PROPN
dpc-4489	203	2	rks	rks	PROPN
dpc-4489	203	3	,	,	PUNCT
dpc-4489	203	4	kesavardhana	kesavardhana	PROPN
dpc-4489	203	5	s	s	PROPN
dpc-4489	203	6	,	,	PUNCT
dpc-4489	203	7	kanneganti	kanneganti	ADJ
dpc-4489	203	8	td	td	NOUN
dpc-4489	203	9	.	.	PUNCT
dpc-4489	203	10	zbp1	zbp1	PROPN
dpc-4489	203	11	and	and	CCONJ
dpc-4489	203	12	tak1	tak1	PROPN
dpc-4489	203	13	:	:	PUNCT
dpc-4489	203	14	master	master	NOUN
dpc-4489	203	15	regulators	regulator	NOUN
dpc-4489	203	16	of	of	ADP
dpc-4489	203	17	nlrp3	nlrp3	ADJ
dpc-4489	203	18	inflammasome	inflammasome	NOUN
dpc-4489	203	19	/	/	SYM
dpc-4489	203	20	pyroptosis	pyroptosis	NOUN
dpc-4489	203	21	,	,	PUNCT
dpc-4489	203	22	apoptosis	apoptosis	NOUN
dpc-4489	203	23	,	,	PUNCT
dpc-4489	203	24	and	and	CCONJ
dpc-4489	203	25	necroptosis	necroptosis	NOUN
dpc-4489	203	26	(	(	PUNCT
dpc-4489	203	27	pan	pan	NOUN
dpc-4489	203	28	-	-	NOUN
dpc-4489	203	29	optosis	optosis	NOUN
dpc-4489	203	30	)	)	PUNCT
dpc-4489	203	31	.	.	PUNCT
dpc-4489	204	1	front	front	ADJ
dpc-4489	204	2	cell	cell	NOUN
dpc-4489	204	3	infect	infect	VERB
dpc-4489	204	4	microbiol	microbiol	PROPN
dpc-4489	204	5	.	.	PUNCT
dpc-4489	205	1	2019;9:406	2019;9:406	PROPN
dpc-4489	205	2	.	.	PUNCT
dpc-4489	206	1	doi	doi	NOUN
dpc-4489	206	2	:	:	PUNCT
dpc-4489	206	3	10.3389	10.3389	NUM
dpc-4489	206	4	/	/	SYM
dpc-4489	206	5	fcimb.2019.00406	fcimb.2019.00406	PROPN
dpc-4489	206	6	.	.	PUNCT
dpc-4489	207	1	pmid	pmid	NOUN
dpc-4489	207	2	:	:	PUNCT
dpc-4489	207	3	31850239	31850239	NUM
dpc-4489	207	4	.	.	PUNCT
dpc-4489	208	1	17	17	NUM
dpc-4489	208	2	.	.	PUNCT
dpc-4489	209	1	karki	karki	PROPN
dpc-4489	209	2	r	r	PROPN
dpc-4489	209	3	,	,	PUNCT
dpc-4489	209	4	sharma	sharma	PROPN
dpc-4489	209	5	br	br	PROPN
dpc-4489	209	6	,	,	PUNCT
dpc-4489	209	7	tuladhar	tuladhar	PROPN
dpc-4489	209	8	s	s	PART
dpc-4489	209	9	,	,	PUNCT
dpc-4489	209	10	et	et	PROPN
dpc-4489	209	11	al	al	PROPN
dpc-4489	209	12	.	.	PROPN
dpc-4489	209	13	synergism	synergism	NOUN
dpc-4489	209	14	of	of	ADP
dpc-4489	209	15	tnf	tnf	PROPN
dpc-4489	209	16	-	-	PUNCT
dpc-4489	209	17	α	α	PROPN
dpc-4489	209	18	and	and	CCONJ
dpc-4489	209	19	ifn	ifn	PROPN
dpc-4489	209	20	-	-	PUNCT
dpc-4489	209	21	γ	γ	NOUN
dpc-4489	209	22	triggers	trigger	VERB
dpc-4489	209	23	inflammatory	inflammatory	ADJ
dpc-4489	209	24	cell	cell	NOUN
dpc-4489	209	25	death	death	NOUN
dpc-4489	209	26	,	,	PUNCT
dpc-4489	209	27	tissue	tissue	NOUN
dpc-4489	209	28	damage	damage	NOUN
dpc-4489	209	29	,	,	PUNCT
dpc-4489	209	30	and	and	CCONJ
dpc-4489	209	31	mortality	mortality	NOUN
dpc-4489	209	32	in	in	ADP
dpc-4489	209	33	sars	sar	NOUN
dpc-4489	209	34	-	-	PUNCT
dpc-4489	209	35	cov-2	cov-2	PART
dpc-4489	209	36	infection	infection	NOUN
dpc-4489	209	37	and	and	CCONJ
dpc-4489	209	38	cytokine	cytokine	VERB
dpc-4489	209	39	shock	shock	NOUN
dpc-4489	209	40	syndromes	syndrome	NOUN
dpc-4489	209	41	.	.	PUNCT
dpc-4489	210	1	cell	cell	NOUN
dpc-4489	210	2	.	.	PUNCT
dpc-4489	211	1	2021;184(1):149	2021;184(1):149	NUM
dpc-4489	211	2	-	-	SYM
dpc-4489	211	3	168.e17	168.e17	NUM
dpc-4489	211	4	.	.	PUNCT
dpc-4489	211	5	doi	doi	NOUN
dpc-4489	211	6	:	:	PUNCT
dpc-4489	211	7	10.1016	10.1016	NUM
dpc-4489	211	8	/	/	SYM
dpc-4489	211	9	j.cell	j.cell	PROPN
dpc-4489	211	10	.2020.11.025	.2020.11.025	PUNCT
dpc-4489	211	11	.	.	PUNCT
dpc-4489	212	1	pmid	pmid	NOUN
dpc-4489	212	2	:	:	PUNCT
dpc-4489	212	3	33278357	33278357	NUM
dpc-4489	212	4	.	.	PUNCT
dpc-4489	213	1	18	18	NUM
dpc-4489	213	2	.	.	PUNCT
dpc-4489	214	1	deng	deng	PROPN
dpc-4489	214	2	g	g	PROPN
dpc-4489	214	3	,	,	PUNCT
dpc-4489	214	4	chen	chen	PROPN
dpc-4489	214	5	w	w	PROPN
dpc-4489	214	6	,	,	PUNCT
dpc-4489	214	7	wang	wang	PROPN
dpc-4489	214	8	p	p	PROPN
dpc-4489	214	9	,	,	PUNCT
dpc-4489	214	10	et	et	PROPN
dpc-4489	214	11	al	al	PROPN
dpc-4489	214	12	.	.	PROPN
dpc-4489	214	13	inhibition	inhibition	NOUN
dpc-4489	214	14	of	of	ADP
dpc-4489	214	15	nlrp3	nlrp3	ADJ
dpc-4489	214	16	inflammasome	inflammasome	NOUN
dpc-4489	214	17	-	-	PUNCT
dpc-4489	214	18	mediated	mediate	VERB
dpc-4489	214	19	pyroptosis	pyroptosis	NOUN
dpc-4489	214	20	in	in	ADP
dpc-4489	214	21	macrophage	macrophage	NOUN
dpc-4489	214	22	by	by	ADP
dpc-4489	214	23	cycloastragenol	cycloastragenol	ADJ
dpc-4489	214	24	contributes	contribute	VERB
dpc-4489	214	25	to	to	ADP
dpc-4489	214	26	amelioration	amelioration	NOUN
dpc-4489	214	27	of	of	ADP
dpc-4489	214	28	imiquimod	imiquimod	ADJ
dpc-4489	214	29	-	-	PUNCT
dpc-4489	214	30	induced	induce	VERB
dpc-4489	214	31	psoriasis	psoriasis	NOUN
dpc-4489	214	32	-	-	PUNCT
dpc-4489	214	33	like	like	ADJ
dpc-4489	214	34	skin	skin	NOUN
dpc-4489	214	35	inflammation	inflammation	NOUN
dpc-4489	214	36	in	in	ADP
dpc-4489	214	37	mice	mouse	NOUN
dpc-4489	214	38	.	.	PUNCT
dpc-4489	215	1	int	int	NOUN
dpc-4489	215	2	immunopharmacol	immunopharmacol	PROPN
dpc-4489	215	3	.	.	PUNCT
dpc-4489	216	1	2019;74:105682	2019;74:105682	X
dpc-4489	216	2	.	.	PUNCT
dpc-4489	216	3	doi	doi	NOUN
dpc-4489	216	4	:	:	PUNCT
dpc-4489	216	5	10.1016	10.1016	NUM
dpc-4489	216	6	/	/	SYM
dpc-4489	216	7	j.intimp.2019.105682	j.intimp.2019.105682	ADV
dpc-4489	216	8	.	.	PUNCT
dpc-4489	217	1	pmid	pmid	NOUN
dpc-4489	217	2	:	:	PUNCT
dpc-4489	217	3	31203155	31203155	NUM
dpc-4489	217	4	.	.	PUNCT
dpc-4489	218	1	19	19	NUM
dpc-4489	218	2	.	.	PUNCT
dpc-4489	218	3	verma	verma	PROPN
dpc-4489	218	4	d	d	PROPN
dpc-4489	218	5	,	,	PUNCT
dpc-4489	218	6	fekri	fekri	PROPN
dpc-4489	218	7	sz	sz	PROPN
dpc-4489	218	8	,	,	PUNCT
dpc-4489	218	9	sigurdardottir	sigurdardottir	VERB
dpc-4489	218	10	g	g	PROPN
dpc-4489	218	11	,	,	PUNCT
dpc-4489	218	12	bivik	bivik	ADV
dpc-4489	218	13	eding	ede	VERB
dpc-4489	218	14	c	c	X
dpc-4489	218	15	,	,	PUNCT
dpc-4489	218	16	sandin	sandin	VERB
dpc-4489	218	17	c	c	X
dpc-4489	218	18	,	,	PUNCT
dpc-4489	218	19	enerbäck	enerbäck	PROPN
dpc-4489	218	20	c.	c.	PROPN
dpc-4489	218	21	enhanced	enhance	VERB
dpc-4489	218	22	inflammasome	inflammasome	NOUN
dpc-4489	218	23	activity	activity	NOUN
dpc-4489	218	24	in	in	ADP
dpc-4489	218	25	patients	patient	NOUN
dpc-4489	218	26	with	with	ADP
dpc-4489	218	27	psoriasis	psoriasis	NOUN
dpc-4489	218	28	promotes	promote	VERB
dpc-4489	218	29	systemic	systemic	ADJ
dpc-4489	218	30	inflammation	inflammation	NOUN
dpc-4489	218	31	.	.	PUNCT
dpc-4489	219	1	j	j	PROPN
dpc-4489	219	2	invest	invest	VERB
dpc-4489	219	3	dermatol	dermatol	NOUN
dpc-4489	219	4	.	.	PUNCT
dpc-4489	220	1	2021;141(3):586	2021;141(3):586	NUM
dpc-4489	220	2	-	-	SYM
dpc-4489	220	3	595.e5	595.e5	NUM
dpc-4489	220	4	.	.	PUNCT
dpc-4489	221	1	doi	doi	NOUN
dpc-4489	221	2	:	:	PUNCT
dpc-4489	221	3	10.1016	10.1016	NUM
dpc-4489	221	4	/	/	SYM
dpc-4489	221	5	j.jid.2020.07.012	j.jid.2020.07.012	PROPN
dpc-4489	221	6	.	.	PUNCT
dpc-4489	222	1	pmid	pmid	NOUN
dpc-4489	222	2	:	:	PUNCT
dpc-4489	222	3	32896537	32896537	NUM
dpc-4489	222	4	.	.	PUNCT
dpc-4489	223	1	pyroptosis	pyroptosis	NOUN
dpc-4489	223	2	proteins	protein	NOUN
dpc-4489	223	3	,	,	PUNCT
dpc-4489	223	4	could	could	AUX
dpc-4489	223	5	reduce	reduce	VERB
dpc-4489	223	6	the	the	DET
dpc-4489	223	7	cleavage	cleavage	NOUN
dpc-4489	223	8	of	of	ADP
dpc-4489	223	9	gsdmd	gsdmd	NOUN
dpc-4489	223	10	in	in	ADP
dpc-4489	223	11	imq	imq	NOUN
dpc-4489	223	12	-	-	PUNCT
dpc-4489	223	13	mediated	mediate	VERB
dpc-4489	223	14	psoriatic	psoriatic	ADJ
dpc-4489	223	15	lesions	lesion	NOUN
dpc-4489	223	16	[	[	X
dpc-4489	223	17	7	7	NUM
dpc-4489	223	18	]	]	PUNCT
dpc-4489	223	19	.	.	PUNCT
dpc-4489	224	1	when	when	SCONJ
dpc-4489	224	2	considering	consider	VERB
dpc-4489	224	3	studies	study	NOUN
dpc-4489	224	4	that	that	PRON
dpc-4489	224	5	target	target	VERB
dpc-4489	224	6	panoptosis	panoptosis	NOUN
dpc-4489	224	7	,	,	PUNCT
dpc-4489	224	8	including	include	VERB
dpc-4489	224	9	the	the	DET
dpc-4489	224	10	one	one	NUM
dpc-4489	224	11	conducted	conduct	VERB
dpc-4489	224	12	by	by	ADP
dpc-4489	224	13	hu	hu	PROPN
dpc-4489	224	14	et	et	PROPN
dpc-4489	224	15	al	al	PROPN
dpc-4489	224	16	.	.	PROPN
dpc-4489	224	17	,	,	PUNCT
dpc-4489	224	18	together	together	ADV
dpc-4489	224	19	with	with	ADP
dpc-4489	224	20	our	our	PRON
dpc-4489	224	21	own	own	ADJ
dpc-4489	224	22	study	study	NOUN
dpc-4489	224	23	showing	show	VERB
dpc-4489	224	24	the	the	DET
dpc-4489	224	25	increased	increase	VERB
dpc-4489	224	26	presence	presence	NOUN
dpc-4489	224	27	of	of	ADP
dpc-4489	224	28	necrotic	necrotic	ADJ
dpc-4489	224	29	keratinocytes	keratinocyte	NOUN
dpc-4489	224	30	and	and	CCONJ
dpc-4489	224	31	their	their	PRON
dpc-4489	224	32	correlation	correlation	NOUN
dpc-4489	224	33	with	with	ADP
dpc-4489	224	34	pasi	pasi	NOUN
dpc-4489	224	35	scores	score	NOUN
dpc-4489	224	36	,	,	PUNCT
dpc-4489	224	37	we	we	PRON
dpc-4489	224	38	support	support	VERB
dpc-4489	224	39	the	the	DET
dpc-4489	224	40	idea	idea	NOUN
dpc-4489	224	41	that	that	SCONJ
dpc-4489	224	42	panoptosis	panoptosis	NOUN
dpc-4489	224	43	plays	play	VERB
dpc-4489	224	44	a	a	DET
dpc-4489	224	45	role	role	NOUN
dpc-4489	224	46	in	in	ADP
dpc-4489	224	47	psoriasis	psoriasis	NOUN
dpc-4489	224	48	’s	’s	PART
dpc-4489	224	49	pathogenesis	pathogenesis	NOUN
dpc-4489	224	50	.	.	PUNCT
dpc-4489	225	1	conclusions	conclusion	NOUN
dpc-4489	225	2	based	base	VERB
dpc-4489	225	3	on	on	ADP
dpc-4489	225	4	studies	study	NOUN
dpc-4489	225	5	demonstrating	demonstrate	VERB
dpc-4489	225	6	the	the	DET
dpc-4489	225	7	efficacy	efficacy	NOUN
dpc-4489	225	8	of	of	ADP
dpc-4489	225	9	drugs	drug	NOUN
dpc-4489	225	10	targeting	target	VERB
dpc-4489	225	11	panoptosis	panoptosis	NOUN
dpc-4489	225	12	,	,	PUNCT
dpc-4489	225	13	which	which	PRON
dpc-4489	225	14	has	have	AUX
dpc-4489	225	15	been	be	AUX
dpc-4489	225	16	shown	show	VERB
dpc-4489	225	17	to	to	PART
dpc-4489	225	18	contribute	contribute	VERB
dpc-4489	225	19	to	to	ADP
dpc-4489	225	20	psoriasis	psoriasis	NOUN
dpc-4489	225	21	’s	’s	PART
dpc-4489	225	22	pathogenesis	pathogenesis	NOUN
dpc-4489	225	23	,	,	PUNCT
dpc-4489	225	24	drugs	drug	NOUN
dpc-4489	225	25	targeting	target	VERB
dpc-4489	225	26	necrotic	necrotic	ADJ
dpc-4489	225	27	keratinocytes	keratinocyte	NOUN
dpc-4489	225	28	might	might	AUX
dpc-4489	225	29	be	be	AUX
dpc-4489	225	30	able	able	ADJ
dpc-4489	225	31	to	to	PART
dpc-4489	225	32	improve	improve	VERB
dpc-4489	225	33	the	the	DET
dpc-4489	225	34	personalized	personalized	ADJ
dpc-4489	225	35	treatment	treatment	NOUN
dpc-4489	225	36	of	of	ADP
dpc-4489	225	37	psoriasis	psoriasis	NOUN
dpc-4489	225	38	in	in	ADP
dpc-4489	225	39	the	the	DET
dpc-4489	225	40	future	future	NOUN
dpc-4489	226	1	[	[	X
dpc-4489	226	2	7	7	NUM
dpc-4489	226	3	]	]	PUNCT
dpc-4489	226	4	.	.	PUNCT
dpc-4489	227	1	at	at	ADP
dpc-4489	227	2	the	the	DET
dpc-4489	227	3	same	same	ADJ
dpc-4489	227	4	time	time	NOUN
dpc-4489	227	5	,	,	PUNCT
dpc-4489	227	6	the	the	DET
dpc-4489	227	7	exact	exact	ADJ
dpc-4489	227	8	function	function	NOUN
dpc-4489	227	9	of	of	ADP
dpc-4489	227	10	necrotic	necrotic	ADJ
dpc-4489	227	11	keratinocytes	keratinocyte	NOUN
dpc-4489	227	12	in	in	ADP
dpc-4489	227	13	psoriasis	psoriasis	NOUN
dpc-4489	227	14	’s	’s	PART
dpc-4489	227	15	pathogenesis	pathogenesis	NOUN
dpc-4489	227	16	remains	remains	AUX
dpc-4489	227	17	incompletely	incompletely	ADV
dpc-4489	227	18	understood	understand	VERB
dpc-4489	227	19	.	.	PUNCT
dpc-4489	228	1	in	in	ADP
dpc-4489	228	2	our	our	PRON
dpc-4489	228	3	study	study	NOUN
dpc-4489	228	4	,	,	PUNCT
dpc-4489	228	5	we	we	PRON
dpc-4489	228	6	quantitatively	quantitatively	ADV
dpc-4489	228	7	demonstrated	demonstrate	VERB
dpc-4489	228	8	the	the	DET
dpc-4489	228	9	presence	presence	NOUN
dpc-4489	228	10	of	of	ADP
dpc-4489	228	11	necrotic	necrotic	ADJ
dpc-4489	228	12	keratinocytes	keratinocyte	NOUN
dpc-4489	228	13	in	in	ADP
dpc-4489	228	14	the	the	DET
dpc-4489	228	15	skin	skin	NOUN
dpc-4489	228	16	of	of	ADP
dpc-4489	228	17	patients	patient	NOUN
dpc-4489	228	18	with	with	ADP
dpc-4489	228	19	psoriasis	psoriasis	NOUN
dpc-4489	228	20	.	.	PUNCT
dpc-4489	229	1	understanding	understand	VERB
dpc-4489	229	2	the	the	DET
dpc-4489	229	3	correlation	correlation	NOUN
dpc-4489	229	4	between	between	ADP
dpc-4489	229	5	those	those	DET
dpc-4489	229	6	necrotic	necrotic	ADJ
dpc-4489	229	7	keratinocytes	keratinocyte	NOUN
dpc-4489	229	8	and	and	CCONJ
dpc-4489	229	9	pasi	pasi	NOUN
dpc-4489	229	10	score	score	NOUN
dpc-4489	229	11	may	may	AUX
dpc-4489	229	12	be	be	AUX
dpc-4489	229	13	useful	useful	ADJ
dpc-4489	229	14	in	in	ADP
dpc-4489	229	15	determining	determine	VERB
dpc-4489	229	16	the	the	DET
dpc-4489	229	17	pathogenesis	pathogenesis	NOUN
dpc-4489	229	18	of	of	ADP
dpc-4489	229	19	psoriasis	psoriasis	NOUN
dpc-4489	229	20	.	.	PUNCT
dpc-4489	230	1	also	also	ADV
dpc-4489	230	2	,	,	PUNCT
dpc-4489	230	3	the	the	DET
dpc-4489	230	4	presence	presence	NOUN
dpc-4489	230	5	of	of	ADP
dpc-4489	230	6	superficially	superficially	ADV
dpc-4489	230	7	located	locate	VERB
dpc-4489	230	8	necrotic	necrotic	ADJ
dpc-4489	230	9	keratinocytes	keratinocyte	NOUN
dpc-4489	230	10	serves	serve	VERB
dpc-4489	230	11	as	as	ADP
dpc-4489	230	12	an	an	DET
dpc-4489	230	13	additional	additional	ADJ
dpc-4489	230	14	diagnostic	diagnostic	ADJ
dpc-4489	230	15	clue	clue	NOUN
dpc-4489	230	16	for	for	ADP
dpc-4489	230	17	psoriasis	psoriasis	NOUN
dpc-4489	230	18	.	.	PUNCT
dpc-4489	231	1	therefore	therefore	ADV
dpc-4489	231	2	,	,	PUNCT
dpc-4489	231	3	we	we	PRON
dpc-4489	231	4	look	look	VERB
dpc-4489	231	5	forward	forward	ADV
dpc-4489	231	6	to	to	ADP
dpc-4489	231	7	further	further	ADJ
dpc-4489	231	8	research	research	NOUN
dpc-4489	231	9	on	on	ADP
dpc-4489	231	10	those	those	DET
dpc-4489	231	11	intriguing	intriguing	ADJ
dpc-4489	231	12	cells	cell	NOUN
dpc-4489	231	13	and	and	CCONJ
dpc-4489	231	14	the	the	DET
dpc-4489	231	15	role	role	NOUN
dpc-4489	231	16	of	of	ADP
dpc-4489	231	17	panoptosis	panoptosis	NOUN
dpc-4489	231	18	in	in	ADP
dpc-4489	231	19	the	the	DET
dpc-4489	231	20	future	future	NOUN
dpc-4489	231	21	.	.	PUNCT
dpc-4489	232	1	references	reference	NOUN
dpc-4489	232	2	1	1	NUM
dpc-4489	232	3	.	.	PUNCT
dpc-4489	233	1	zhang	zhang	PROPN
dpc-4489	233	2	y	y	PROPN
dpc-4489	233	3	,	,	PUNCT
dpc-4489	233	4	xu	xu	PROPN
dpc-4489	234	1	x	x	PROPN
dpc-4489	234	2	,	,	PUNCT
dpc-4489	234	3	cheng	cheng	PROPN
dpc-4489	234	4	h	h	PROPN
dpc-4489	234	5	,	,	PUNCT
dpc-4489	234	6	zhou	zhou	PROPN
dpc-4489	234	7	f.	f.	PROPN
dpc-4489	234	8	aim2	aim2	PROPN
dpc-4489	234	9	and	and	CCONJ
dpc-4489	234	10	psoriasis	psoriasis	NOUN
dpc-4489	234	11	.	.	PUNCT
dpc-4489	235	1	front	front	ADJ
dpc-4489	235	2	immunol	immunol	NOUN
dpc-4489	235	3	.	.	PUNCT
dpc-4489	236	1	2023;14:1085448	2023;14:1085448	X
dpc-4489	236	2	.	.	PUNCT
dpc-4489	236	3	doi	doi	NOUN
dpc-4489	236	4	:	:	PUNCT
dpc-4489	236	5	10.3389	10.3389	NUM
dpc-4489	236	6	/	/	SYM
dpc-4489	236	7	fimmu.2023.1085448	fimmu.2023.1085448	NOUN
dpc-4489	236	8	.	.	PUNCT
dpc-4489	237	1	pmid	pmid	NOUN
dpc-4489	237	2	:	:	PUNCT
dpc-4489	237	3	36742336	36742336	NUM
dpc-4489	237	4	.	.	PUNCT
dpc-4489	238	1	2	2	X
dpc-4489	238	2	.	.	X
dpc-4489	238	3	albanesi	albanesi	PROPN
dpc-4489	238	4	c	c	X
dpc-4489	238	5	,	,	PUNCT
dpc-4489	238	6	madonna	madonna	PROPN
dpc-4489	238	7	s	s	PROPN
dpc-4489	238	8	,	,	PUNCT
dpc-4489	238	9	gisondi	gisondi	NOUN
dpc-4489	238	10	p	p	NOUN
dpc-4489	238	11	,	,	PUNCT
dpc-4489	238	12	girolomoni	girolomoni	ADJ
dpc-4489	238	13	g.	g.	PROPN
dpc-4489	238	14	the	the	DET
dpc-4489	238	15	interplay	interplay	NOUN
dpc-4489	238	16	between	between	ADP
dpc-4489	238	17	keratinocytes	keratinocyte	NOUN
dpc-4489	238	18	and	and	CCONJ
dpc-4489	238	19	immune	immune	ADJ
dpc-4489	238	20	cells	cell	NOUN
dpc-4489	238	21	in	in	ADP
dpc-4489	238	22	the	the	DET
dpc-4489	238	23	pathogenesis	pathogenesis	NOUN
dpc-4489	238	24	of	of	ADP
dpc-4489	238	25	psoriasis	psoriasis	NOUN
dpc-4489	238	26	.	.	PUNCT
dpc-4489	239	1	front	front	ADJ
dpc-4489	239	2	immunol	immunol	NOUN
dpc-4489	239	3	.	.	PUNCT
dpc-4489	240	1	2018;9:1549	2018;9:1549	NOUN
dpc-4489	240	2	.	.	PUNCT
dpc-4489	241	1	doi	doi	NOUN
dpc-4489	241	2	:	:	PUNCT
dpc-4489	241	3	10.3389	10.3389	NUM
dpc-4489	241	4	/fimmu.2018.01549	/fimmu.2018.01549	NOUN
dpc-4489	241	5	.	.	PUNCT
dpc-4489	242	1	pmid	pmid	NOUN
dpc-4489	242	2	:	:	PUNCT
dpc-4489	242	3	30034395	30034395	NUM
dpc-4489	242	4	.	.	PUNCT
dpc-4489	243	1	3	3	X
dpc-4489	243	2	.	.	PUNCT
dpc-4489	243	3	duan	duan	PROPN
dpc-4489	243	4	x	x	PROPN
dpc-4489	243	5	,	,	PUNCT
dpc-4489	243	6	liu	liu	PROPN
dpc-4489	243	7	x	x	PROPN
dpc-4489	243	8	,	,	PUNCT
dpc-4489	243	9	liu	liu	PROPN
dpc-4489	243	10	n	n	PROPN
dpc-4489	243	11	,	,	PUNCT
dpc-4489	243	12	et	et	PROPN
dpc-4489	243	13	al	al	PROPN
dpc-4489	243	14	.	.	PROPN
dpc-4489	243	15	inhibition	inhibition	NOUN
dpc-4489	243	16	of	of	ADP
dpc-4489	243	17	keratinocyte	keratinocyte	NOUN
dpc-4489	243	18	necroptosis	necroptosis	NOUN
dpc-4489	243	19	mediated	mediate	VERB
dpc-4489	243	20	by	by	ADP
dpc-4489	243	21	ripk1	ripk1	PROPN
dpc-4489	243	22	/	/	SYM
dpc-4489	243	23	ripk3	ripk3	NOUN
dpc-4489	243	24	/	/	SYM
dpc-4489	243	25	mlkl	mlkl	PROPN
dpc-4489	243	26	provides	provide	VERB
dpc-4489	243	27	a	a	DET
dpc-4489	243	28	protective	protective	ADJ
dpc-4489	243	29	effect	effect	NOUN
dpc-4489	243	30	against	against	ADP
dpc-4489	243	31	psoriatic	psoriatic	ADJ
dpc-4489	243	32	inflammation	inflammation	NOUN
dpc-4489	243	33	.	.	PUNCT
dpc-4489	244	1	cell	cell	NOUN
dpc-4489	244	2	death	death	NOUN
dpc-4489	244	3	dis	dis	PROPN
dpc-4489	244	4	.	.	PUNCT
dpc-4489	245	1	2020;11(2):134	2020;11(2):134	NUM
dpc-4489	245	2	.	.	PUNCT
dpc-4489	246	1	doi	doi	NOUN
dpc-4489	246	2	:	:	PUNCT
dpc-4489	246	3	10.1038	10.1038	NUM
dpc-4489	246	4	/	/	SYM
dpc-4489	246	5	s41419	s41419	NUM
dpc-4489	246	6	-	-	PUNCT
dpc-4489	246	7	020	020	NUM
dpc-4489	246	8	-	-	PUNCT
dpc-4489	246	9	2328	2328	NUM
dpc-4489	246	10	-	-	PUNCT
dpc-4489	246	11	0	0	NUM
dpc-4489	246	12	.	.	PUNCT
dpc-4489	247	1	pmid	pmid	NOUN
dpc-4489	247	2	:	:	PUNCT
dpc-4489	247	3	32075957	32075957	NUM
dpc-4489	247	4	.	.	PUNCT
dpc-4489	248	1	4	4	X
dpc-4489	248	2	.	.	X
dpc-4489	248	3	wang	wang	PROPN
dpc-4489	248	4	l	l	PROPN
dpc-4489	248	5	,	,	PUNCT
dpc-4489	248	6	zhu	zhu	PROPN
dpc-4489	248	7	y	y	PROPN
dpc-4489	248	8	,	,	PUNCT
dpc-4489	248	9	zhang	zhang	PROPN
dpc-4489	248	10	l	l	PROPN
dpc-4489	248	11	,	,	PUNCT
dpc-4489	248	12	et	et	PROPN
dpc-4489	248	13	al	al	PROPN
dpc-4489	248	14	.	.	PROPN
dpc-4489	248	15	mechanisms	mechanism	NOUN
dpc-4489	248	16	of	of	ADP
dpc-4489	248	17	panoptosis	panoptosis	NOUN
dpc-4489	248	18	and	and	CCONJ
dpc-4489	248	19	relevant	relevant	ADJ
dpc-4489	248	20	small	small	ADJ
dpc-4489	248	21	-	-	PUNCT
dpc-4489	248	22	molecule	molecule	NOUN
dpc-4489	248	23	compounds	compound	NOUN
dpc-4489	248	24	for	for	ADP
dpc-4489	248	25	fighting	fight	VERB
dpc-4489	248	26	diseases	disease	NOUN
dpc-4489	248	27	.	.	PUNCT
dpc-4489	249	1	cell	cell	NOUN
dpc-4489	249	2	death	death	NOUN
dpc-4489	249	3	dis	dis	PROPN
dpc-4489	249	4	.	.	PUNCT
dpc-4489	250	1	2023;14(12):851	2023;14(12):851	X
dpc-4489	250	2	.	.	PUNCT
dpc-4489	250	3	doi	doi	NOUN
dpc-4489	250	4	:	:	PUNCT
dpc-4489	250	5	10.1038	10.1038	NUM
dpc-4489	250	6	/	/	SYM
dpc-4489	250	7	s41419	s41419	NUM
dpc-4489	250	8	-	-	PUNCT
dpc-4489	250	9	023	023	NUM
dpc-4489	250	10	-	-	PUNCT
dpc-4489	250	11	06370	06370	NUM
dpc-4489	250	12	-	-	PUNCT
dpc-4489	250	13	2	2	NUM
dpc-4489	250	14	.	.	PUNCT
dpc-4489	251	1	pmid	pmid	NOUN
dpc-4489	251	2	:	:	PUNCT
dpc-4489	251	3	38129399	38129399	NUM
dpc-4489	251	4	.	.	PUNCT
dpc-4489	252	1	5	5	X
dpc-4489	252	2	.	.	X
dpc-4489	252	3	lu	lu	PROPN
dpc-4489	252	4	l	l	PROPN
dpc-4489	252	5	,	,	PUNCT
dpc-4489	252	6	zhang	zhang	PROPN
dpc-4489	252	7	b	b	PROPN
dpc-4489	252	8	,	,	PUNCT
dpc-4489	252	9	shi	shi	PROPN
dpc-4489	252	10	m	m	PROPN
dpc-4489	252	11	,	,	PUNCT
dpc-4489	252	12	liu	liu	PROPN
dpc-4489	252	13	a.	a.	NOUN
dpc-4489	252	14	identification	identification	NOUN
dpc-4489	252	15	of	of	ADP
dpc-4489	252	16	panoptosisrelated	panoptosisrelate	VERB
dpc-4489	252	17	biomarkers	biomarker	NOUN
dpc-4489	252	18	and	and	CCONJ
dpc-4489	252	19	immune	immune	ADJ
dpc-4489	252	20	infiltration	infiltration	NOUN
dpc-4489	252	21	characteristics	characteristic	NOUN
dpc-4489	252	22	in	in	ADP
dpc-4489	252	23	psoriasis	psoriasis	NOUN
dpc-4489	252	24	.	.	PUNCT
dpc-4489	253	1	medicine	medicine	NOUN
dpc-4489	253	2	(	(	PUNCT
dpc-4489	253	3	baltimore	baltimore	PROPN
dpc-4489	253	4	)	)	PUNCT
dpc-4489	253	5	.	.	PUNCT
dpc-4489	254	1	2023;102(42):e35627	2023;102(42):e35627	NOUN
dpc-4489	254	2	.	.	PUNCT
dpc-4489	255	1	doi	doi	NOUN
dpc-4489	255	2	:	:	PUNCT
dpc-4489	255	3	10.1097/	10.1097/	NUM
dpc-4489	255	4	md.0000000000035627	md.0000000000035627	PROPN
dpc-4489	255	5	.	.	PUNCT
dpc-4489	256	1	pmid	pmid	PROPN
dpc-4489	256	2	:	:	PUNCT
dpc-4489	256	3	37861483	37861483	NUM
dpc-4489	256	4	.	.	PUNCT
dpc-4489	257	1	6	6	X
dpc-4489	257	2	.	.	X
dpc-4489	257	3	gullett	gullett	PROPN
dpc-4489	257	4	jm	jm	PROPN
dpc-4489	257	5	,	,	PUNCT
dpc-4489	257	6	tweedell	tweedell	NOUN
dpc-4489	257	7	re	re	NOUN
dpc-4489	257	8	,	,	PUNCT
dpc-4489	257	9	kanneganti	kanneganti	ADJ
dpc-4489	257	10	td	td	NOUN
dpc-4489	257	11	.	.	PUNCT
dpc-4489	258	1	it	it	PRON
dpc-4489	258	2	’s	’	VERB
dpc-4489	258	3	all	all	PRON
dpc-4489	258	4	in	in	ADP
dpc-4489	258	5	the	the	DET
dpc-4489	258	6	pan	pan	NOUN
dpc-4489	258	7	:	:	PUNCT
dpc-4489	258	8	crosstalk	crosstalk	NOUN
dpc-4489	258	9	,	,	PUNCT
dpc-4489	258	10	plasticity	plasticity	NOUN
dpc-4489	258	11	,	,	PUNCT
dpc-4489	258	12	redundancies	redundancy	NOUN
dpc-4489	258	13	,	,	PUNCT
dpc-4489	258	14	switches	switch	NOUN
dpc-4489	258	15	,	,	PUNCT
dpc-4489	258	16	and	and	CCONJ
dpc-4489	258	17	interconnectedness	interconnectedness	NOUN
dpc-4489	258	18	encompassed	encompass	VERB
dpc-4489	258	19	by	by	ADP
dpc-4489	258	20	panoptosis	panoptosis	NOUN
dpc-4489	258	21	underlying	underlie	VERB
dpc-4489	258	22	the	the	DET
dpc-4489	258	23	totality	totality	NOUN
dpc-4489	258	24	of	of	ADP
dpc-4489	258	25	cell	cell	NOUN
dpc-4489	258	26	death	death	NOUN
dpc-4489	258	27	-	-	PUNCT
dpc-4489	258	28	associated	associate	VERB
dpc-4489	258	29	biological	biological	ADJ
dpc-4489	258	30	effects	effect	NOUN
dpc-4489	258	31	.	.	PUNCT
dpc-4489	259	1	cells	cell	NOUN
dpc-4489	259	2	.	.	PUNCT
dpc-4489	260	1	2022;11(9):1495	2022;11(9):1495	NUM
dpc-4489	260	2	.	.	PUNCT
dpc-4489	261	1	doi	doi	NOUN
dpc-4489	261	2	:	:	PUNCT
dpc-4489	261	3	10.3390	10.3390	NUM
dpc-4489	261	4	/	/	SYM
dpc-4489	261	5	cells11091495	cells11091495	PROPN
dpc-4489	261	6	.	.	PUNCT
dpc-4489	262	1	pmid	pmid	NOUN
dpc-4489	262	2	:	:	PUNCT
dpc-4489	262	3	35563804	35563804	NUM
dpc-4489	262	4	.	.	PUNCT
dpc-4489	263	1	7	7	X
dpc-4489	263	2	.	.	X
dpc-4489	263	3	hu	hu	PROPN
dpc-4489	264	1	xm	xm	PROPN
dpc-4489	264	2	,	,	PUNCT
dpc-4489	264	3	zheng	zheng	PROPN
dpc-4489	264	4	s	s	PROPN
dpc-4489	264	5	,	,	PUNCT
dpc-4489	264	6	zhang	zhang	PROPN
dpc-4489	264	7	q	q	PROPN
dpc-4489	264	8	,	,	PUNCT
dpc-4489	264	9	et	et	PROPN
dpc-4489	264	10	al	al	PROPN
dpc-4489	264	11	.	.	PUNCT
dpc-4489	264	12	panoptosis	panoptosis	NOUN
dpc-4489	264	13	signaling	signal	VERB
dpc-4489	264	14	enables	enable	VERB
dpc-4489	264	15	broad	broad	ADJ
dpc-4489	264	16	immune	immune	ADJ
dpc-4489	264	17	response	response	NOUN
dpc-4489	264	18	in	in	ADP
dpc-4489	264	19	psoriasis	psoriasis	NOUN
dpc-4489	264	20	:	:	PUNCT
dpc-4489	264	21	from	from	ADP
dpc-4489	264	22	pathogenesis	pathogenesis	NOUN
dpc-4489	264	23	to	to	ADP
dpc-4489	264	24	new	new	ADJ